stock_PFE r_up	biotech:1 losses:1 deal:2 point:1 almost:3 agreed:2 reduce:3 results:1 rose:2 2.9:1 licensing:2 have:4 stronger-than-expected:1 seek:3 market:3 impact:1 cents:1 said:1 biotechnology:1 $:5 pay:2 45:3 had:3 third-quarter:2 declined:1 their:3 potential:1 earnings:1 which:2 under:1 expected:1 investors:1 net:1 500:1 stock:4 24:1 after:1 's:1 plans:3 income:1 share:1 company:2 million:2 but:1 pressure:1 fell:1 invested:3 additional:1 they:3 70:3 assessed:1 100:1 volatility:3 billion:1 7:1 assets:3 rights:2 could:2 futures:2 round:1 trimmed:1 while:2 points:2 products:2 pension:3 350:2 easing:1 reduced:3 once:3
stock_PFE r_down	0.9:1 prevent:1 boosted:1 financial:1 cancer:4 heart:1 had:1 0.8:1 blood-thinning:1 replace:1 down:1 rate:1 actively:1 trading:2 taking:2 setbacks:1 star:1 makers:2 remain:1 1:1 use:1 findings:1 lead:3 sector:3 lackluster:1 warfarin:1 while:1 shares:1 than:3 looking:1 lost:1 compelling:1 take:2 which:1 hormones:4 women:4 500:1 higher:2 decliners:1 used:1 's:1 widely:1 combination:3 whose:1 strokes:1 earnings:2 after:3 stronger-than-expected:1 falls:1 worries:1 fell:2 therapy:3 breast:3 despite:1 report:2 using:2 cases:1 stocks:1 approved:2 stage:2 closed:1 rhythms:1 showed:1 irregular:1 did:2 its:1 could:1 companies:2 disease:2 drug:7 maker:2 n't:3 --:2 patients:1 session:1 diagnosed:2 were:3 landmark:1 downward:2 slightly:1 study:1
stock_PFE r_up	prevent:1 cancer:1 heart:1 labels:1 blood-thinning:1 used:1 cardiovascular:1 said:1 $:1 pay:1 stake:1 40:3 strokes:1 potential:1 treat:1 added:1 's:1 risk:1 generic-drug:1 warnings:1 drugs:1 million:1 problems:1 240:1 prostate:1 approved:1 diabetes:1 rhythms:1 irregular:1 --:1 drug:1 patients:1 maker:1
stock_PFE r_down	sector:1 saying:1 annual:1 developed:1 share:2 around:1 replace:1 high:1 peer:1 growth:1 blockbuster:1 its:2 viewed:1 before:1 setbacks:1 use:1 slow:1 adds:1 $:1 takeover:2 start:1 patent:1 make:1 stars:2 detail:1 next:1 confident:1 investigational:1 much:1 development:1 earnings:2 widely:1 which:1 2015:1 clinical:1 flow:1 several:1 said:2 engine:2 franc:1 program:1 million:3 's:3 plans:1 protection:1 started:1 sights:1 company:2 rise:2 took:1 buyback:2 lift:2 wake:1 propelling:2 report:2 world:1 hovers:1 inhibitor:1 off:1 target:1 effective:1 --:2 region:2 larger:1 itself:1 cash:1 drug:2 loses:1 thought:1 became:2 can:1 evaluating:1 usually:1 800:1 block:1 latest:2
stock_PFE r_down	antibiotic:1 bottomline:1 sales:1 helped:1 businesses:1 year:1 its:2 said:2 20:3 generic:1 research:1 finally:1 version:1 launching:1 higher:1 gaining:1 after:1 's:1 swell:1 earlier:1 approval:1 second-quarter:1 contract:1 injectable:1
stock_PFE r_up	all:1 into:1 move:1 sales:3 due:1 itself:2 shares:1 approval:1 been:1 throughout:1 its:3 sell:2 unusual:1 said:1 additional:1 profit:3 trying:1 had:2 third-quarter:1 comments:1 yet:1 late:1 their:1 without:1 details:1 has:1 stock:1 flat:2 premium:1 same:1 drugs:1 big:1 company:2 after:2 drug:2 part:1 nearly:1 half:1 last:1 month:1 approved:1 raising:1 anemia:1 value:1 lower:3 made:1 attempt:1 success:1 lost:1 launch:1 --:1 cash:1 reports:3 n't:1 takeover:1 treatment:1 analysts:1 time:1 built:1
stock_PFE r_down	agreed:2 results:2 ended:1 through:1 thanks:2 its:6 osteoporosis:4 increase:1 $:6 rose:2 expectations:4 analyst:2 charge:2 denosumab:2 criminal:2 details:2 government:2 background:1 during:2 lymphoma:1 disappointed:2 treating:1 --:3 companies:1 fewer:1 did:1 benefit:1 settle:2 small:1 works:1 shed:1 because:1 product:1 challenges:1 individual:2 plead:2 regulator:1 said:1 profit:1 shares:1 research:1 cell:1 investigation:2 new:1 net:2 evaluation:1 full:2 decline:1 million:2 diagnostic:1 operating:2 key:4 manufacturing:2 manufacturer:1 quarter:2 improved:1 triggers:1 guilty:2 drug:8 products:2 stand:1 maker:2 first:2 comment:1 cancer:1 into:1 per-share:1 tools:1 pharmaceutical:1 strong:2 third-quarter:3 submit:1 more:1 750:6 company:3 exactly:1 catalyst:2 known:2 former:2 posted:1 11:6 launch:2 n't:1 below:2 outstanding:1 exceeded:2 sales:6 evidence:1 dropped:2 seek:1 any:1 pay:2 also:2 earnings:1 income:2 effectiveness:1 plant:2 's:11 though:1 cost-effectiveness:1 recent:2 lower:1 light:1 disease:1 costs:3 came:2
stock_PFE r_down	emerging:1 agreed:1 lack:1 discovered:1 ended:1 manager:1 research:1 its:2 increase:1 $:4 charge:1 treatment:1 96:1 2010:1 meant:1 government:1 lymphoma:2 treating:1 name:1 --:1 companies:1 did:1 benefit:1 settle:1 lapses:1 shed:1 because:1 plead:1 regulator:1 said:2 forecast:1 cell:1 investigation:1 evaluation:1 available:1 led:1 million:2 diagnostic:1 manufacturing:1 manufacturer:1 payout:1 improved:1 would:1 triggers:1 funded:1 drug:3 stand:1 raised:1 cancer:1 tools:1 pharmaceutical:2 strong:1 her:1 cost-effectiveness:1 third-quarter:1 submit:1 resists:1 recommend:1 markets:1 750:3 efficacy:1 drugs:1 company:1 exactly:1 former:1 posted:1 regimen:1 made:1 publicly:1 n't:2 guilty:1 sales:1 evidence:1 full-year:1 seek:1 any:1 pay:1 detail:1 also:1 which:2 effectiveness:1 brand:1 week:1 criminal:1 plant:2 's:13 treatments:1 driven:1 data:1 diabetes:1 light:1 disease:1 2002:1 profits:1
stock_PFE r_up	increasingly:1 agreed:2 move:1 results:1 competitive:1 discovered:1 manager:1 businesses:1 shares:1 its:1 $:7 marks:1 has:1 big:1 early:1 setback:1 they:1 owning:1 lapses:1 speculation:1 shunned:1 deal:1 trend:1 some:1 recently:1 comments:1 research:1 access:1 market:2 led:1 business:1 hefty:1 lessens:1 million:2 step:1 franchise:1 payout:1 900:1 her:1 restructuring:1 drug:1 carries:1 analysts:1 efforts:1 maker:1 venture-backed:1 been:1 shutdown:1 throughout:1 shrinking:1 unit:1 would:1 long:1 orthopedics:1 diabetes:1 buy:2 company:2 all-cash:1 analyst:1 buying:1 96:1 valued:1 up:1 neurovascular:2 risks:1 following:1 1.5:2 investors:1 sales:1 say:1 tag:1 have:1 sell:1 develop:1 1:1 potential:1 details:1 week:1 plant:1 's:6 price:1 after:1 treatments:1 exposure:1 billion:3 cover:1 2002:1 push:1 latest:1
stock_PFE r_down	associated:2 help:1 providers:1 win:1 energy:1 health-care:1 results:1 related:1 two:2 widened:2 defense:1 tablets:1 reports:3 follows:1 alternative:1 blockbuster:2 its:2 uncertainties:1 unusual:1 said:2 bottles:2 distributed:1 due:2 supplied:1 linked:1 also:1 which:2 quarterly:1 numerous:1 cited:1 third-party:1 stock:1 product:2 infrastructure:1 's:3 plans:1 again:2 may:1 odor:2 were:3 pressure:1 incident:1 complaints:1 month:1 earlier:1 manufacturer:1 customer:1 boost:1 could:2 drug:4 keep:1 prior:1 while:1 bottle:1 recall:3 recalls:1 maker:2 latest:1
stock_PFE r_up	in-house:1 focus:1 years:1 held:1 session:1 including:1 cuts:1 its:1 $:1 candidate:1 employee:1 2.16:1 hope:1 earnings:1 then:1 complaint:1 bonds:1 big:1 whistleblower:1 valued:1 report:1 --:1 recalls:1 heavy:1 deal:1 warns:1 cash:1 see:1 trading:1 lawyer:1 multimillion-dollar:1 further:1 said:1 lead:1 shares:2 firms:1 dominate:1 originated:1 odor:1 notable:1 active:1 debt:1 payout:1 drug:3 requests:1 reaping:1 number:1 privately:1 market:1 little:1 likely:1 outbreaks:1 interviews:1 there:1 clinical:1 wrongdoing:1 more:1 roundup:1 buy:1 way:1 company:2 races:1 plague:1 catalyst:1 suspected:1 he:1 fraud:1 elections:1 while:1 plunges:1 have:1 investors:1 helped:1 file:1 rally:1 inflows:1 stake:1 also:1 details:1 's:5 looming:1 moving:1 stocks:2 data:2 recent:1 billion:1 bottle:1
stock_PFE r_down	operations:5 sector:2 help:3 heavily:1 industrials:1 in-house:1 results:4 not:2 manager:1 session:2 including:2 legal:1 broader:2 battle:1 exclusivity:3 fine:1 its:14 decade:1 litigation:1 giant:1 cut:3 $:11 rose:4 headed:3 had:1 29:1 analyst:1 beat:1 only:1 program:2 surprise:1 rosy:1 premarket:1 400:1 employee:1 2.16:1 he:3 2011:1 achieve:1 gave:1 giants:1 then:1 updated:2 financial-services:2 gains:3 close:1 get:1 asbestos:5 big:1 whistleblower:1 rise:1 focus:2 objective:1 valued:1 they:1 despite:3 10-year:1 world:3 exact:1 day:2 loss:3 end:2 approach:1 held:1 --:7 edge:1 drop:3 companies:1 tap:1 settle:1 cholesterol:4 small:1 businesses:1 higher:4 noted:1 enforcement:1 privately:1 week:2 because:4 crowd:1 acquired:3 estimates:1 related:1 elections:8 past:1 growth:2 trading:1 projections:1 lawyer:1 year:11 multiple:1 insurance:1 declined:1 out:3 n't:1 said:6 proceeding:1 bullish:1 profit:10 jumped:4 take:1 integration:1 comments:2 research:3 election:1 35:1 500:2 health:1 generics:1 capital:1 new:3 strategist:1 we:1 earlier:3 risen:1 pharmaceutical:1 dividends:1 dental:1 million:2 points:7 bulls:1 drug:8 takeover:1 would:1 boosting:1 dividend:1 100:2 strong:2 1.47:1 arthritis:1 panel:1 payout:1 reaction:1 39:4 quarter:1 last:7 beef:3 reported:3 double-digit:3 reports:2 products:3 analysts:1 wiped:2 faces:3 regulator:1 turf:1 slightly:1 maker:3 first:2 comment:1 among:1 major:1 revenue:3 two-day:1 coming:1 while:1 awaited:2 third-quarter:7 down:2 everyone:1 multiple-sclerosis:1 edged:2 article:1 68:4 equity:1 throughout:1 positive:1 market:4 conference:1 decline:1 management:1 deal:1 merger-related:4 spending:1 unknown:1 interviews:1 night:1 due:1 flat:2 next:1 confident:1 much:1 call:2 income:1 way:2 rates:1 percentage:3 closed:2 markets:3 gained:2 today:1 more:2 wants:2 billion:8 ``:3 buy:1 wrongdoing:1 offering:1 treat:1 company:6 under:1 pipeline:4 else:1 reaping:1 races:1 gain:1 hopes:1 suspected:1 than:1 especially:2 sound:1 '':3 fraud:1 effective:1 midterm:6 meeting:3 polls:3 chief:1 up:3 air:1 flagship:3 near:1 complaint:1 hope:1 familiar:1 necessarily:1 adjusted:1 2012:6 spotlight:1 acquisition:1 published:1 breakeven:1 climbed:3 associated:1 write-downs:1 investors:1 voters:3 almost:2 well:1 multimillion-dollar:1 tax:1 sales:10 0.6:1 weighed:4 dropped:4 file:1 our:1 ready:1 sharp:1 recommendations:1 result:1 11:1 'll:1 generic:2 balloon:1 able:1 detail:2 1:1 also:1 high:1 other:3 5:1 details:3 which:1 largest:3 interview:1 outlook:1 becoming:1 stock:9 development:1 begin:1 acquire:1 's:22 tried:1 generic-drug:1 though:1 earnings:6 price:2 outcome:1 losses:2 driven:2 fell:3 debt:1 70:9 nothing:1 such:1 stocks:3 barrel:1 4:2 ago:3 purchase:4 booked:1 happening:1 scenario:1 charges:5 synergies:1 futures:11 sclerosis:1 others:1 rather:1 priced:1 costs:6 so:1 time:1 jittery:2 weigh:2 diversify:3 2009:1 corporate:1 profits:1
stock_PFE r_up	company’s:1 saying:1 consolidated:1 dollar:1 results:2 quarters:1 leads:2 ended:1 its:1 decade:1 $:1 surprises:2 advisories:2 gains:1 asbestos:1 anticipated:1 nearly:1 --:1 companies:2 doubled:1 popular:1 quarter:1 week:1 because:1 deal:1 euro-zone:1 second:1 growth:1 usher:1 year:3 declined:1 out:1 said:1 profit:2 jumped:1 version:1 net:1 exchange:1 marketing:1 blue-chips:1 drug:3 news:1 strong:1 roundup:1 39:1 last:2 region:1 climbed:1 according:1 reports:1 foreign:1 survey:1 rose:1 first:1 major:1 wave:1 awaited:1 68:1 pharmaceutical:1 industrials:1 merger-related:1 spending:1 leading:1 third-quarter:1 stock:1 expected:1 meeting:1 more:1 firm:1 gain:1 than:1 weighed:1 midterm:2 elections:2 future:1 following:1 interest-rate:1 weaker:1 investors:2 sales:1 helped:2 dropped:1 generic:1 politicians:1 earnings:2 higher:4 development:1 's:3 boosted:1 earlier:1 70:3 pair:1 stocks:4 data:1 billion:1 purchase:1 manufacturing:1 charges:1 hikes:1 points:1 time:1 corporate:1 latest:1
stock_PFE r_down	doldrums:2 even:2 's:4 results:2 enough:2 cure:2 election:2 not:2 stocks:2 might:2
stock_PFE r_down	sagging:1 intraday:1 cheered:1 's:1 since:1 investors:1 saw:1 rise:1 first:1 its:1 5:1 economy:1 200-point:1 stocks:1 effort:1 stimulate:1 soared:1 latest:1
stock_PFE r_down	less:1 move:1 through:1 7.7:3 its:2 clearance:1 $:6 had:2 late:1 candidates:1 treatment:1 mid-stage:1 potentially:1 has:3 killer:1 early:1 wreckage:1 --:1 16:1 morning:1 including:1 noted:1 development:1 set:1 sifting:1 acquired:1 hard:1 some:1 competition:1 cash:1 3.6:1 see:1 year:2 's:3 subject:1 pressured:1 profit:2 shares:1 health:1 downturn:1 public:1 300:1 million:4 leadership:1 focused:1 regulatory:1 received:1 hits:1 contract:1 trial:1 analysts:1 maker:1 industrial:1 revenue:2 into:2 hearing:1 down:1 weather:1 been:1 foray:1 1990s:1 market:2 would:2 initial:1 third-quarter:1 least:1 next:2 start:1 doubt:1 expected:1 clinical:1 historically:1 painful:1 drugs:1 acquire:1 but:1 fund:1 than:1 posted:1 paying:1 made:1 17:1 versions:1 19:1 up:1 patients:1 bet:1 dropped:1 due:1 slid:1 investors:1 cents:2 share:2 something:1 have:1 seen:1 technology:1 mutual:1 recovery:1 generic:1 lately:1 role:1 boon:1 stock:1 week:1 pain:1 earlier:1 fell:1 phase:1 ties:1 stocks:2 capitalize:1 diabetes:1 billion:1 task:1 off:1 stem-cell:1 disease:1 agreeing:1 800:1 typical:1
stock_PFE r_down	attorney:3 because:1 statements:4 consider:1 small:1 into:2 influence:2 one:4 down:1 contract:1 through:1 shares:1 lawyer:1 news:1 false:4 counts:2 throughout:1 mutual:1 documents:2 proceeding:2 federal:3 agency:2 had:1 handed:1 indexes:2 start:1 investigation:2 candidates:1 details:1 statement:1 grand:1 falling:1 indictment:1 's:2 company:2 announced:1 stock:1 illegally:2 jury:1 business:1 government:1 may:1 price:1 tumbles:2 fund:1 regulators:2 4th:1 focused:1 updates:1 background:1 fall:2 not:1 prescription:2 obstructing:4 beginning:1 former:3 count:4 four:2 stocks:1 task:1 prosecutors:2 whether:2 official:2 sifting:1 drug:8 does:1 lose:1 promoted:2 making:4 wreckage:1 maker:1 charged:4
stock_PFE r_up	said:1 's:4 ahead:1 schedule:1 trials:1 company:1 disease:2 drug:2 n't:1 running:1 clinical:1 been:1 have:1 termination:1 second:1 affected:1 studies:1 experimental:1 recent:1
stock_PFE r_down	exceed:2 deal:1 point:1 sales:1 '':2 expect:1 determine:1 year:1 's:3 spokeswoman:1 said:2 early:1 additional:1 original:1 intends:1 reduction:1 eliminate:2 which:1 largest:1 more:1 ``:2 jobs:2 our:1 company:1 measures:1 workforce:1 expects:1 15:1 we:1 part:1 too:1 regulatory:1 world:1 now:1 than:1 purchase:1 last:1 target:2 did:1 many:1 drug:1 maker:2 n't:1 connection:1 planned:1 filing:1
stock_PFE r_down	stake:1 decision:1 do:1 evaluate:1 people:1 back:1 6.7:3 against:1 defense:1 including:2 names:1 part:1 table:1 18.5:1 yet:1 matter:1 previous:1 5.1:2 compared:1 end:1 $:6 their:1 investing:1 surprises:1 top:1 there:1 comments:1 its:1 late:1 few:1 revenue:1 other:1 come:1 disclosed:1 interest:1 boosted:1 has:1 drug:1 pursue:1 his:1 's:5 increased:1 wanted:1 reaching:1 billionaire:1 company:1 largest:1 possible:1 but:1 fund:1 explored:1 wake:1 background:1 regulatory:1 world:1 hedge:1 stocks:1 investor:1 he:1 billion:2 alternatives:1 bid:1 hostile:1 third:1 --:4 came:1 could:1 30:4 companies:1 according:2 value:1 filing:1 whether:1 which:1 maker:1 so:1 analysts:1 familiar:1 were:1 biotechnology:1 quarter:2 out:1 blue-chip:1 acquisition:1 unlikely:1
stock_PFE r_down	investors:1 caffeinated:1 6.7:1 's:2 moves:1 increased:1 compared:1 end:1 $:1 blue-chip:1 stake:1 research:1 announce:2 lawmakers:1 previous:1 discovery:2 urge:1 his:1 star:1 filings:1 boosted:1 collaboration:2 fund:1 link:1 new:2 hedge:1 stocks:1 spur:2 he:1 billion:1 reveal:1 third:1 medicines:2 drinks:1 trial:1 act:1 worries:1 quarter:2 latest:1
stock_PFE r_down	cuts:2 research:1 children:1 staff:1 setbacks:2 announcement:1 giant:1 cut:2 pharma:1 parents:1 include:2 unprecedented:1 good:4 hit:1 around:2 returning:1 overall:1 world:1 now:1 investor:1 lost:1 --:2 bad:4 cholesterol:4 downward:1 work:1 force:1 significantly:4 series:1 closures:2 cost:3 's:12 2.7:1 said:1 adds:1 factory:2 its:3 safety:5 restoring:2 shows:1 franc:2 jobs:1 marketing:1 pressure:1 job:2 base:3 boosting:4 manufacturing:1 $:1 met:4 study:4 restructuring:2 drug:5 levels:4 products:1 faces:1 maker:2 experimental:4 first:1 cancer:1 revamp:1 aimed:2 market:1 long:1 6:2 biggest:1 drugstore:1 more:1 firm:1 lowering:4 buy:1 drugs:1 company:1 billion:2 goals:4 prices:1 kind:4 has:2 showed:4 recall:1 shelves:1 n't:1 while:4 launched:1 detailed:1 been:1 again:1 struggles:1 concerns:1 details:1 difficult:1 product:1 pain:1 after:1 convincing:1 involving:4 tricky:1 task:2 4,800:3 edge:1
stock_PFE r_up	work:1 force:1 significantly:1 people:1 bad:1 back:1 edge:1 due:1 good:1 have:1 pain:1 children:1 market:1 again:1 cut:1 private-label:1 while:1 long:1 its:2 concerns:2 safety:3 6:1 parents:1 has:1 drugstore:1 filled:1 shows:1 firm:1 lowering:1 buy:1 's:6 returning:1 drugs:1 difficult:1 void:1 after:1 convincing:1 met:1 involving:1 goals:1 boosting:1 scrapped:1 despite:1 now:1 investor:1 tricky:1 kind:1 task:2 announcement:1 showed:1 created:1 recall:2 study:1 shelves:1 lost:1 drug:2 n't:1 more:1 switch:1 levels:1 products:1 developing:1 faces:1 cholesterol:1 maker:1 experimental:1 first:1
stock_PFE r_down	all:1 because:1 timing:1 supplement:1 against:2 have:1 approval:1 rally:1 improvement:1 sexual:1 its:1 said:1 syndrome:1 consumers:1 no:1 trials:1 anti-clotting:1 makers:1 apixaban:1 other:1 performance:1 gets:1 touted:1 ingredient:1 hormone:1 prescriptions:1 rules:1 after:1 therapy:1 they:1 new:1 active:1 using:1 meaningful:1 advanced:1 recent:1 natural:1 showed:1 ended:1 --:1 warned:1 could:1 drug:3 patients:2 dietary:1 enhance:1 male:1 changes:1
stock_PFE r_down	sector:1 help:1 deal:1 exploring:1 civil:1 parties:1 back:1 brought:1 have:1 year:1 should:1 next:1 relatively:1 pharmaceutical:1 $:3 federal:1 alleged:1 long:1 suits:1 also:1 3:3 other:1 treasury:1 new:1 might:1 2010:1 fiscal:1 continues:1 's:1 government:1 after:1 break:1 most:2 acquisitions:1 come:1 structure:1 recent:1 billion:1 assess:1 companies:1 quiet:1 against:1 deadlock:1 options:1 mergers:1
stock_PFE r_down	help:2 deal:2 exploring:2 civil:1 parties:2 brought:1 have:1 year:1 $:3 federal:1 alleged:1 long:2 suits:1 also:2 3:3 other:2 treasury:1 new:2 might:2 fiscal:1 government:1 continues:2 break:2 most:2 structure:2 recent:1 billion:1 assess:2 companies:1 against:1 deadlock:2 options:2
stock_PFE r_up	project:1 we:1 's:1 suggestion:1 great:1 next:1 director:1 thing:1 have:1 works:1 out:1
stock_PFE r_down	named:6 set:1 mandatory:2 people:2 executive:5 appoints:1 years:2 down:2 accused:1 names:1 policy:2 1990s:1 plan:2 its:4 comments:1 turnover:1 1:4 retirement:2 doctor:1 retiring:1 graph:1 veteran:2 since:2 chief:5 legal:1 analyst:1 current:2 industry:1 old:2 compensate:1 board:4 widely:2 under:2 expected:2 new:6 2011:2 company:4 chairman:4 injured:1 move:2 's:5 seeking:1 replacing:2 sixth:1 price:1 counsel:1 but:2 65:2 fund:1 step:2 weight-loss:1 updates:1 background:2 president:4 beginning:1 pharmaceutical:1 he:2 regimen:1 prosecutors:1 third:1 succeed:1 records:1 55:2 turns:2 medical:1 longtime:1 up:1 drug:2 facing:2 while:2 continue:4 due:2 succession:2 popular:1 claims:1 stock:1 starting:4 maker:1 signaling:2
stock_PFE r_up	named:1 right:1 shortcuts:1 twists:1 executive:1 some:1 its:1 current:1 fit:1 while:1 1:1 board:1 new:1 you:1 chairman:1 full:1 but:1 gifts:1 detours:1 not:1 always:1 keep:1 chief:1 continue:1 can:1 turns:1 starting:1 investments:1 road:1
stock_PFE r_down	saying:2 being:2 probe:2 results:1 years:1 four:1 manager:1 planning:1 identify:1 exacerbate:1 its:2 6.8:1 25:1 had:1 signals:1 treatment:2 under:2 has:3 2010:1 good:1 far:1 big:2 new:2 hedge:2 him:1 loss:2 --:1 tumors:1 annually:1 minimal:1 small:2 signing:1 people:1 testing:1 further:1 reinsurer:1 makers:1 said:3 crucial:1 per:1 investigation:2 health:1 progress:1 red:2 million:1 reported:1 pancreatic:2 rare:1 could:2 according:3 drug:4 trial:2 experimental:2 first:1 major:1 cancer:3 harness:2 co-founder:1 terminated:2 prove:1 two:1 clinical:2 formally:2 form:1 funds:2 company:1 scrutiny:2 benefits:2 insider-trading:2 effort:1 charity:1 made:2 developing:1 up:2 n't:1 patients:2 complications:1 making:1 adults:1 health-care:2 examined:2 kidney:1 efficacy:1 investment:1 also:2 potential:1 potentially:1 bets:2 's:3 treatments:1 designed:2 stocks:2 approved:2 disease:2 analysis:2 premiums:1 so:1 invests:1 wine:2
stock_PFE r_up	bankruptcies:1 lifted:1 developing:1 deal:1 up:1 being:1 well:1 into:1 probe:2 nearing:1 funds:1 years:1 held:1 examined:1 trading:3 related:1 news:1 equity:1 makers:1 co-founder:1 signals:1 giant:1 said:1 $:1 would:1 major:1 merger:1 binge:1 disease:1 crucial:1 two:1 timed:1 also:1 health:2 400:1 biggest:1 progress:1 charity:1 identify:1 bought:1 firm:1 ago:1 all:1 good:1 's:3 around:1 big:1 company:1 million:1 treatments:1 new:2 scrutiny:3 reported:2 making:1 nearly:1 closely:1 three-week:1 report:2 insider-trading:1 hedge:1 effort:1 care:2 acquisitions:2 purchase:1 financing:1 prove:1 signing:1 --:1 could:1 cap:1 companies:1 mergers:2 drug:2 morning:1 deals:1 private:1 gathers:1 skin-care:1 time:1 newspaper:1 under:3 flagged:1 acquisition:1 stakes:1
stock_PFE r_up	rating:3 oncology:1 consider:1 just:1 saying:3 over:4 executive:5 results:1 years:5 four:1 cheer:2 batteries:1 session:3 6.3:1 comments:5 stepping:1 world:1 talks:1 shrugged:2 data:2 its:4 stock-index:2 recharge:1 setbacks:1 whose:2 giant:2 tick:1 slipped:2 23:1 personal:1 noted:2 less:2 had:2 him:2 failed:1 citing:2 program:3 4:2 premarket:1 under:1 3.75:1 enthusiasm:1 has:3 treating:1 move:1 finance:5 demands:1 possible:6 primary:1 haul:3 made:1 five:2 know:1 words:1 fall:1 immediately:1 spend:1 day:4 retreat:2 drugmaker:1 desire:1 regarding:1 promising:1 stabilize:3 lost:2 55:1 bailouts:4 companies:2 mild:2 calling:1 extremely:1 steps:6 she:1 avoiding:1 worries:3 nice:1 heading:1 development:1 indications:1 unexpected:1 says:1 6.1:1 people:1 series:1 reins:1 back:1 unexpectedly:3 disappointing:2 economic:1 trading:2 year:1 close:2 resigned:1 2.6:1 declined:3 out:2 shown:1 said:2 lead:1 avoid:3 shares:3 research:1 written:1 tears:1 crisis:2 unit:1 weighs:1 surprise:4 newly:2 before:2 sluggish:1 leader:1 officer:2 slot:1 earlier:1 weighing:1 43:1 tenure:1 mulled:1 focus:1 expansion:3 following:2 job:3 leadership:1 demanding:1 abate:2 offset:4 put:1 news:2 100:3 debt:5 downgraded:3 change:1 received:1 cautious:1 rare:1 region:4 uncertainty:1 reason:1 drug:5 rocky:1 prompted:1 admit:1 analysts:2 positive:1 insufficient:3 climb:1 studies:1 first:1 named:1 diagnosed:2 retired:4 family:1 point:2 reasons:1 troubles:2 treatment:1 one:5 down:7 chronic:2 simply:1 long:3 spotlight:1 old:1 open:2 he’s:1 market:2 often:2 strong:3 would:3 few:1 leading:2 top:1 single:1 ministers:5 been:1 insider:1 board:1 praised:1 statement:1 convene:4 taken:1 clinical:1 markets:3 start:2 500:5 more:5 flat:1 ``:2 1/2:1 relationship:1 some:1 company:6 exactly:1 took:1 wiping:1 eyed:2 stabilizing:1 last:3 payrolls:2 trying:1 spin:1 than:2 me:1 '':2 troubled:1 readied:1 showed:1 16:4 18:1 up:2 worn:1 nations:4 n't:2 patients:1 actively:2 today:1 policies:3 were:6 regulators:1 3.2:1 my:1 taking:1 unlikely:1 1.6:1 later:2 costly:4 play:1 investors:4 modestly:1 0.1:1 well:2 cited:1 sales:2 helped:1 say:1 his:5 dropped:5 shrugging:1 seem:1 moves:2 fillip:1 relatively:1 affairs:1 compared:1 recovery:1 4.3:1 retiring:1 veteran:1 means:1 s:2 event:1 1:1 stock-market:4 potential:1 3.25:1 chairman:3 which:3 largest:1 shocker:1 stimulus:1 stepped:1 2.4:1 gains:3 stock:4 week:4 independent:1 topping:1 's:42 though:1 replacing:1 price:1 after:8 problems:2 leukemia:2 dented:1 prepared:2 director:1 superior:1 weighed:2 fell:4 fatigue:2 negatives:1 previous:2 stocks:7 weekend:3 response:1 thoughts:1 goal:1 fiscal:3 lower:5 off:3 sentiment:1 medical:1 futures:14 stronger:1 departure:4 breather:1 chief:8 points:14 time:3 picture:1 weigh:1 senior:1 12:1 away:1 came:4
stock_PFE r_down	limited:2 executive:1 years:1 ended:1 shake:1 go:1 follow:2 data:1 its:2 stock-index:1 before:1 certainly:1 20:1 $:1 winning:3 late:1 going:1 4:1 premarket:1 19.9:1 has:3 might:1 tentatively:1 do:1 gains:2 means:1 survival:1 fall:1 during:1 month:1 day:4 bank:1 three-day:2 60:1 like:1 course:1 --:2 outperform:1 continue:1 officer:2 night:1 worries:5 eases:1 heading:1 often:1 reins:1 back:1 him:1 close:1 insurance:1 out:2 even:1 said:5 bullish:1 tried:1 shares:2 increase:2 central:1 closed:1 falling:1 boost:1 can’t:1 we:1 led:1 ability:2 stem:2 job:1 group:1 debt:4 last:2 could:1 30:1 drug:2 noted:1 admit:1 long-term:1 commit:1 maker:1 south:3 upgraded:1 retired:1 cancer:1 biotech:1 spreading:2 private:1 one:1 down:2 losses:3 sounds:1 open:1 crisis:3 market:3 quit:1 leading:1 been:1 willing:1 asset:1 lot:1 which:1 taken:1 markets:1 speaking:1 more:1 ``:3 1/2:1 funds:1 company:2 1.9:1 stem-cell:1 wake:1 rare:1 negativity:1 he:1 disappointing:1 look:1 announcing:1 2015:1 up:1 flagship:1 streak:3 purchases:3 climbed:1 600:1 willingness:1 sales:1 '':3 some:1 if:1 strength:2 end:1 recovery:1 perform:1 veteran:1 hampered:2 equipment:1 arguments:1 fourth:2 interview:1 stepped:1 economy:1 shrug:1 's:8 mat:1 may:1 after:5 most:1 weighed:1 stocks:12 weekend:1 billion:1 lower:1 off:2 lead:1 futures:1 stimulate:1 chief:3 points:1 tech:2 components:1 time:1
stock_PFE r_down	comment:1 his:3 financial:1 less:1 executive:1 ``:1 departure:1 '':1 helm:1 manager:1 planning:1 emerging-markets:1 reached:1 years:1 further:1 hedge:1 declined:1 said:1 end:1 reform:1 retiring:2 brief:1 baseball:1 citing:1 details:1 interview:1 surprise:1 team:1 announced:1 told:1 available:1 head:1 retire:1 's:3 business:1 after:2 fund:1 job:1 five:1 talks:1 known:1 immediately:1 'm:1 month:1 than:1 he:1 stress:1 calls:1 could:1 favorite:1 days:1 drug:1 n't:2 holdings:1 chief:1 bearish:1 were:1 failures:1 chairman:1 stock:1 maker:1
stock_PFE r_up	advisory:1 less:1 executive:3 years:2 batteries:1 planning:1 helm:1 yet:1 recharge:1 move:1 whose:1 retirement:1 $:3 16.5:1 equity:1 has:1 his:2 demands:1 five:1 hedge:1 replace:1 bank:1 desire:1 internally:1 heightened:1 obesity:1 related:1 year:1 investment:1 declined:1 retire:1 said:2 network:1 expert:1 brief:1 spokesman:2 surprise:2 announced:2 told:1 pioneering:1 shut:1 recently:1 business:2 million:1 job:1 beginning:1 change:1 panel:1 last:1 package:1 many:1 could:1 according:1 drug:3 plus:1 maker:2 first:1 comment:1 named:1 retired:1 family:1 linking:1 down:1 vote:1 unit:1 positive:1 caught:1 least:1 next:1 pharmaceuticals:1 final:1 more:1 firm:1 ``:2 month:1 funds:1 company:2 scrutiny:1 doctors:1 than:1 he:1 13:1 value:1 n't:2 determined:1 industry:1 cited:1 recommendation:1 head:2 days:1 '':2 end:1 retiring:2 pay:1 veteran:1 government:1 potential:1 underestimate:1 interview:1 week:2 's:9 after:2 'm:1 3rd:1 amid:1 departure:1 emerging-markets:1 chief:2 time:1 spend:1
stock_PFE r_up	saying:1 all:3 they:2 limited:1 year-to-date:1 over:1 global:1 focus:4 effects:1 quarters:1 halting:4 course:1 session:2 through:1 7.4:1 world:1 years:1 15:1 7.9:1 bank:1 injuries:2 setbacks:4 whose:2 death:2 overhaul:1 21:1 head:1 adverse:1 surprises:2 point:1 outlook:1 edge:2 late:1 industry:1 advisories:2 treatment:1 premarket:1 poised:1 fatal:2 500’s:2 2010:1 updated:1 executive:1 expirations:3 get:1 big:2 bid:3 rise:2 wave:3 game:1 updates:1 background:1 report:1 during:1 hedge:1 trade:6 day:1 hired:1 target:1 outweigh:1 jump:1 amid:1 heightened:1 cable:1 held:1 --:3 follows:1 drop:2 companies:3 policyholders:1 morning:2 bad:1 after-hours:1 voluntarily:2 stock:9 its:5 two:5 investigators:1 pioneering:1 attorney:1 set:2 deal:1 people:1 series:3 competition:3 unexpectedly:1 talks:1 second:1 actively:2 trading:3 result:1 year:4 further:1 investment:1 index:3 2011:1 said:7 network:1 sentiment:1 review:1 rose:3 shares:5 research:3 business:1 0.4:1 deficit:1 closed:1 new:1 receiving:2 highs:1 available:1 24:1 shut:1 2.9:1 25:3 activity:1 deliver:1 wild:1 doctors:1 takeover:2 offset:3 regulatory:1 news:1 100:2 falls:1 beginning:1 $:1 roundup:1 last:1 movers:2 could:1 climbed:1 joining:2 according:2 drug:18 called:1 range:1 fell:2 figures:1 swing:1 2.25:1 traded:1 maker:4 among:2 3.5:1 letters:1 claim:1 tight:1 unemployment:1 one:3 down:3 flat:1 guard:2 because:1 simply:1 been:1 narrowed:1 market:2 likely:2 addition:1 top:1 deaths:2 informed:1 three:2 least:3 next:1 their:1 scrutiny:1 clinical:4 injury:3 markets:2 500:14 more:1 firm:1 gained:5 ``:4 buyout:1 mostly:1 offer:1 0.5:1 company:5 benchmark:1 took:1 rejected:2 telephone:1 released:1 lift:1 ended:2 liver:6 former:1 setback:1 benefits:3 cases:2 highest:1 surged:1 than:1 linking:1 helped:1 funds:1 has:1 rejection:1 14:1 19:1 recall:1 ouster:1 edged:1 up:4 while:3 future:1 were:2 following:1 spotlight:1 dropped:1 gone:1 associated:1 links:1 mirrors:1 health-care:2 moved:2 sales:2 general:1 '':4 hypertension:5 reports:5 world-wide:3 close:1 blockbuster:1 widening:1 information:1 4.7:1 end:1 generic:3 media:2 government:1 40:1 regions:4 also:3 other:4 earnings:1 which:3 largest:1 expecting:1 struggling:3 gets:1 expose:3 higher:5 worldwide:1 explaining:1 product:4 's:16 users:3 price:2 after:5 looming:3 leaving:2 corruption:1 levels:1 user:1 coming:1 changing:2 stocks:2 data:3 died:1 recent:1 short:1 exports:1 expert:1 third:1 studies:1 futures:9 improve:1 patent:3 gap:1 points:11 withdraw:1 trials:3 claims:1 cholesterol:1 corporate:1 decision:1 latest:5
stock_PFE r_up	illness:1 retired:2 market:1 increasingly:1 unexpectedly:2 elected:2 foods:1 its:2 succeeding:2 said:2 stave:1 citing:2 health:1 board:2 chairman:2 week:2 independent:2 turning:1 creating:1 director:2 fast-growing:1 fatigue:2 last:2 former:2 off:1 like:1 companies:1
stock_PFE r_down	increasingly:1 results:1 setback:2 session:3 skin:1 its:5 succeeding:1 before:1 whose:1 retirement:1 20:1 rose:5 had:2 should:1 better:1 citing:1 program:1 treatment:2 samples:1 policy:4 3.25:1 has:2 dramatically:1 earnings:1 rise:1 watch:1 focus:1 possibly:2 2:2 report:1 using:1 little:1 advanced:1 treating:1 level:1 --:1 companies:1 morning:1 19:1 continue:1 after-hours:2 become:1 stock:3 round:1 names:2 heavy:1 ahead:1 because:1 suspended:2 people:2 trend:1 posts:1 testing:1 up:3 unexpectedly:1 elected:1 second:1 economic:2 trading:3 year:1 first-quarter:1 've:1 really:1 index:3 said:6 lead:2 decision:6 while:1 p.m.:2 health:2 new:1 previous:1 strategist:1 we:1 await:1 turning:1 creating:1 schedule:1 300:1 monetary:2 free:1 key:2 active:1 chairman:5 100:2 change:1 gained:1 last:1 language:1 taking:1 diminished:1 drug:6 trial:3 connection:2 plus:1 efforts:2 retail:2 slightly:3 maker:1 experimental:2 already:1 retired:1 cancer:3 headed:1 stave:1 awaited:2 world’s:1 decrease:1 raises:3 another:2 dividend:3 68:1 along:1 market:1 '':1 likely:1 due:2 cents:2 clinical:2 statement:1 6:2 biggest:1 payout:1 500:2 more:2 roundup:1 ``:1 selling:1 option:1 form:1 offer:1 drugs:1 company:3 but:1 1.9:1 quarterly:1 surface:1 former:1 doctors:1 emeritus:1 than:3 those:1 11:3 disappointing:1 12:2 14:1 announcing:1 whether:1 board:1 spokeswoman:1 patients:3 were:3 sets:1 study:1 launched:1 illness:1 investors:2 0.1:1 bigger-than-expected:1 0.2:1 share:1 sales:3 sting:1 helped:1 currency:1 foods:2 need:1 any:2 fill:1 information:1 melanoma:1 sensitive:1 began:1 same:1 1:1 shifts:1 edge:2 role:2 take:1 you:1 sidelines:2 tapped:1 higher:2 week:2 independent:1 added:1 's:1 see:1 after:4 director:1 fast-growing:1 fatigue:1 easing:1 nothing:1 stocks:1 data:4 died:3 ago:1 off:2 third:1 older:1 ranks:1 futures:6 retail-sales:2 points:6 time:3 quantitative:1 order:1 latest:1
stock_PFE r_down	shot:1 closely:1 office:2 diplomacy:1 increasingly:1 agreed:1 executive:3 midnight:2 finalizes:1 committee:1 its:3 giant:3 retirement:1 21:1 graph:1 had:1 internal:1 has:2 scheduled:1 pay:1 retire:1 diseases:2 alternatives:1 continues:1 keeping:1 cultural:1 260:1 updates:1 background:1 chairmen:1 now:1 like:1 warned:1 posts:1 race:1 succession:1 small:1 official:1 mandatory:1 leaders:1 deal:2 companies:1 back:1 3.6:1 programs:1 individual:1 year:2 tender:1 turning:1 makers:2 said:1 bounties:1 since:1 while:1 health:1 market:1 new:2 firms:1 conditions:1 terms:2 creating:3 team:1 slated:1 expire:1 members:1 beginning:2 undermine:1 $:1 employees:1 compliance:1 drug:3 turn:1 products:1 associates:1 maker:2 executives:2 named:1 key:1 previously:1 stave:1 into:3 within:1 financial:1 fraud:1 unit:2 pharmaceutical:2 heads:1 additional:1 5th:1 there:2 two:1 been:1 next:1 their:1 slowly:1 expected:1 markets:2 more:2 ``:2 buy:2 offer:4 drugs:2 company:1 mine:1 gold:1 than:1 he:1 kind:2 valued:1 join:1 expanded:1 flu:1 up:2 devices:1 project:1 near:1 protected:1 expiration:1 making:2 10th:1 medical:1 illness:1 painkiller:1 unchanged:1 health-care:1 head:1 '':2 pushed:1 foods:1 his:1 sells:1 moves:1 painkillers:1 again:1 end:2 no:1 personnel:1 elevated:1 also:1 other:1 chairman:3 babies:1 tapped:1 stock:1 extended:1 's:6 plans:1 though:1 price:1 mother:1 fast-growing:3 produce:1 letter:1 date:1 billion:1 off:1 effective:1 vice:1 mandate:1 age:1 worked:1 2002:1 chief:1 so:1 diagnostics:1 push:2 first:1
stock_PFE r_up	worldwide:1 marketplace:1 says:1 over:1 mirroring:1 trading:1 year:1 close:1 alternative:1 terminated:1 end:1 trials:1 two:1 least:1 clinical:1 safety:1 treatment:1 marks:1 has:2 's:2 500:3 development:1 earlier:1 formally:1 withdraw:1 company:1 arthritis:1 but:1 markets:1 put:1 approach:1 hold:1 concerns:1 both:1 safe:1 abandoned:1 --:2 consumer:1 drug:2 n't:1 switch:1 allow:1 road:1 behavior:1 were:1 changes:1 experimental:1
stock_PFE r_down	global:1 month:1 businesses:1 its:4 previous:1 $:9 rose:1 makers:1 disclosed:1 under:1 enthusiasm:1 2011:6 2010:1 executive:2 his:1 gains:1 big:1 new:3 look:1 money-making:2 impressive:1 large:1 worries:1 investors’:1 better-than-expected:1 some:2 trading:1 year:2 2.6:1 best:1 out:1 shares:2 surprise:1 red:1 cables:1 million:5 midpoint:1 pleasant:1 pressure:1 base:3 groups:1 regulatory:1 both:1 many:1 industry:1 30:1 drug:1 succeed:1 plus:3 maker:1 named:1 although:1 slipped:1 down:1 performer:1 names:1 miss:1 telecommunications:1 market:1 industrials:1 regulation:1 2:1 don’t:1 markets:1 500:1 head:1 mostly:1 company:1 but:1 posted:1 10:1 target:2 compensation:2 were:2 150:1 1.7:4 1.2:2 0.1:1 0.3:1 weighed:1 good:1 reports:1 want:1 technology:2 again:1 scrutinized:1 pay:2 fears:1 ideas:2 investment:2 1:1 earnings:2 performance:1 1.33:1 stock:1 play:1 repeat:1 's:6 bonus:4 fell:2 registry:1 included:1 stocks:1 tighter:1 salary:4 lower:1 off:1 amid:1 chief:2 points:2 tech:1 components:1 overseas:1 filing:1 came:1 weakest:1
stock_PFE r_up	comment:1 investors:1 departing:1 retire:2 share:1 years:1 challenges:1 slowed:1 economic:1 devices:1 another:1 year:3 helm:1 tumultuous:1 still:1 hospitals:1 its:1 self-inflicted:1 giant:1 said:2 end:2 three:1 than:1 current:2 also:1 waiting:1 chairman:1 medicine:1 downturn:1 suffered:1 has:1 company:2 kick:1 more:1 poor:1 updated:1 executive:1 's:2 plans:2 business:1 tenure:1 some:1 price:1 after:1 but:1 hurt:1 pressure:1 traffic:1 wounds:1 background:1 performance:1 during:2 trouble:1 stocks:1 analyst:1 successor:1 fiscal:2 search:1 spinal-device:1 acquisition:1 integrating:1 industry:1 such:2 drug:1 large:1 chief:1 painful:1 time:1 maker:1 medical-device:1
stock_PFE r_up	emerging:1 another:1 investors:2 blockbuster:1 sales:3 due:2 held:1 through:1 drug:3 have:1 year:1 sought:1 reached:1 still:1 crisis:1 issues:1 out:1 marking:2 stocks:1 bottles:3 willingness:1 credit:1 since:2 waiting:1 its:2 better:1 returns:1 other:1 fourth:2 medicine:1 new:2 markets:1 2010:2 painful:1 hit:2 plans:2 price:1 after:1 19,000:6 records:2 said:1 complaints:1 such:2 safer:1 debt:2 reports:1 hiding:1 assets:1 odor:1 hardball:1 high-yield:3 months:1 companies:1 up:1 deal:1 recession:1 record:1 kick:1 recall:4 playing:1 talk:1
stock_PFE r_up	saying:1 nearing:1 have:1 year:1 no:1 their:1 attractive:1 new:1 final:1 combination:1 earlier:1 introduce:1 act:1 regulators:1 takeover:1 rejected:1 longer:1 abandoned:1 pill:1 drama:1 cholesterol:1 efforts:1
stock_PFE r_up	state-run:1 agreed:1 year:1 kidney:1 given:1 cut:1 cancer:1 should:1 their:1 recommended:1 new:1 price:1 earlier:1 's:6 combination:1 company:1 after:1 introduce:1 regulators:1 rejected:1 abandoned:1 --:1 drug:1 pill:1 patients:1 cholesterol:1 efforts:1
stock_PFE r_down	nerve:1 past:1 resubmitted:1 growth:1 its:1 seemed:1 proceed:1 field:1 rather:1 crises:1 application:1 does:1 factor:1 performance:1 poor:1 pain:1 killer:1 but:1 stem:1 new:1 news:1 class:1 entire:1 drug:1 n't:1 left:1 changes:1 mean:1
stock_PFE r_up	senators:1 suspend:1 painkiller:3 companies:1 probe:1 expects:1 '':1 spinal:1 have:2 linked:2 out:2 pharmaceutical:1 26:1 said:1 trials:2 unemployment:1 damage:2 been:2 blog:1 may:2 clinical:3 new:2 hold:1 type:1 more:1 giants:1 ``:1 pain:1 around:2 drugs:2 confirmed:1 halted:2 joint:2 now:1 concerns:2 those:2 roundup:1 articles:1 kind:1 word:1 developing:1 surgeries:1 posts:1 drug:1 placed:1 studies:1 experimental:1
stock_PFE r_up	tap:1 deal:1 point:1 expanding:1 agreed:2 offerings:1 held:2 farms:1 looks:1 its:1 developer:2 said:1 would:1 veterinary:2 also:1 offers:1 health:2 animal:2 into:1 division:1 's:1 business:1 clinics:1 acquire:2 diagnostic:1 services:1 president:1 segment:1 care:1 industry:1 while:1 products:3 allow:1 diagnostics:2 growing:1 enhance:1 laboratories:1 privately:2
stock_PFE r_down	bankruptcies:1 all:1 investors:1 lock:1 shed:1 related:1 down:1 economic:1 trading:1 ascent:1 strong:1 jobless:1 two-year:3 overlook:1 stocks:3 points:1 equity:1 biggest:1 '11:2 gains:1 reaching:1 market’s:1 highs:3 after:2 volume:1 industrials:1 private:1 fall:1 news:1 manufacturing:1 data:2 retreat:1 recent:1 acquisitions:1 financing:1 light:1 morning:1 gathers:1 following:1 slightly:2 round:1 mergers:1
stock_PFE r_up	shed:1 investors:1 predict:1 lock:1 ca:1 weighed:1 ended:1 ducklings:1 trading:1 year:1 need:1 close:1 ascent:1 birds:1 market:2 strong:1 end:1 two-year:1 writes:1 since:1 28:1 bearish:1 next:1 also:1 points:1 equity:1 swans:1 2011:1 overlooked:1 today:1 do:1 we:3 's:5 gains:1 0.1:1 highs:1 after:1 but:1 forecasts:1 its:1 five:1 know:1 such:1 stocks:1 data:2 day:1 recent:1 lower:1 manufacturing:1 performers:1 underpriced:1 big-caps:1 face:1 n't:2 ugly:1 renew:1 economic:1 volumes:1 time:1 following:1 worst:1 2008:1 highest:1 slightly:1 round:1
stock_PFE r_up	's:1 underpriced:1 big-caps:1 renew:1 time:1 such:1
stock_PFE r_up	enrollees:1 among:1 looms:1 600:2 cancer:1 cents:1 over:2 creation:1 some:1 direct:1 past:1 6.6:1 see:2 trading:1 against:1 year:1 carry:1 acid:1 its:2 declined:1 out:1 pharmaceutical:1 hold:1 $:3 her:1 agreeing:2 veteran:1 nature:2 diseases:1 discounts:1 genetic:1 much:2 messenger:1 4:2 premarket:1 gains:2 has:3 2010:1 therapies:1 stock:1 development:3 paying:2 such:1 rise:1 's:1 expirations:1 missing:1 dividends:1 collaboration:2 million:2 agreement:1 promise:1 wave:1 vindication:1 11:1 focused:1 ends:1 favorites:1 demand:1 2:1 information:1 believe:1 recent:1 pact:2 represents:1 target:1 held:1 turns:1 could:2 expanded:3 companies:2 up:1 drug:4 picks:1 large:1 patent:1 approval:1 researchers:1 were:1 growing:1 cash-rich:1 maker:2 comes:1
stock_PFE r_up	among:1 because:1 significant:1 cancer:1 low-cost:1 year:2 multinational:1 one:1 '':1 set:1 hypertension:1 cuts:1 still:1 makers:1 if:1 industries:1 license:1 said:1 expert:2 generic:2 make:1 informed:1 comments:1 other:1 version:1 under:1 override:1 has:1 2011:2 stock:3 wants:1 sell:1 ``:1 move:1 's:2 diseases:1 10:2 successful:1 company:1 pick:1 treatments:1 infection:1 most:1 five:1 background:1 report:1 buy:1 hold:1 analyst:1 treating:1 both:1 last:1 showed:1 announcing:1 --:1 companies:1 drug:2 precedent:1 context:1 were:1 picks:2 maker:1 patents:1
stock_PFE r_up	agreed:1 executive:1 including:1 its:2 weekly:2 giant:1 $:2 rose:1 should:1 4:1 under:1 8:1 has:1 2010:1 division:1 gains:1 big:1 closely:1 milestone:1 report:2 advanced:1 payments:1 retailers:1 stock:1 large-cap:1 's:4 best:1 index:1 said:2 state:1 market:1 comebacks:1 new:1 dividends:1 million:2 clues:1 100:1 stage:1 gained:1 nonfarm:1 ahead:1 drug:1 34:1 a.m.:1 options:1 upfront:1 awaited:1 labor:1 unit:1 use:1 jobless:2 due:1 500:1 more:2 company:2 payrolls:1 than:1 rights:1 whether:1 evaluating:1 control:1 investors:1 give:1 health-care:1 sales:1 disappointing:1 reports:1 watched:1 keep:1 technology:1 pay:1 able:1 potential:1 which:1 products:1 several:1 higher:1 200:1 edged:1 stocks:1 data:1 tracking:1 futures:3 chief:1 points:3 equities:1 claims:2
stock_PFE r_down	own:1 being:1 developed:1 chunk:1 executive:1 sales:1 including:1 expect:1 blockbuster:1 pills:1 said:1 away:1 rivals:1 does:1 take:1 's:1 big:1 arthritis:2 he:1 --:1 drug:1 n't:1 rheumatoid:1
stock_PFE r_down	help:1 proposed:1 agreed:1 executive:1 expects:1 years:1 through:2 threshold:1 its:4 before:2 group:1 just:1 rose:2 should:1 treatment:1 has:1 2011:1 2010:1 hope:1 expirations:1 exceptional:1 auto:1 results:2 grew:1 affect:1 sixfold:1 --:4 quarter:3 dip:2 diabetes-drug:1 fired:1 past:1 second:1 year:4 our:1 happen:1 84:1 even:1 said:8 profit:4 jumped:1 profitability:1 forecast:1 3:2 market:1 for-profit:1 new:2 net:2 we:1 after:1 recently:1 million:3 leukemia:1 regulatory:2 approval:1 strong:1 21:2 pipeline:2 rallying:1 months:1 drug:5 efforts:1 maker:3 first:1 comment:1 seeing:1 alliance:1 cancer:3 revenue:1 period:1 strategic:1 weather:1 lung:1 apply:1 writing:1 unit:3 manufacturing:2 segment:1 there:1 three:1 next:2 gig:1 few:1 lot:1 doubling:1 improve:1 more:1 ``:1 interest:1 form:1 drugs:2 company:1 sales:5 part:1 than:1 10:2 12:1 reducing:1 18:1 while:2 're:1 my:1 biotech:1 climbed:1 process:1 partnership:1 tax:1 head:1 '':1 unveiled:1 education:1 any:1 kidney:1 increased:1 sell:1 develop:1 releases:1 ingredients:1 patent:1 things:1 began:1 indexes:2 application:1 details:1 interview:1 sidelines:1 difficult:1 's:6 earlier:2 treatments:1 driven:1 helped:1 hired:1 72:3 preliminary:1 guys:1 diabetes:1 billion:3 lower:1 think:1 chief:1 costs:1 rallies:2
stock_PFE r_up	proposed:1 executive:2 expects:1 threshold:1 research:2 find:1 personal:1 candidates:1 treatment:2 big:2 fortune:1 --:3 versions:2 bets:2 financial:1 deal:1 year:1 close:1 happen:1 living:1 said:3 its:2 3:2 version:1 market:2 provider:2 new:3 biosimilar:1 we:1 terms:1 inhaled:1 drug:3 lucrative:1 alone:1 approval:1 pipeline:1 months:1 put:1 contract:2 amount:1 insulin:1 think:1 seeing:1 alliance:2 cancer:3 into:1 within:1 three:1 regulatory:1 lung:1 apply:1 unit:3 copies:1 next:1 clinical:1 opposed:1 lot:1 disclosed:1 company’s:1 ``:2 selling:1 form:1 drugs:6 formed:3 part:2 hopes:1 12:1 developing:1 18:1 cells:1 n't:1 're:1 were:1 heart:1 head:1 '':2 itself:1 biologics:1 our:1 blockbuster:1 kidney:1 sell:2 provide:1 things:1 which:1 interview:1 sidelines:1 development:1 begin:1 's:3 intended:1 leukemia:1 services:1 diabetes:3 traditional:1 generic:1 chief:1 push:2 biotechnology:2
stock_PFE r_down	biotech:2 now:2 own:2 have:1 heart:1 his:1 over:2 people:1 discover:1 longevity:2 alone:1 itself:1 been:1 human:1 dividend:1 go:1 's:1 cold:1 still:1 find:1 best:2 begin:1 index:1 use:1 stocks:3 develop:1 pharma:1 no:1 profit:1 writes:2 there:1 long:1 current:1 equipment:1 high:1 winners:1 electrical:1 market:1 way:1 plenty:1 strong:1 pal:1 2010:2 stock:1 life:1 selling:1 terms:1 extend:1 drugs:2 version:1 there’s:1 groups:1 compound:1 hopes:1 such:1 promote:2 data:1 past:1 short:1 room:1 performers:1 --:2 invest:1 tricks:1 months:1 put:1 up:1 drug:1 generic:1 upside:1 can:2 18:1 usually:1 massive:1 efforts:1
stock_PFE r_up	because:1 moved:1 likely:1 smaller:1 64:1 company:1 firms:1 terms:1 out:1 partners:1 stocks:2 lead:1 their:1 quickly:1 hitting:1 52-week:1 concerns:1 interest:1 grow:1 has:1 markets:1 highs:1 diversify:1 his:1 's:5 which:1 efficacy:1 pharmaceutical:1 big:1 screen:1 million:1 flurry:1 recalled:1 affect:1 hypertension:1 manufacturing:1 data:1 rein:1 acquisitions:1 lupus:1 short:1 piles:1 could:1 list:1 cash:1 drug:3 excitement:1 renew:1 overpay:1 tablets:1 problem:1 spend:1
stock_PFE r_up	's:1 list:1 companies:1 50:3 cash:1 stockpiles:1 biggest:1 world:1
stock_PFE r_down	's:2 $:2 company:1 700,000:1 shares:1 drug:1 6.1:2 bought:1
stock_PFE r_down	delaying:2 increasingly:1 settlements:1 results:1 month:1 ended:1 tablets:2 litigation:1 cut:1 20:1 $:1 spite:1 sodium:1 had:1 failed:1 citing:1 treatment:2 under:1 fuel:2 has:3 2010:1 gave:1 started:1 affected:1 expirations:1 confidential:1 government:1 joint:1 cutting:1 therapy:1 they:1 judge:1 him:2 strengths:1 --:2 companies:2 try:1 did:1 drug-patent:1 continue:1 release:1 quarter:1 smaller:2 heartburn:1 back:1 likely:1 makers:2 large:1 said:3 consumers:1 federal:1 research:2 version:1 7:1 conduct:2 thriving:1 boost:1 relationships:1 inhaled:1 drug:5 approval:2 last:1 ahead:1 ventures:1 deals:1 months:1 35:1 insulin:1 long-term:1 approve:2 asked:3 block:1 major:1 into:1 because:1 multiple-sclerosis:1 licensing:1 total:1 market:1 bolster:1 pharmaceutical:1 working:1 there:1 detailing:1 two:2 been:2 their:1 clinical:2 agreements:1 statement:1 6:1 inhaled-insulin:1 markets:1 more:3 selling:1 pipelines:1 drugs:1 company:3 but:1 part:1 organizations:1 12:1 pursue:1 wholesale:1 see:1 n't:3 while:1 many:1 dispute:1 30:1 health-care:1 1.8:1 sales:1 helped:2 contract:1 have:2 sells:1 any:2 increased:1 again:1 documents:1 patent:1 trials:2 40:1 also:1 other:1 boom:2 fourth:1 instead:2 developers:1 requested:1 's:9 popular:1 price:2 looming:1 fast-growing:1 data:1 approved:1 billion:1 antitrust:1 amid:1 well:1 maker:1 generic:2 which:2 costs:2 push:1 biotechnology:2
stock_PFE r_up	scheduled:1 ability:1 deal:1 painkiller:1 cents:1 guaranteed:1 detailing:1 settlements:1 midnight:2 back:1 increased:1 month:1 down:1 pushed:1 trading:1 drug:1 have:1 tender:2 gave:1 sells:1 its:1 amended:1 litigation:1 again:1 shareholders:1 documents:1 end:1 $:3 their:1 28:1 while:1 shares:2 previously:1 other:1 eliminate:1 premarket:2 which:2 9:1 has:1 boost:1 seeks:1 closed:1 week:1 requested:1 process:1 buy:1 's:1 complete:1 confidential:1 offer:2 judge:1 price:2 time:1 slated:1 delivery:1 popular:1 expire:1 therapy:1 7:1 date:1 now:1 recent:1 last:1 multiple-sclerosis:1 antitrust:1 --:1 wholesale:1 companies:1 6:1 35:1 asked:1 drug-patent:1 part:1 expiration:1 were:2 release:1 through:1 dispute:1 maker:1 block:1
stock_PFE r_up	operations:1 agreed:2 milestone:1 ``:1 held:2 innovative:1 its:4 osteoporosis:2 1:5 slow:2 group:1 $:8 fix:1 4:1 has:3 earnings:1 his:2 which:1 every:1 intellectual:1 despite:2 during:1 like:1 --:4 payments:1 quarter:1 husband:1 says:1 some:2 related:1 budget:1 year:1 further:1 said:2 profit:4 deeply:1 new:3 improperly:1 425:1 announced:1 discovery:1 achievements:1 earns:1 million:2 reported:2 cut:1 upfront:1 regulatory:1 vaccine:1 search:1 last:1 met:1 many:1 annual:1 drug:3 ensure:1 maker:1 late-stage:1 comment:1 fourth-quarter:4 cancer:2 offset:1 period:1 575:1 brought:1 privately:2 conference:1 shareholders:1 additional:1 would:1 transfer:1 initial:2 been:1 strategy:1 rivals:1 clinical:1 9.8:2 call:1 interests:1 billion:6 head:1 buy:2 company:4 acquire:1 but:1 hurt:1 those:1 he:1 10:1 grew:2 cash:1 patients:1 property:1 biotech:2 up:4 penny:1 sales:3 '':1 sued:1 reports:1 have:1 technology:1 melanoma:1 patent:1 pay:1 claiming:1 delay:1 also:1 details:1 fourth:1 products:1 development:2 's:4 plans:1 tops:1 'll:1 ago:1 neck:1 sale:1 failures:1
stock_PFE r_up	help:1 fourth-quarter:1 agreed:1 settlements:2 years:1 held:1 including:2 signs:2 settlement:2 its:1 osteoporosis:1 24:1 giant:1 slow:1 $:10 treatment:2 premarket:2 under:1 has:2 pill:1 expirations:3 views:1 rise:1 wave:3 background:1 despite:1 world:3 --:1 deals:2 payments:1 cholesterol:2 quarter:2 approaching:2 achievements:1 deal:1 acquired:1 related:3 cash:1 trading:2 makers:3 said:2 profit:1 shares:2 version:2 new:1 425:1 announced:2 available:1 blow:1 million:2 reported:2 offset:1 regulatory:1 vaccine:1 prescription:2 30:1 drug:8 comes:1 late-stage:1 comment:1 among:1 cancer:2 revenue:3 upfront:1 575:1 one:2 down:1 privately:1 68:1 total:2 additional:1 initial:1 threatening:3 third-quarter:1 their:1 2:1 9.8:1 expected:1 clinical:1 branded:2 flat:1 head:1 selling:1 0.5:1 company:3 prices:1 partially:1 grew:1 16:2 up:3 while:1 were:2 closing:1 biotech:1 share:1 sales:4 high:2 buy:1 swinging:1 seen:1 melanoma:1 patent:3 pay:1 detail:1 topped:1 lately:1 1:1 details:1 largest:1 performance:3 development:1 begin:1 's:7 milestone:1 after:1 coming:1 pair:2 recent:2 billion:2 blood-pressure:1 neck:1 third:2 face:1 generic:3 accounted:2 2009:1 profits:1 latest:3
stock_PFE r_down	heart:1 financial:1 providers:1 sepsis:1 global:1 share:1 setback:3 leads:2 seen:1 big-cap:1 find:1 announced:1 industries:1 pharmaceutical:2 needs:1 pharma:1 ways:2 treatment:1 shares:1 research:1 makers:2 outside:1 too:1 way:1 capital:1 new:1 firms:1 drugmaker:1 day:1 stock:1 development:1 after:1 greater:1 tumbles:1 they:1 than:1 change:2 must:2 down:2 lower:1 sectors:1 --:2 industry:2 funded:1 drug:4 flux:1 risks:1 promising:1 dragged:1
stock_PFE r_up	reductions:1 issued:1 move:1 through:1 thanks:1 cuts:1 year-earlier:3 find:1 overhaul:1 $:2 rose:3 expectations:1 than:2 citing:1 has:1 2011:4 achieve:1 details:2 louder:1 effects:1 world:1 austerity:1 loss:1 --:2 warned:1 large:3 recall:1 cost:1 economic:1 year:3 inflated:3 said:4 reform:1 profit:1 nets:1 forecast:1 behind:1 health:1 above:1 medicine:1 new:1 terms:1 business:1 each:1 dividend:1 care:1 last:1 getting:1 annual:1 12000:3 keep:1 fell:2 graph:1 mixed:1 slightly:3 maker:1 experimental:1 first:1 comment:2 fourth-quarter:3 tough:1 cancer:1 revenue:1 period:3 market:1 confident:1 6:1 more:2 direction:1 company:3 biotech:1 gain:3 94:7 launches:1 plunged:3 up:1 while:3 growth:1 can:1 evaluating:1 closing:1 heart:1 associated:1 health-care:1 sales:5 drug:4 linked:1 again:2 patent:2 imminent:1 1:1 earnings:4 which:2 largest:1 struggling:1 higher:1 product:2 's:1 price:1 faces:1 4th:1 such:1 data:1 billion:2 short:2 third:1 programs:1 6th:1 dent:1 divestiture:3 costs:1 pay:1 corporate:1 profits:1 left:1
stock_PFE r_down	among:1 1300:1 disclosure:1 refuses:1 ends:1 hearing:1 jump:1 report:1 second:1 hurdle:1 fail:2 close:1 seek:1 its:3 bankruptcy:1 stocks:1 send:1 day:1 failed:1 misses:1 earnings:1 statement:1 500:1 higher:2 hurdles:2 arrives:1 jobs:1 parent:1 permission:1 company:1 reporting:1 but:2 slated:1 plan:2 judge:1 approving:1 former:1 those:1 thrift:1 11:1 hair:1 outline:1 clear:2 economics:1 ask:1 12000:2 below:1 edge:1 voting:1 called:1 creditors:1 stick:1
stock_PFE r_up	all:1 increased:1 see:1 watch:1 some:1 focus:1 likely:1 trading:1 earnings:1 which:1 activity:1 report:1 spotlight:1 market:1 joining:1
stock_PFE r_up	12000:3 1300:1 adds:1 less:1 issued:1 agreed:2 global:4 focus:4 picks:1 years:6 quotes:1 6.5:1 session:3 including:2 comments:1 cuts:2 forecast:1 economist:3 its:12 fifth:1 previous:1 setbacks:3 whose:3 giant:2 cut:1 $:15 also:5 rose:13 refocus:2 outside:1 signals:1 previously:1 program:1 those:2 months:2 8:1 struck:1 has:3 advanced:4 over:4 overcome:2 2012:6 giants:2 activities:2 his:1 return:1 gains:6 impacts:1 big:1 continues:1 results:3 made:1 updates:1 background:1 24:2 part:2 now:2 comply:2 areas:1 awaited:2 bit:1 bring:1 --:6 signal:1 debut:1 companies:4 deals:5 traders:6 indication:1 after-hours:1 higher:5 notes:1 looks:3 development:3 right:1 above:1 significantly:3 existing:1 4:1 reduce:3 back:4 competition:7 cash:2 actively:3 trading:3 recommendation:1 81:1 expects:2 targets:1 await:1 said:11 gainers:1 bottom:1 profit:2 blue-chip:4 since:4 projected:1 shares:5 research:7 enough:2 exit:2 digest:2 closed:2 boosted:1 new:2 tax:1 announced:2 turmoil:2 earlier:1 outsourcing:1 business:2 pharmaceutical:1 wo:2 retains:1 seventh:1 shareholders:1 blizzards:2 job:1 weight-loss:1 acquisitions:1 repurchase:1 eye:1 along:2 manufacturing:5 beginning:3 remaining:1 declining:1 gained:5 sending:1 pipeline:2 cautious:1 last:4 prepare:1 piles:1 shift:3 dollars:3 climbed:5 revamp:2 host:1 drug:7 7:3 prior:1 23.5:3 tripled:2 awaiting:3 month:4 faces:1 efforts:1 traded:2 maker:3 comes:1 first:1 fourth-quarter:4 major:5 protests:1 revenue:5 battery:2 string:4 coming:3 number:1 billions:3 tracking:2 down:3 batch:1 suffered:1 adding:1 another:1 robust:1 throughout:2 post:1 market:9 conference:1 decline:3 use:1 industrials:4 8.5:1 smorgasbord:1 would:2 100:4 spending:3 achieve:1 two:1 next:2 start:1 board:1 call:1 authorized:1 under:1 biggest:1 markets:5 500:7 more:6 cutbacks:1 roundup:1 ``:3 buy:1 39:1 upcoming:2 drugs:1 influence:2 company:9 pursuing:1 encouraging:1 but:1 site:1 expected:3 construction:1 '':3 buyback:2 line:1 than:5 buying:3 posted:2 weighed:1 13:1 include:1 rejection:1 1997:4 reducing:1 18:2 largely:2 bellwether:1 up:5 pour:1 pill:3 n't:2 while:1 economic:3 ruling:2 growing:2 meet:1 closing:1 similar:1 move:1 spotlight:2 acquisition:1 1.6:1 1.7:1 other:2 1.1:1 1.2:1 1.3:1 best:4 certain:1 year:2 moved:3 1.9:2 expenses:1 high:1 experts:1 reports:5 have:2 stock-index:1 some:1 moves:3 any:1 increased:1 sell:2 functions:1 blockbuster:3 recovery:1 sit:1 generic:7 2.7:4 44:1 agency:1 fears:1 overshadowed:1 note:1 shifts:1 historic:1 strategy:1 5:3 details:4 near:1 performance:5 outlook:1 resources:1 stock:13 gaining:1 rise:3 's:18 plans:2 capitalization:1 though:3 keep:1 earnings:14 price:1 after:1 southern:2 paid:2 levels:1 73:1 70:2 highlighting:2 stocks:5 data:8 recent:2 billion:11 late:1 center:2 antitrust:2 charges:1 amid:1 futures:15 flow:1 disease:1 daily:1 face:2 46:2 chief:3 points:14 form:1 time:1 decliners:1 corporate:3 spend:1
stock_PFE r_down	sector:1 saying:1 sporting:1 quarters:1 signs:1 budding:1 its:3 generous:1 $:1 surprises:2 troubles:1 advisories:2 treatment:1 has:1 pill:2 real:1 gains:1 very:1 big:1 nation:1 inflation:1 world:2 above:1 bar:1 like:1 --:1 companies:4 1.2:1 large:1 prescribing:2 stopped:1 higher:1 some:1 back:1 past:1 year:1 makers:1 out:2 severance:1 profit:3 blue-chip:1 since:1 looking:1 health:1 closed:1 new:1 boost:1 shows:1 we:1 giant:1 possibility:1 focused:1 news:1 strong:2 roundup:1 last:1 package:1 leaves:1 12000:2 cures:2 stand:2 plummets:1 first:1 among:1 major:2 diagnosed:2 bell:1 one:1 dividend:1 pharmaceutical:2 industrials:1 raise:1 their:1 biggest:1 themselves:4 more:1 head:1 buy:1 offering:1 company:1 rejected:1 gain:3 distance:1 rejection:1 up:1 near:1 future:1 closing:1 illness:2 investors:1 measure:1 tax:2 high:1 proves:1 drug:4 have:1 different:2 end:1 same:2 also:1 earnings:1 9:1 instead:1 gets:1 stock:2 such:1 's:3 plans:1 boosted:1 problems:1 treatments:1 diet:2 debt:1 upheaval:1 stocks:1 why:1 billion:1 kept:1 manufacturing:1 space:1 looked:1 reports:2 without:1 time:1 2008:1 corporate:1 latest:2
stock_PFE r_up	sector:1 fourth-quarter:2 being:1 results:1 setback:1 trade:2 shares:1 research:2 its:2 issues:1 interesting:1 better:1 treatment:1 has:3 divergent:1 gains:2 combination:1 government:1 beat:1 truly:1 balancing:1 they:1 report:2 world:2 look:1 loss:4 --:1 companies:1 write-down:1 flagship:2 truth:1 small:1 large-cap:1 leaders:1 decliner:1 recently:1 facing:1 said:2 profit:2 decision:1 4:1 legal:1 forecast:2 safety:1 innovation:1 new:3 sliding:1 led:1 deliver:1 expansion:1 pressure:1 dire:1 offset:1 strong:1 search:1 dollars:1 against:1 prior:2 products:1 1.62:2 long-term:2 maker:2 experimental:2 first:1 among:1 facility:1 billions:1 because:1 often:1 leading:1 support:1 two:1 anyone:1 returns:2 much:1 biggest:1 clinical:1 entered:1 more:1 flat:2 drugs:1 season:1 slides:1 stick:1 posted:1 made:1 abandoned:1 challenge:1 value:1 choices:1 n't:2 while:1 can:1 abandon:1 situation:1 study:1 heart:2 investors:1 almost:1 sales:1 disappointing:1 drug:7 close:1 swung:1 linked:1 if:1 needs:1 concerns:1 patient:1 earnings:1 stock:1 week:1 used:1 's:4 effect:1 falls:1 designed:1 stocks:2 recent:1 emerging-markets:1 spend:1 so:1 therapy:1 having:1
stock_PFE r_up	named:1 adults:1 investors:1 health-care:1 competition:1 second:1 against:1 want:1 leaders:1 asks:1 stock-picking:1 review:1 pros:1 two:1 research:1 better:1 returns:1 winners:1 quarterly:1 new:1 divergent:1 week:1 obese:1 's:2 governors:1 deliver:1 biggest:1 made:1 balancing:1 billions:1 they:1 world:2 law:1 case:1 10:1 heaven:1 pressure:1 dollars:1 companies:1 beats:1 drug:2 choices:1 relief:1 spend:1
stock_PFE r_down	just:1 conundrum:1 economic:1 including:1 slashing:1 jobs:1 counting:1 pharmaceutical:1 lead:1 spending:1 lawsuits:1 promoting:1 take:1 giants:1 illegally:1 's:1 plans:1 labs:1 regulators:1 uses:1 plan:1 not:1 approved:1 those:1 like:1 center:1 many:1 industry:1 underscores:1 drug:3 high-tech:1 closing:1
stock_PFE r_up	lobbying:1 down:1 hiring:1 say:1 want:1 corporations:1 would:1 writes:1 actually:1 re:1 much:2 between:1 contrast:1 rules:1 protect:1 employers:1 water:1 cops:1 they:2 lobby:2 hire:1 whistleblowers:3 guilty:1 calling:1 n't:2 s:1 massive:1 growing:1
stock_PFE r_down	cancer:2 chances:1 results:2 tumors:2 growth:2 lung:2 doubled:2 supportive:2 its:3 best:2 giant:2 said:4 patent:2 positive:2 detail:1 tablets:2 current:2 stemming:2 advanced:2 medicine:2 care:2 therapies:2 more:2 firm:2 lived:2 's:4 time:2 pancreatic:2 sales:2 strength:2 balancing:1 than:2 raising:2 recent:2 pipeline:2 showed:2 --:2 study:2 losses:2 drug:5 tumor:2 odds:1 patients:2 without:2 plus:2 published:2 found:2 balance:1 studies:2 maker:1
stock_PFE r_down	sector:1 crunch:1 ``:1 's:1 pharmaceutical:1 drug:1 worried:1 '':1 sick:1 time:1 makers:1
stock_PFE r_up	leaders:1 deal:1 health-care:1 sales:1 due:1 say:1 fees:1 inspections:1 beyond:1 speed:1 mid-cap:1 blow:1 huge:1 analyst:1 generic:1 lining:1 two:1 pharmacy:1 behind:1 way:1 proposal:1 several:1 2011:1 2012:3 plant:1 hit:1 expirations:1 government:1 drugs:2 wave:1 chiefs:1 kicking:1 user:1 fall:1 approval:1 best-selling:1 10:1 off:1 candidate:1 world:1 versions:1 favors:1 industry:2 shelves:1 companies:1 up:1 drug:2 takeout:1 patent:1 products:1 innovative:1 pay:1 small:1 could:1 medical-device:1
stock_PFE r_up	biotech:2 addressing:1 deal:1 point:1 almost:1 both:1 strategic:1 expect:1 likely:1 unlikely:1 expensive:1 concern:1 pharmaceutical:1 giant:1 $:1 prove:1 ease:1 system:1 least:1 way:2 finding:1 new:2 challenges:1 diabetes:1 might:1 week:1 meets:1 's:7 diseases:1 get:1 may:1 company:1 never:1 treatments:1 like:1 landmark:1 lot:1 spree:1 chatter:1 cancer:1 population:1 billion:1 purchase:1 look:1 industry:1 according:1 future:1 small:1 disorder:1 study:1 acquisition:1 latest:1
stock_PFE r_down	all:1 caused:2 still:1 family:1 interesting:1 had:1 civil:1 treatment:2 main:2 2010:1 do:2 them:2 gains:1 therapy:1 half:2 not:1 hedge:1 advanced:1 ruled:2 always:1 activity:1 unaware:2 weight:2 some:1 jump:1 cost:1 makers:1 out:2 regulator:1 said:1 culprit:2 federal:1 section:1 enough:2 health:2 pets:2 reading:1 shields:1 exercise:2 problems:2 excess:2 active:1 vaccine:1 owners:2 watchers:1 country:1 drug:1 rose:1 product-liability:1 makes:1 maker:1 cancer:1 previously:1 appropriate:1 carry:1 stocks:1 would:2 lawsuits:1 initial:1 system:1 their:1 cats:2 cost-effective:1 dogs:2 obese:2 ``:1 funds:1 but:1 than:2 posted:1 helped:1 16:1 n't:3 patients:1 were:3 claim:1 costly:2 health-care:1 condition:1 '':1 have:1 kidney:1 court:2 able:2 note:1 which:1 finding:1 stock:1 used:1 's:12 overweight:2 most:1 regular:1 law:1 approved:1 types:1 especially:1 fully:1 profit:1 severe:2
stock_PFE r_down	attorney:1 official:1 1.8:3 appeals:1 settlement:1 millions:1 said:1 court:1 $:3 decision:1 should:1 bilking:1 out:1 's:2 patent-infringement:1 reversed:1 lawsuit:1 billion:1 1998:1 dollars:1 clients:1 against:1 plaintiffs:1
stock_PFE r_up	plunge:1 takes:2 center:2 drug:1 drug-stock:2 does:1 trading:2 plan:1 time:1 not:1 news:1 approve:1 its:1 stage:2
stock_PFE r_down	questions:1 its:4 issues:1 before:1 partners:1 candidate:1 instance:1 facility:2 controls:1 blog:1 treatment:4 has:2 2010:1 around:1 early:1 new:2 affect:2 articles:1 --:4 companies:1 did:1 ban:2 disorder:1 noted:1 because:1 alfa:1 another:1 trend:2 posts:1 some:2 second:1 trading:1 pills:2 declined:2 regulator:1 said:6 comments:1 asking:2 import:2 injections:2 regulatory:1 news:1 manufacturing:1 roundup:1 rare:2 drug:9 products:2 analysts:1 studies:1 maker:2 experimental:2 first:1 comment:1 prospective:1 supply:4 shutdown:1 throughout:1 unit:2 would:1 been:1 genetic:2 clinical:2 more:4 north:2 drugs:3 company:2 short:1 made:2 developing:1 work:1 plunged:1 up:1 submitted:1 n't:2 plunges:2 share:1 have:1 partner:2 moves:1 information:3 generic:3 trials:1 agency:1 application:1 details:1 which:1 answer:1 stock:2 requested:2 plant:1 's:14 price:2 stocks:2 data:1 chemistry:1 approve:3 disease:3 compete:1 2009:1
stock_PFE r_up	sector:1 gaining:1 nicotine:1 final:1 investors:1 hunger:1 ground:1 sense:1 comments:1 month:1 oil:1 drug:3 eliminating:1 smoking:1 led:1 news:1 during:1 market:1 relatively:1 considering:1 busy:1 lead:2 technology:1 top:1 there:1 while:1 shares:1 rally:1 their:2 safety:1 black:1 weeks:1 utility:1 's:2 quitting:1 today:1 nervousness:1 hard:1 north:3 rose:1 warnings:1 relieved:1 after:1 stop:1 blue-chips:1 most:1 were:1 advised:1 prices:1 using:1 stocks:5 day:1 those:1 recent:1 third-straight:1 12:1 performing:1 well:1 pause:1 gum:1 morning:1 s:1 official:1 time:1 averages:1 having:1
stock_PFE r_down	sector:2 already:1 doing:1 doesn:1 celebrating:1 second:2 economic:1 names:1 go:1 still:1 makers:1 market:1 really:1 working:1 sensitive:1 headline:1 9:1 today:1 good:1 's:2 market’s:1 flurry:1 birthday:2 value:1 defensive:1 bull:1 stocks:1 lower:1 like:1 solid:1 reports:1 bag:1 s:1 t:1 underway:1 mixed:1 economically:1 bet:1
stock_PFE r_up	raised:1 investors:1 venture-backed:1 sale:1 breakthrough:1 67:1 ready:1 melanoma:1 $:3 potential:1 treatment:1 fourth:1 largest:1 discovering:1 capital:1 's:2 way:1 company:1 million:1 those:1 cash:1 venture:2
stock_PFE r_up	heavy:1 sector:1 1.1:1 investors:1 over:1 move:1 losing:1 competition:1 month:1 fierce:1 second:1 growth:1 seen:1 rally:1 employment:1 best:1 pharmaceutical:1 strong:1 pharma:1 driving:1 bears:1 had:1 three:1 lags:2 3:1 reading:1 's:2 more:1 main:1 head:1 jobs:1 returned:1 than:1 jumps:1 bulls:1 cheers:1 fund:1 report:1 hedge:1 stocks:1 day:1 areas:1 prospects:1 has:1 talent:1 ignites:1 months:1 underscores:1 up:1 surge:1 while:1 activity:1 small:1
stock_PFE r_down	all:2 help:2 unemployment:1 being:2 global:1 years:3 four:1 including:3 signs:1 its:4 $:2 10.7:1 rose:1 had:1 symptoms:3 investigational:1 treatment:1 main:2 showing:1 nearly:2 condition:2 loss:3 success:2 --:4 morning:1 cholesterol:1 tablets:1 rheumatoid:3 competition:2 second:2 trading:1 year:1 throughout:1 projected:1 research:2 newly:2 announced:1 specialist:1 jobs:1 met:2 lucrative:2 key:4 offset:2 reaction:1 pipeline:3 last:1 reported:2 study:1 30:2 drug:9 trial:4 fell:1 placebo:1 studies:2 patents:1 late-stage:4 comment:1 revenue:1 into:2 one:3 reducing:3 market:3 has:1 rebounded:1 two:1 patients:1 painful:2 drugs:3 company:2 goals:2 analyst:1 include:1 16:2 up:1 submitted:1 below:1 were:1 following:1 called:2 150:1 tap:2 hoping:2 cents:1 sales:2 world-wide:1 compared:1 generic:2 six:2 administration:1 details:1 which:2 9:1 stock:1 product:1 's:5 may:2 arthritis:3 important:2 coming:2 prepares:1 data:1 recent:1 billion:1 2009:1 fighter:1 effective:1 slightly:1 futures:1 daily:1 time:1 first:1 oral:1 once:1
stock_PFE r_down	shot:1 prompted:1 deaths:1 caused:1 prompt:1 some:2 ending:1 four:1 examine:1 grants:1 seen:1 children:1 halt:1 widely:1 use:1 said:1 no:1 peanut:1 there:1 had:1 two:1 vaccines:1 concerns:2 health:2 goes:1 international:1 cause:1 public:1 week:1 used:1 's:2 fourth:1 government:1 here:1 recalled:1 effects:1 they:1 new:1 authorities:1 salmonella:1 dose:1 butter:1 15:1 receive:1 age:1 months:2 reports:1 side:1 whether:1 officials:1 shots:1 serious:1 starting:1 notion:1 block:1
stock_PFE r_up	just:1 deaths:1 over:1 primary:1 past:1 experts:1 children:1 before:1 deal:1 two:1 vaccines:1 new:2 care:1 connected:1 's:1 five:1 they:1 trying:1 payment:1 died:1 panel:1 payout:1 medical:1 months:1 n't:3 pediatric:1 were:1 opinion:1 model:1
stock_PFE r_down	biotech:1 executive:1 some:1 years:1 weather:2 investment:1 pharmaceutical:1 said:1 pay:1 alternate:1 research:1 adverse:1 potentially:1 between:1 product:1 's:1 gains:1 warnings:2 company:1 expire:1 key:1 coming:1 device:1 news:1 stocks:3 off:1 losses:1 reports:1 banking:1 chief:1 small:1 recalls:2 maker:1 patents:1
stock_PFE r_down	prices:1 biotech:2 large-cap:1 just:1 consent:1 binding:1 years:1 hopes:1 against:1 depends:1 improvements:1 drug:1 broader:1 makers:1 market:1 really:1 decree:1 puts:1 three:1 shares:2 children:1 symptoms:1 tight:1 potential:1 treatment:2 declines:1 fuel:1 downturn:1 if:1 's:4 string:1 discovered:1 commerce:1 collaboration:1 under:1 looks:1 scrutiny:1 matters:1 new:1 regulatory:1 approval:1 manufacturing:1 vaccine:1 panel:1 plants:1 buck:1 lupus:2 actual:1 candidate:1 drop:1 signed:1 s:1 products:1 rallies:2 secretary:1 its:1 first:1
stock_PFE r_up	sector:2 biotech:2 says:1 products:1 positive:1 top:1 up:1 unchanged:1 one:1 remain:1 rates:1 market:1 close:2 analyst:1 boosts:2
stock_PFE r_up	just:1 67:1 sales:1 including:1 12000:1 year:1 affected:1 its:1 little:1 $:3 jumped:1 writes:1 shaved:1 40:1 late:1 between:1 deal:1 insurers:1 shrink:1 life:1 's:2 under:1 modest:1 base:1 triple-digit:1 billion:3 loss:2 could:1 35:1 fell:1 afternoon:1
stock_PFE r_down	sector:1 ran:1 series:1 into:1 two:2 spinal:1 slip:1 sector’s:1 out:1 4.6:1 $:1 troubles:1 integration:1 shares:1 indexes:1 injury:1 bought:1 gained:1 delayed:1 key:1 stocks:1 climb:1 billion:1 both:1 has:1 study:1 companies:1 drug:2 afternoon:1 stand:1 action:1 2008:1
stock_PFE r_down	operations:1 global:1 site:1 around:1 3.1:1 its:2 out:1 giant:1 cut:1 $:1 review:1 500:3 more:1 's:2 plans:1 drugs:1 million:1 southern:1 said:1 report:1 than:1 positions:1 drug:1 part:1 finds:1
stock_PFE r_up	just:1 investors:1 selloff:1 focus:1 private:1 high:1 rate:1 economic:1 reaching:1 year:1 decade:1 out:1 decline:1 eye:1 $:2 spending:1 plans:1 placing:1 generally:1 shares:1 recovers:1 shifts:1 emphasis:1 health:1 upbeat:1 brand:1 's:2 greater:1 prescriptions:1 government:1 rebound:1 after:1 but:1 rapidly:1 part:1 sold:1 prices:1 climbing:1 stocks:2 data:1 multiyear:1 developments:1 recent:1 keeping:1 last:1 name:1 medicines:1 restrain:1 large:1 portion:1 push:1 reclaim:1
stock_PFE r_up	lifted:1 people:1 over:1 have:2 crisis:1 out:1 pharma:1 nervous:2 radiation:1 shares:1 only:1 writers:1 upside:1 decades:1 do:1 's:1 couple:1 ago:1 10:2 faster:1 economics:1 analysis:1 so:2
stock_PFE r_down	months:1 over:1 weighed:1 session:1 rising:1 shares:1 losses:1 before:1 use:1 generic:2 tensions:1 legal:1 approved:1 between:1 expected:1 consecutive:1 has:1 sued:1 's:1 advances:1 earlier:1 popular:1 five:1 prices:1 effort:1 than:1 down:1 lower:1 third:1 rights:1 versions:1 drug:1 escalating:1 allow:1 action:1 closing:1 crude-oil:1 slightly:1 maker:1
stock_PFE r_down	they:1 ...:1 businesses:1 up:1 ended:1 trading:1 animal-health:2 close:1 open:1 before:1 pharmaceutical:1 giant:1 said:2 4.1:1 $:3 establish:1 shares:1 power:1 their:1 call:1 combine:1 ever:1 public:1 donors:1 after:1 's:2 plans:1 combination:1 drugs:1 price:1 million:1 regulations:1 ranked:1 anonymous:1 news:1 100:3 received:1 school:1 transaction:1 off:1 gift:1 university:1 cash:1 reports:1 complexity:1 prescribing:1 have:1 following:1 rising:1 multiple-sclerosis:1 medical:1 came:1
stock_PFE r_down	sector:1 development:1 one-year:1 right:1 being:1 year:1 some:1 idea:1 past:1 have:1 measure:1 market:1 overhaul:1 head:1 start:1 administration:1 anniversary:1 shares:1 firm:1 chances:1 health:2 income:1 tax:1 holiday:1 no:1 multinational:1 ...:1 we:2 's:5 get:1 big:1 marketing:1 wildly:1 rejected:1 most:1 'd:3 every:1 plan:1 world:1 multinationals:1 care:2 week:1 exception:1 has:1 look:1 bill:1 companies:1 stand-alone:1 drug:1 six-month:1 gyrate:1 relief:1 time:1 popular:1 overseas:1 treated:1
stock_PFE r_up	firm:1 product:1 medication:1 return:1 rights:1 amid:1 agreed:1 pipeline:1 investigational:1 review:1 partner:1 's:1 its:1
stock_PFE r_up	limited:1 managers:3 consider:1 widely:1 money:2 sales:1 cleared:1 two:1 held:1 suspended:1 useful:1 investment:1 vaccines:1 use:1 said:1 top:1 had:1 ideas:1 been:1 1:1 source:1 concerns:1 health:1 way:1 factor:1 safety:1 them:1 used:1 risk:1 resume:1 but:1 soon:1 fund:3 important:1 know:2 authorities:1 hedge:3 stocks:1 data:1 whose:1 amid:1 misleading:1 can:1 making:2 childhood:1
stock_PFE r_down	own:1 financial:1 disaster:1 producer:1 give:1 guidelines:1 back:1 years:1 put:1 have:1 ties:1 makers:1 working:1 40:1 writing:1 stock:1 them:1 's:1 cardiology:1 track:1 big:1 paid:1 worst:1 doctors:1 device:1 such:1 speeches:1 many:1 study:1 companies:1 according:1 drug:1 coal:1 published:1 following:1
stock_PFE r_up	n't:1 sue:1 prescription:1 pharmaceutical:1 drugs:1 large:1 ca:1 health-care:1 companies:1 allegations:1 county:1 facilities:1 overcharged:1 they:1 public:1 ruled:1
stock_PFE r_down	among:1 major:1 industrial:1 managed:1 year:1 turned:1 period:1 items:1 ended:1 motor:1 close:1 177:1 's:3 work:1 during:1 disasters:1 market:1 85:1 little:1 highest:1 gainers:1 $:4 trucker:1 since:1 political:1 40:2 its:2 consulting:1 their:1 clinical:1 best:1 strong:1 9:1 2011:2 2010:1 speaking:1 higher:1 turmoil:1 finish:1 led:1 gains:1 boosted:1 million:2 rail:1 paid:2 most:1 doctors:1 bumpy:1 such:1 stocks:2 natural:1 amid:1 ride:1 changed:1 smooth:1 other:1 trials:1 2008:1 stock:1 averages:1 institutions:1
stock_PFE r_up	major:1 brakes:1 price:1 companies:1 drug:1 increases:1 pressing:1 including:1 groups:1 put:1 religious:1
stock_PFE r_up	sector:3 bankruptcies:1 all:1 futures:3 session:1 among:1 past:1 agreed:2 top:2 finished:1 sales:1 private:2 up:2 high:1 prices:3 oil:5 trading:1 year:1 's:7 34:2 range:1 private-equity:1 arm:2 out:2 sell:1 trade:2 indexes:1 said:1 $:14 108:2 technology:1 acquire:1 2.38:4 flat:1 its:3 semiconductor:1 other:1 edge:2 low:1 premarket:1 equity:1 biggest:1 2.4:5 today:1 higher:1 firm:1 roundup:1 marked:1 selling:3 hit:2 gains:2 business:3 big:1 after:1 acquisitions:1 focus:2 volume:2 average:1 capsule:2 related:1 report:1 news:2 major:1 stocks:4 active:1 billion:5 sending:1 financing:1 narrow:1 showed:1 level:1 movers:1 light:1 industry:1 drop:1 cash:2 morning:2 while:1 gathers:1 tech:3 push:1 fresh:1 stock:1 eke:2 mergers:1
stock_PFE r_down	heart:1 deal:1 health-care:1 pharma:1 spending:1 2.38:2 treat:1 hottest:1 has:1 war:1 firm:1 adviser:1 's:4 propose:1 failure:1 moment:1 chips:2 $:2 talent:1 patients:1 making:1 changes:1
stock_PFE r_down	deal:1 partnering:1 into:1 businesses:1 blue:2 unusual:1 ripe:2 writes:1 way:1 diseases:1 treatments:1 part:1 shareholder:1 chips:2 great:1 rare:1 spinoffs:2 early-stage:1 value:1 can:1 push:1 enhance:1
stock_PFE r_up	nonprofits:1 kind:1 partnership:1 voluntary:1 world:1 getting:1 markets:1 writes:1 global:3 companies:1 emerging:1 around:1 underway:1 businesses:1 time:1 goes:2 international:1 new:1 effort:1 governments:1
stock_PFE r_up	rating:1 force:1 retailer:1 manager:1 out:1 generic:1 agency:1 shares:1 pharmacy:1 version:1 way:1 has:1 gives:1 's:3 seeking:1 judge:1 lawsuit:1 throw:1 benefits:1 clear:1 drug:2 asked:1
stock_PFE r_up	among:1 emerging:1 formed:1 's:5 significantly:1 joint:1 did:1 global:1 3:3 drug:1 n't:1 trial:1 patients:1 focused:1 venture:1 early:1 improve:1 markets:1 movers:1 late-stage:1
stock_PFE r_down	advisory:1 indications:1 cancer:2 over:1 global:1 $:1 slowing:1 down:1 backed:1 growth:1 transport:1 use:1 just:1 skidding:1 two:1 2.5:1 107:1 treat:1 spike:1 falling:1 panel:1 type:1 today:1 more:1 undercut:1 oil:1 drugs:1 possibility:1 market:1 recent:1 somewhat:1 demand:1 prices:3 stocks:1 than:1 fret:1 pancreatic:1 has:1 rare:1 --:1 approach:1 taking:1 amid:1 barrel:1
stock_PFE r_up	sector:1 process:1 developed:1 reduce:1 resistance:2 one:1 defense:1 impact:1 n't:1 errors:1 behind:1 today:1 more:1 's:4 far:1 arthritis:1 weigh:1 stocks:1 chatter:1 than:1 medical:1 budget:1 drug:1 having:1 project:1 patients:1 found:1 rheumatoid:1 study:1
stock_PFE r_up	unusual:1 getting:1 recalling:1 odor:1 after:1 some:2 two:1 drug:1 linked:1 lots:1 potentially:1 complaints:1 treated:1 its:1 unit:1
stock_PFE r_down	biotech:1 weaker:1 deal:1 reinvigorate:1 headwinds:1 dollar:1 sales:1 one:1 growth:1 including:1 drug:1 cuts:1 's:3 biggest-ever:1 makers:1 shareholders:1 strong:1 20:1 $:1 would:1 patent:1 refocus:1 flying:1 its:1 their:1 potential:1 struggling:1 company:1 dispute:1 first-quarter:1 expirations:1 business:1 government:1 some:1 price:1 quell:1 lift:1 key:1 device:1 aiming:1 billion:1 against:1 giving:1 figures:1 acquisition:1 medical-device:1
stock_PFE r_up	company’s:1 all:1 prescriptions:1 soars:2 drugs:1 make:1 after:1 up:1 release:1 according:1 more:1 better-than-expected:1 study:1 drug:1 90:1 hopes:2 rally:1 now:1 data:1 than:1 78:1
stock_PFE r_down	results:1 still:1 its:8 osteoporosis:1 24:3 75,000:1 $:4 treat:1 expectations:1 analyst:1 treatment:1 updated:1 gains:1 rules:1 12:1 not:1 during:1 continued:1 anemia:1 --:3 debut:2 companies:1 24.4:1 common:1 injectable:1 quarter:1 bone:1 early-stage:1 nearing:1 3.6:3 trading:1 year:1 's:3 medications:1 profit:1 while:1 shares:1 closed:1 new:1 conditions:1 focuses:1 sold:2 million:1 drug:4 struggle:1 approval:1 strong:1 beginning:1 helping:1 last:2 many:1 double-digit:1 19.90:1 range:3 products:1 planned:2 rose:1 changes:1 maker:1 first:1 comment:1 cancer:2 one:1 aimed:1 another:1 pharmaceutical:1 their:1 stock:2 expected:1 percentage:1 more:2 firm:2 selling:1 drugs:1 company:2 hurt:1 than:2 disappointing:1 made:1 14:1 showed:1 16:2 launches:1 up:1 patients:1 launched:1 developing:1 infections:1 exceeded:1 share:1 sales:1 expenses:1 13th:1 dropped:1 end:2 generic:1 high:2 details:1 units:1 higher:1 product:1 oil:1 first-quarter:1 price:4 after:1 driven:1 most:1 men:1 recent:2 reimbursement:1 contraceptive:1 well:1 traditional:1 maintain:1
stock_PFE r_down	taxi:1 results:1 session:1 go:2 still:1 its:3 osteoporosis:1 whose:1 rose:1 had:2 expectations:1 treatment:1 8:2 happened:1 then:2 updated:1 woman:3 hit:1 closed:1 rules:1 now:1 continued:1 day:1 anemia:1 --:3 companies:1 53:1 18:1 sidewalk:1 higher:2 bone:1 right:1 alive:1 3.6:3 second:2 actively:1 trading:1 exceeded:1 7th:1 first-quarter:1 profit:1 shares:1 7:1 between:1 new:1 911:1 after-hours:1 struggle:1 strong:1 gained:1 quarter:1 last:3 drug:4 products:1 changes:1 maker:1 first:1 cancer:1 one:2 another:1 additional:1 her:1 there:1 two:1 next:1 call:1 500:1 started:1 hurt:1 dead:2 analyst:1 me:1 1994:1 showed:1 launches:1 work:2 up:1 patients:1 were:1 my:1 launched:1 year:1 sales:1 expenses:1 disappointing:1 dropped:1 if:2 details:1 stock:1 product:1 added:1 's:2 tried:1 price:1 driven:1 most:1 stocks:1 recent:2 reimbursement:1 off:1 6th:1 well:1 traditional:1 points:3 came:1
stock_PFE r_up	biotech:2 appeal:1 investors:1 may:1 average:1 drug:2 leads:2 not:1 underestimating:1 fall:1 downgrade:1 stocks:2 company:1 your:1 retreat:2 developer:1
stock_PFE r_up	challenging:1 executive:1 nearing:1 surgical:1 used:1 its:1 market:1 giant:1 end:1 $:3 21.3:2 giving:1 reshape:1 away:1 40-year:1 injuries:1 16.6:1 health:1 treat:1 biggest:1 has:1 fractures:1 global:1 's:5 business:1 may:1 company:1 acquire:1 but:1 takeover:1 during:1 trying:1 care:1 billion:3 purchase:1 lead:1 career:1 devices:1 times:1 n't:1 chief:1 2006:1 consumer:1 maker:1 medical-device:1
stock_PFE r_up	fourth-quarter:1 findings:1 consolidated:1 profit:1 blockbuster:1 jump:1 judge:1 say:1 aimed:1 file:1 federal:1 alone:1 submit:1 declined:1 sell:1 25:3 said:2 end:1 would:1 no:1 generic:1 trials:2 regulatory:1 two:2 legal:1 next:1 signals:1 whether:1 detected:1 version:1 safety:1 treatment:2 clinical:1 net:1 unit:1 meeting:1 final:1 more:1 week:1 's:2 estimates:1 company:1 arthritis:1 standard:2 early:2 applications:1 chance:1 five:1 decide:1 new:1 improving:1 approval:1 setting:1 than:1 stage:1 fiscal:1 effective:1 reported:1 --:1 could:1 drug:5 exiting:1 spokeswoman:1 addition:1 analysts:1 were:2 distribution:1 pivotal:1 rheumatoid:1 its:2 experimental:1 late-stage:2
stock_PFE r_up	operations:1 limited:1 emerging:1 unemployment:2 businesses:1 comments:2 research:2 year-earlier:1 its:7 $:9 graph:2 show:2 attractive:1 integrate:1 has:1 2011:1 2010:4 earnings:1 versus:1 fourth:1 updates:2 background:1 him:1 nearly:1 products:1 excluding:1 --:1 follows:1 list:2 50:1 payments:1 set:2 ten:1 competition:1 rate:2 growth:2 year:1 first-quarter:2 declined:1 said:3 profit:2 projected:1 hepatitis:1 forecast:1 version:1 health:1 appeal:1 sixth:1 million:2 acquisition-related:2 tripled:2 beginning:4 generate:1 change:2 pharma:1 reaction:1 pipeline:1 working:1 items:1 according:2 drug:3 range:1 figures:1 published:1 slightly:1 maker:2 projection:1 economists:2 previously:1 bolster:1 targeting:1 additional:1 puts:1 spending:3 8.8:2 5th:1 been:1 next:2 which:1 expected:2 markets:1 ``:1 drugs:1 registered:2 corrected:1 released:2 lowered:1 doctors:1 analyst:1 11:3 professionals:1 up:1 while:2 cost:1 9th:1 10th:1 acquisition:1 certain:2 health-care:1 sales:2 '':1 full-year:1 end:1 no:2 generic:1 pay:1 1:2 also:1 other:1 details:2 holding:1 a.m.:1 company:1 stock:2 development:1 's:7 boosted:1 price:2 earlier:1 helped:1 services:1 payment:1 billion:1 lower:3 savings:1 costs:2 diversify:1 2009:2 consumer:1 8th:1
stock_PFE r_up	stock:2 already:2 says:1 just:1 people:1 previously:2 recognize:1 guidelines:2 sign:1 sales:1 trade:1 not:2 see:1 session:1 numbers:1 gave:2 been:1 tomorrow:1 plans:1 whose:1 slow:1 cancer:4 federal:1 marketed:2 regulatory:2 recommended:2 shares:1 research:1 vaccines:1 their:1 behind:1 won:2 tape:1 treat:1 widely:2 6:2 expected:1 new:2 proposal:1 has:1 public:1 treatment:2 shipments:1 customers:1 buy:1 's:4 premarket:2 auto:1 under:1 watch:2 but:2 parents:1 said:2 plan:1 doctors:1 active:1 approval:4 injection:2 promote:4 had:2 $:2 13:2 look:1 same:1 insurance:1 industry:1 latest:2 up:3 drug:4 until:2 n't:2 cigarettes:1 patients:2 indication:4 allow:2 were:2 addicted:1 employees:1 more:2 its:5 could:2 dropped:2
stock_PFE r_down	summer:1 proposed:1 over:2 move:1 focus:5 trade:1 leads:1 ended:1 session:4 businesses:7 comments:2 signs:1 still:1 decisions:1 its:13 24:1 whose:4 giant:7 anticipation:3 likes:1 $:4 22:1 rose:6 guidance:3 non-core:1 analyst:1 revenue:7 stock-market:1 4:3 premarket:3 under:1 quarterly:4 health:7 weeks:1 has:2 2011:4 details:1 bin:1 ...:1 evening:2 hit:4 animal:3 provisions:3 bonds:2 rise:1 watch:2 possible:1 results:3 putting:1 know:1 background:1 fall:3 report:2 month:1 continued:2 pharmaceutical:9 developments:1 gave:1 amid:4 2012:3 like:1 stranger:1 --:8 fully:1 drop:5 companies:10 50:1 fewer:4 morning:1 ignore:1 did:1 bad:1 t:1 after-hours:2 gauge:1 higher:2 better-than-expected:3 shed:7 set:1 financial:1 prompted:1 energy:2 estimates:3 actively:4 trading:8 year:3 first-quarter:6 2.7:1 best:1 out:1 investor:2 excitement:1 said:3 adds:1 missed:3 profit:6 review:1 cut:2 contributed:3 slick:2 shares:11 research:4 favor:1 3:1 safety:2 grads:1 closed:1 new:2 boost:2 leader:2 shows:1 setbacks:1 we:1 surge:1 forces:1 business:3 slight:3 continuing:1 cholesterol:3 weak:2 brand-name:3 20:3 hours:2 pressure:2 protection:2 alone:1 news:1 100:1 close:3 beginning:3 half:1 care:3 gained:1 reaction:1 pipeline:1 roster:1 last:1 ahead:1 reported:7 technical:1 eke:1 losses:2 37:1 reports:5 costs:5 affirmed:3 s:1 fell:1 economic:1 analysts:1 graph:2 mixed:4 insufficient:1 casino:1 heart:1 traded:2 silver:2 demise:1 among:1 hands:1 expects:1 slipped:2 headed:2 orders:1 three:1 down:10 been:1 determine:1 brokerage:1 cancel:1 exchanges:1 throughout:1 soon:1 telecommunications:2 market:2 significantly:2 pouring:1 long:1 figure:1 start:3 positive:1 top:3 initial:1 charts:1 tiny:1 their:1 returns:1 growth:1 nearly:1 way:1 which:4 expected:2 just:1 markets:2 unchanged:1 500:7 more:1 company’s:1 eyes:1 health-care:1 complete:1 releases:1 slumping:4 fundamentals:1 some:2 company:7 hotel:1 but:5 scrutiny:1 terror:1 decline:3 gain:1 8:1 line:3 than:2 those:1 posted:1 10:19 virtually:1 builds:3 edged:5 up:6 n't:2 while:4 lose:2 replaced:1 midday:1 were:5 flagging:1 college:1 10th:1 spotlight:2 dropped:1 point:2 0.8:1 weaker:1 slip:1 investors:5 1.3:2 bigger-than-expected:3 correction:1 dumped:2 tax:3 sales:12 disappointing:2 death:1 adding:1 drug:7 have:2 12th:1 2.2:1 blockbuster:3 yet:1 any:1 risk:1 sell:1 factory:1 4.6:2 firm:1 no:1 patent:2 seeking:1 data:1 mix:2 materials:2 earnings:11 fourth:1 9:1 you:1 several:3 brace:2 stock:7 hone:3 oil:2 's:28 plans:2 though:4 absorb:1 price:1 after:5 helped:3 4th:1 shareholder:1 announce:1 coverage:1 coming:3 such:3 stocks:9 guys:1 concerns:1 billion:1 lower:9 off:4 charges:4 slightly:2 futures:7 finished:1 rule:1 points:11 came:1 trades:1 basket:1 latest:1 consumer:3 order:1 profits:1 updates:1
stock_PFE r_up	roundup:1 saying:1 stocks:1 surprises:2 move:1 companies:1 reports:1 quarters:1 advisories:2 earnings:1 future:1 corporate:1 today:1 latest:1
stock_PFE r_down	saying:1 agreed:1 allegations:1 find:1 benefits:1 group:1 $:1 22:3 lackluster:1 had:1 should:1 choose:1 has:1 they:1 using:1 settle:1 kickbacks:1 series:1 sign:1 urgent:1 cost:1 year:1 arm:1 said:2 lead:2 profit:1 its:2 enough:1 net:1 million:1 leukemia:1 promoted:1 opposition:1 pharma:2 prescription:1 drug:6 changes:1 options:2 frequent:1 fourth-quarter:1 one:1 another:1 refined:1 expensive:1 their:2 system:1 one-time:1 whom:1 treatment:1 outweighs:1 drugs:2 brand:1 bladder:2 gain:1 doctors:1 prices:1 lifestyle:1 than:1 aren’t:1 n't:1 patients:1 growing:2 more:1 biotech:1 certain:1 health-care:1 high:1 say:1 experts:1 have:1 need:1 variety:1 pay:2 makers:3 earnings:1 which:1 illegally:1 used:1 's:1 may:1 earlier:1 treatments:2 fell:1 multiply:2 stocks:3 lower:2 sentiment:1 sale:1 maker:1 south:1 dragged:1
stock_PFE r_up	pharmaceutical:1 creating:1 apps:1 increasingly:1 websites:1 void:1 reps:1 sales:1 been:1 tools:1 filling:1 other:1 drug:1 have:1 digital:1 eliminated:1 now:1 thousands:1 makers:1
stock_PFE r_up	advisory:1 investors:1 saying:1 over:1 years:1 vote:1 return:1 plan:1 total:1 its:1 top:1 three:1 recommending:1 other:1 has:1 firm:1 's:2 shareholder:1 proxy:1 last:1 influential:1 companies:1 against:1 large:1 compensation:1 executives:1
stock_PFE r_down	set:1 money:1 probe:1 allegations:1 number:1 continued:1 1st:1 11th:1 settlement:1 said:2 bottles:1 antipsychotic:1 would:2 graph:1 offensive:2 aside:1 chemical:2 source:1 add:1 investigation:1 details:2 discovering:2 several:2 company:2 stock:1 illegally:1 's:1 trace:2 government:1 price:1 after:2 promoted:1 recalled:1 contamination:1 adds:1 beginning:1 potential:1 unauthorized:1 countries:2 recall:2 drug:2 amount:1 lapses:1 uses:1 toward:1
stock_PFE r_up	into:2 probe:1 long-running:1 slip:1 shines:2 $:3 negative:1 1:3 territory:1 's:1 seeking:1 marketing:1 but:2 most:1 fall:1 stocks:3 antipsychotic:1 billion:1 resolve:1 prosecutors:1 roughly:1 drug:2 slide:2
stock_PFE r_up	all:1 expects:1 surrounding:1 its:1 litigation:1 $:3 pay:1 least:1 9:3 higher:1 million:1 drugs:1 tally:1 but:1 therapy:1 10:3 13:3 resolve:1 could:1 stories:3 ultimate:1 product-liability:1
stock_PFE r_up	oncology:2 holds:2 executive:2 ninth:2 years:2 session:1 including:2 shares:2 cuts:2 fifth:2 setbacks:2 whose:1 discloses:1 cancer:5 also:4 had:2 signals:1 production:1 bank:2 has:2 updated:2 advances:2 therapy:2 background:2 timing:2 advanced:2 designation:2 12th:2 companies:1 morning:1 view:2 exists:2 51:1 orphan:2 slowdown:1 actively:1 trading:1 said:4 decision:4 comments:2 boosted:1 new:4 filings:1 schedule:2 weak:1 diagnostic:2 regulators:2 regulatory:5 approval:4 beginning:2 received:2 last:2 months:4 according:1 drug:9 efforts:2 traded:2 maker:2 experimental:5 stakes:1 major:2 industrial:1 slipped:1 point:1 2nd:2 down:1 lung:2 news:1 throughout:2 market:1 given:5 holdings:2 housing:1 been:2 priority:5 expected:2 type:2 500:1 more:1 much-needed:2 offer:2 company:2 review:4 10:2 none:2 target:2 while:1 shortened:2 certain:2 brutal:1 have:2 sells:1 sell:3 4.6:1 provide:2 six:2 lung-cancer:2 1:1 application:3 details:6 which:2 test:2 several:2 fast-track:2 stock:2 status:7 's:18 may:2 quote:2 treatments:2 fell:1 significant:2 stocks:1 data:1 recent:2 lower:1 accelerates:2 filed:4 points:2 time:2 filing:2
stock_PFE r_up	investors:1 dividend-paying:3 results:2 trade:1 assess:1 need:1 second:1 yield:1 carefully:3 stocks:4 likely:1 make:2 looking:1 stock:1 company’s:1 modestly:1 sure:1 gains:1 after:2 but:1 includes:1 gain:2 rises:2 payout:1 healthy:1 wins:1 companies:1 days:1 contract:1 continue:1 loves:1 many:1 higher:1
stock_PFE r_down	saying:1 filed:1 years:2 four:1 held:1 session:1 same:1 7.5:1 still:2 its:2 whose:1 death:1 group:1 $:2 lackluster:1 rose:1 3:1 resubmit:1 treatment:3 has:2 petition:1 tests:1 evening:1 return:1 around:1 seeking:1 survival:2 overall:1 early:1 nearly:1 dose:1 --:2 hunt:1 companies:3 large:1 did:2 ban:1 found:2 early-stage:1 deal:1 testing:2 alive:2 rate:1 actively:1 trading:1 measure:1 2.2:1 arm:1 said:1 competitor:1 marketed:1 ovarian:1 shares:1 outside:1 new:1 scientific:1 notable:1 slated:1 article:1 gained:1 received:2 last:1 receive:1 study:3 annual:1 37:1 drug:7 tumor:1 trial:3 carries:1 published:2 placebo:1 studies:1 asked:1 experimental:3 repair:1 cancer:4 presence:1 contender:1 number:1 owned:1 one:1 lung:3 privately:2 two-year:1 market:1 conventional:1 additional:1 beef:1 leading:1 two:2 clinical:3 rates:1 meeting:1 500:1 more:1 buy:1 upcoming:1 company:2 delayed:1 but:1 two-thirds:2 hole:1 highest:1 than:1 women:1 include:1 14:1 up:1 n't:3 patients:4 growth:1 were:2 treated:1 could:1 control:1 months:1 year:1 reports:1 have:1 climbed:1 compared:2 form:3 pay:1 consumer:1 40:1 other:1 which:1 online:1 higher:1 's:5 4,000:1 64:3 after:2 much:1 most:1 involving:1 blood:1 significant:1 stocks:1 data:1 billion:2 effective:1 home:1 traded:1 maker:1 points:3 serious:1 starting:2 latest:1
stock_PFE r_down	hip:1 thinner:1 session:1 people:1 2.9:1 actively:1 trading:1 have:1 surgery:1 plodding:1 out:1 whose:1 8.3:1 slow:2 rose:1 45:1 spiral:2 shares:1 3:2 winners:1 health:1 closed:1 new:1 you:1 500:1 higher:1 fool:1 's:1 big:2 clots:1 handful:1 regulators:1 death:2 let:1 blood:2 knee:1 along:1 stocks:3 approved:1 gained:1 climbed:1 companies:1 points:3 losers:1 components:1 after-hours:1 replacement:1 prevention:1 stick:1
stock_PFE r_down	comment:1 major:1 broader:3 troubles:1 over:1 share:1 one:1 13th:1 trading:1 have:1 7th:1 11th:1 standards:1 crisis:1 market:3 ground:1 6th:1 renewed:1 adds:1 fears:1 comments:1 makers:1 another:1 units:1 meeting:1 price:1 movement:1 's:5 increased:1 company:2 after:1 background:1 fall:1 regulatory:1 debt:1 analyst:1 10th:1 manufacturing:1 follows:2 drug:2 loses:1 regulator:1 afternoon:1 9th:1 country:1 found:1 8th:1 its:1 south:2 first:1
stock_PFE r_down	comment:1 set:1 sees:1 companies:1 tax:3 spectrum:1 '':1 bring:1 say:2 own:1 12.5:2 its:3 fifth:1 regime:1 group:1 would:2 detail:1 lawmakers:2 match:1 across:1 500:1 introducing:1 ``:1 's:2 convincing:1 pitfalls:1 let:1 plan:1 background:1 backed:1 line:1 opportunity:1 change:1 case:1 high:1 lower:1 has:2 --:4 region:1 proposals:1 rate:4 near:1 three-year:1 market-cap:1 permit:2 corporate:2
stock_PFE r_up	saying:1 being:1 years:1 session:2 including:2 its:3 blow:1 whose:2 rose:2 failed:1 treatment:2 2015:6 momentum:2 details:1 good:1 boon:1 watch:2 nearly:1 month:1 like:1 --:5 companies:2 53:1 cholesterol:1 logistics:1 prevent:1 generation:1 actively:2 trading:2 3.3:1 multiple:1 makers:1 delivered:1 said:3 shares:2 research:2 vaccines:2 3:2 health:1 new:3 seventh:1 regulatory:2 approval:2 beginning:1 reaction:1 pipeline:2 attacks:1 could:1 climbed:1 drug:6 trial:1 fell:1 mixed:1 efforts:1 traded:2 experimental:2 13,000:3 harness:1 market:3 pharmaceutical:3 clinical:1 treat:1 way:1 500:2 4:1 ``:1 drugs:3 company:3 but:1 hopes:2 analyst:1 11:6 stolen:1 17:1 up:1 while:1 officials:1 were:1 making:1 industry:1 1.4:1 heart:2 slid:1 investors:1 '':1 against:1 file:2 string:1 generic:1 pills:1 build:2 which:1 units:1 higher:1 's:8 plans:2 strokes:1 earlier:1 thefts:1 halted:1 involving:1 stocks:2 eighth:1 recent:3 center:1 weapon:1 sclerosis:1 disease:4 points:6 latest:1
stock_PFE r_up	8.1:1 whose:1 5.2:1 's:1 22:1 rose:1 climbed:1 companies:1 up:1 shares:1 points:3 trading:1 actively:1 closed:1 after-hours:1 session:1 stocks:1 500:1 higher:1
stock_PFE r_down	outlook:2 investors:1 flat:1 being:1 over:1 year:2 sales:2 years:1 down:1 see:2 vow:1 trading:1 shares:1 cuts:1 forecast:1 lifts:2 digest:1 decline:2 said:3 revised:1 would:1 prior:1 spending:4 leading:1 avoid:1 40:1 research:1 fall:2 equal:1 growth:1 bank:2 way:1 provider:1 --:1 percentage:2 has:1 company:2 more:1 development:1 200:3 ``:1 his:1 's:4 price:1 time:1 expects:1 early:1 higher:1 updates:1 background:1 coming:1 services:1 central:2 stocks:4 than:2 change:1 '':1 lower:2 last:1 lead:1 third:1 did:1 slightly:1 could:1 likely:1 drug:1 leader:1 n't:1 sensitive:1 points:1 economic:1 afternoon:1 things:1 banks:1 climb:1 stock:1 steep:1 economically:1 expect:1
stock_PFE r_down	emerging:2 generic-drug:2 in-house:2 all:2 '':2 second:2 expect:2 year:2 decisions:4 its:2 considering:2 pharmaceutical:2 giant:2 said:4 business:4 should:2 start:2 intends:3 generics:3 big:2 expected:2 branded:3 markets:2 ``:2 collaborate:3 form:3 though:2 marketing:3 joint:3 bang:2 announcement:2 half:2 manufacturing:3 he:2 announcing:2 standalone:2 whether:2 single:2 n't:2 did:2 remain:2 venture:3 become:2 once:2
stock_PFE r_down	comment:4 prevent:8 adjusted:1 packaged-food:1 investors:1 competitor:4 period:1 trade:2 down:1 session:2 tablets:4 projections:1 approval:4 margins:1 swung:1 year-earlier:1 its:4 1.6:1 sell:4 whose:2 said:12 actively:2 $:1 representative:2 bottom:1 profit:2 able:2 third-quarter:1 shares:3 better:1 version:8 2019:2 treatment:4 fourth:2 suit:4 expected:2 outlook:1 heavier:1 price:2 movement:2 applied:4 selling:4 's:11 beat:1 sixth:2 company:5 after:1 immediately:2 sales:1 hours:1 generic:8 takeover:1 focused:1 updates:2 filed:4 regulatory:4 suing:4 line:1 matter:2 fiscal:1 disappointing:1 has:4 third:2 current:1 companies:2 drug:4 n't:2 patent:6 costs:1 expiration:6 were:1 following:1 quarter:1 prior:4 maker:4 thanks:1
stock_PFE r_down	measuring:1 because:1 investors:1 win:1 ca:1 held:1 promise:1 year:1 deal:1 patent:1 research:1 other:1 which:1 surprise:1 personalized:1 meeting:1 therapies:1 more:1 interests:1 's:1 samples:1 offering:1 infringement:1 company:1 reach:1 blood:1 plenty:1 subsidiary:1 than:1 ruled:1 case:1 faster:1 effective:1 --:1 could:1 against:1 n't:1 patients:1 buzz:1 medicines:1 patents:1
stock_PFE r_up	comment:1 developed:1 over:1 patent-infringement:1 argues:1 four:1 held:1 clinic:1 appeals:1 participate:1 its:1 scoring:1 $:1 should:1 samples:1 2010:1 do:1 big:1 intellectual:1 using:1 ruled:1 countries:1 --:1 companies:2 victories:1 smaller:1 deal:1 cuts:2 some:1 cost:1 booming:1 said:1 funding:1 visiting:1 research:1 looking:1 written:1 new:1 method:1 shows:1 measuring:1 business:1 backed:1 along:1 conducting:1 benefits:1 getting:1 dollars:1 computers:1 drug:2 keen:1 drug-coated:1 military:1 patents:2 yearly:1 already:1 extra:1 win:1 ca:1 billions:1 because:1 promise:1 1990s:1 coatings:1 relating:1 top:1 their:1 way:1 researchers:1 markets:1 interests:1 company:1 pricey:1 subsidiary:1 than:1 case:1 homes:1 kind:1 smartphones:1 look:1 n't:1 patients:1 ruling:3 were:1 making:1 property:1 region:1 heart:2 have:1 against:1 prostate-cancer:1 sought:1 hospitals:1 court:3 trial:2 rather:1 1:1 which:3 development:1 's:5 earlier:1 blood:1 opinion:1 frequently:1 billion:1 metal:1 stents:2 came:2 affirmed:1
stock_PFE r_down	looking:1 after:1 says:1 $:2 may:1 many:1 drop:1 new:1 employers:1 1:2 health:1 rising:1 coverage:1 2014:1 rates:1 salmonella:1
stock_PFE r_up	just:1 over:1 month:1 vacancy:1 against:1 chicken:1 its:1 $:1 writes:1 detected:1 candidates:1 very:1 big:1 stop:1 protesters:2 early:1 five:2 nearly:1 years:2 rental:1 like:2 level:2 --:1 companies:1 who’s:1 signing:1 streets:1 some:1 hair:1 rate:1 our:1 organizing:1 said:1 concessions:1 research:1 new:1 turning:1 million:1 free:1 100:1 stage:1 drug:3 creates:2 feed:1 protests:1 into:1 aimed:1 another:1 jobless:1 next:1 their:1 low:1 more:4 lowest:1 ``:1 prices:1 effort:1 up:1 below:1 drags:1 lease:1 treated:1 have:1 tax:1 0.7:1 '':1 rent:1 want:1 fill:1 recovery:1 agency:1 potential:1 animal:1 several:1 used:1 's:2 peaks:1 collaborative:1 after:1 fell:1 guys:1 break:1 longer:1 medical:1 chickens:1 sale:1 analysis:1 spend:1 2007:1 corporate:2 institutions:1
stock_PFE r_down	pharmaceutical:1 giant:1 cleared:1 's:5 business:1 antitrust:1 --:1 regulator:1 said:1 health:1 has:1 consumer:1 acquisition:1
stock_PFE r_up	company’s:1 rating:1 all:1 raise:1 burst:1 over:1 global:2 helped:1 mild:1 economic:1 through:1 cuts:1 carry:1 rally:1 surgery:1 find:2 out:1 swine-flu:1 $:3 4.3:3 positive:1 plans:1 agency:1 administration:1 exceeding:1 shares:1 its:2 targets:1 program:1 2019:2 treatment:1 2015:1 enthusiasm:1 overshadows:1 slips:2 gains:1 allowing:1 groups:1 downgrade:1 news:1 post:1 stocks:6 vaccine:2 charity:1 billion:1 advance:1 training:1 criticize:1 calls:1 largely:1 budget:1 deals:1 donations:1 relief:2 rallies:2 worries:1 aid:1 climb:2 corporate:1 mergers:2
stock_PFE r_up	revised:2 some:2 focus:2 trading:4 have:2 year:2 close:2 positive:2 market:2 pharmaceutical:2 $:10 candidate:2 pay:2 shares:4 its:2 1:2 other:2 much:2 implant:2 has:2 stock:2 development:2 royalties:2 product:6 's:4 though:2 may:2 0.5:2 company:2 million:2 agreement:4 results:2 early:4 trials:2 despite:2 21:2 upturn:2 amid:2 glaucoma:2 up:4 order:2 plus:2 broad:2 were:4 fallen:2 maker:2
stock_PFE r_down	plant:1 lead:1 warns:1 problems:1 drug:1 procedures:1 review:1
stock_PFE r_up	comment:1 heart:4 associated:2 market:1 up:1 being:2 certain:1 approaching:1 sap:1 back:2 increased:1 existing:1 down:1 been:1 sector:1 analysis:1 quits:1 patient:1 next:1 fifth:1 cardiovascular:3 one:1 information:1 '':1 said:2 onto:1 lead:1 pharmaceuticals:1 patent:1 legal:1 revenue:1 long:1 label:1 increase:3 reasons:2 other:3 call:1 don’t:1 storm:2 conduct:1 chugging:1 new:1 has:1 might:3 events:2 announced:1 updated:1 's:6 risk:1 leg:1 may:1 big:1 problems:1 fast:1 soon:2 markets:1 regulators:1 protection:1 billions:1 smoking:3 stocks:3 beginning:1 cliff:2 goes:1 11:2 ``:1 versions:1 attacks:3 many:1 could:1 disease:3 drug:4 dollars:1 --:5 patients:4 risks:1 lose:1 drugs:1 toward:1 studies:1 asked:1 generic:1
stock_PFE r_up	billion:1 1.5:1 recommends:1 sees:1 $:1 drugs:2 pay:1 annual:1 sales:1 two:1 key:1 2020:1 coverage:1 opinion:1 's:3 leaders:1 change:1 anemia:1
stock_PFE r_up	consider:1 developed:2 over:8 ninth:1 trade:1 6.7:1 quotes:4 session:4 including:2 higher:2 committed:2 follow:1 its:5 6.9:1 whose:4 $:10 title:2 rose:3 28:2 public:2 treatment:2 passion:1 has:2 health:2 physicians:2 finance:1 background:2 breast:2 they:2 milestone:2 58:2 lost:1 --:1 follows:2 medicines:2 companies:4 morning:2 verdict:1 cholesterol:5 worries:2 stock:7 prevent:2 because:2 past:4 actively:4 trading:7 year:4 's:13 2.5:1 out:1 said:3 adds:4 patients:2 shares:8 access:2 favor:3 written:1 version:4 tainted:1 closed:1 new:8 appeal:2 issue:2 correct:2 jury:1 marketing:7 payment:2 million:2 boosting:5 futures:3 gained:2 essentially:4 ahead:5 climbed:4 37:2 drug:16 trial:1 recently:2 a.m.:2 published:2 mixed:1 traded:2 designed:2 comment:1 cancer:2 point:1 address:2 safety:2 period:4 three:6 down:4 appropriate:2 64:2 losses:1 69:1 open:1 unit:2 use:2 would:1 weekend:1 wiped:1 due:2 eighth:1 their:2 expected:2 markets:1 500:3 flat:4 ``:4 drugs:2 company:1 rejected:2 1.9:1 line:5 women:3 case:1 weighed:2 13:1 17:1 developing:2 default:1 meeting:1 up:4 n't:1 while:4 expiration:5 were:8 slid:1 months:4 recognize:2 0.4:2 0.6:2 '':4 have:4 our:2 after-hours:1 patent:5 fears:1 ministers:1 potentially:2 details:2 entitled:1 product:5 added:2 pain:9 watch:2 after:1 76:1 75:2 important:2 but:1 stocks:5 judgment:2 approved:7 recent:4 lower:1 short:1 third:2 later:5 remain:2 points:8 responsibility:2 order:1
stock_PFE r_up	caused:2 trade:1 manager:1 planning:1 including:1 thanks:1 its:3 whose:1 rose:1 pharmacy:1 diseases:2 seeking:2 rise:1 watch:1 number:2 front:1 continued:1 condition:2 countries:2 follows:2 companies:1 benefit:1 session:1 stock:1 strengthened:1 often:2 tumble:1 some:1 actively:1 trading:1 110:2 pain:6 margins:2 said:3 network:1 lead:2 patients:2 shares:2 injuries:2 3:2 new:1 sinks:2 notable:1 diagnostic:1 regulators:1 approval:2 declining:2 central:4 getting:1 study:2 30:1 drug:4 afternoon:1 nervous:2 placebo:2 approve:1 first:1 nerve:2 already:2 primary:2 third-quarter:1 reducing:2 market:1 additional:1 renewal:1 top:2 system:2 been:1 treat:4 expected:1 injury:2 store:1 company’s:1 north:2 successful:1 company:1 part:1 gain:2 drug-stocks:1 n't:2 while:3 growth:1 were:1 following:2 making:1 associated:2 impacts:1 bigger-than-expected:1 sales:2 contract:1 have:1 moves:1 negotiations:1 compared:2 generic:1 also:1 earnings:1 which:2 test:1 higher:1 gaining:2 product:1 's:2 such:2 stocks:9 data:1 approved:2 diabetes:2 fiscal:1 refuse:1 effective:2 amid:1 without:1
stock_PFE r_down	thinner:1 plans:1 needle:1 looming:1 dosing:1 drug:1 competition:1 popular:1 new:1 arthritis:1
stock_PFE r_up	midpoint:2 global:2 dollar:1 results:2 trade:2 against:1 6.4:1 coli:1 portfolio:2 prospects:1 its:8 weekly:1 24:1 whose:4 cut:2 group:1 $:6 hint:2 point:1 premarket:1 equity:1 fuel:1 has:1 2011:2 risk:2 get:2 3.65:2 weakness:1 rise:4 watch:2 early:1 putting:2 additional:2 they:1 fall:2 report:1 austerity:1 day:2 lost:2 56:1 companies:5 session:4 testing:1 round:3 better-than-expected:1 heavy:1 prompted:1 signs:2 second:2 actively:4 trading:3 year:2 further:1 makers:1 declined:4 out:1 closes:1 said:1 continuing:1 stands:1 pressured:2 profit:1 patients:1 shares:5 forecast:2 medicine:1 new:1 boost:2 reporting:1 core:1 earlier:1 jobs:1 sinks:2 adding:1 weak:1 million:2 notable:1 standard:1 following:1 no:2 key:1 analyzed:1 news:2 spark:1 manufacturing:2 declining:2 jobless:5 hits:2 2.8:2 irregular:1 losses:3 drug:3 paring:1 products:1 heartbeat:1 blood:3 among:3 outlook:3 thinner:3 projection:2 facility:2 into:1 down:2 shun:1 3.2:2 another:1 reached:2 100:2 pouring:1 8.5:1 investors:3 start:2 positive:1 lawsuits:1 faltering:1 larger-than-expected:1 their:2 doubt:1 biggest:2 bonds:1 territory:1 500:5 more:1 selling:1 efficacy:1 funds:1 offered:2 slump:1 39:1 but:3 expected:2 lowered:2 wake:1 goals:1 than:1 showed:1 shielded:1 rival:1 likely:1 late-stage:1 while:2 growth:10 attention:1 were:1 growing:2 making:1 steep:1 spotlight:2 dropped:2 1.4:1 slid:3 futures:8 1.1:1 1.2:1 1.3:1 slowing:2 strain:1 stroke:1 caution:2 biologics:2 spooked:1 moves:1 again:1 respective:1 easing:2 5.5:1 trial:2 generic:1 divided:1 government:1 preventing:1 concerns:1 5:1 stock:8 gaining:2 draw:1 used:1 's:10 index:3 strokes:1 after:5 extending:1 fell:7 plan:3 quantitative:2 authorities:1 such:1 stocks:11 data:3 euro:1 purchase:2 lower:2 downbeat:1 alleging:1 disease:1 traditional:1 reports:2 points:8 time:2 claims:5 once:1 consumer:1 latest:2
stock_PFE r_down	limited:1 all:1 help:1 proposed:1 being:1 money:2 over:2 executive:1 results:1 setback:2 years:1 themes:1 held:1 session:5 including:2 its:1 before:3 24:1 whose:5 giant:1 $:9 2011’s:2 18:2 it’s:1 fared:2 than:1 pre-market:1 treatment:2 premarket:2 developed:2 health:1 weeks:1 bipartisan:1 2011:1 worth:1 details:1 good:1 hit:1 around:1 far:3 big:1 watch:1 break:1 they:1 using:2 trade:1 bringing:1 comment:1 skeptical:1 lost:4 impact:1 --:2 companies:5 throughout:1 morning:1 did:1 common:2 after-hours:2 release:1 bond:1 blood-thinner:1 temporarily:1 financial:1 methods:2 deal:2 midyear:1 700:1 back:1 you’re:1 3.6:1 analyst:1 likely:1 actively:5 trading:7 3.3:1 lawyer:1 year:1 's:16 investment:1 declined:3 said:2 apixaban:1 shares:6 powerhouse:1 written:1 version:2 volatile:1 unit:1 closed:1 medicine:2 new:4 turmoil:1 we:1 shakes:2 jobs:1 creating:1 business:1 state:1 million:1 agreement:1 reported:1 labeling:1 although:1 news:1 strong:2 come:1 generate:1 earlier:1 gained:1 regulations:1 protect:1 last:1 32:4 taking:1 30:1 36:1 drug:8 hired:1 figures:1 mixed:1 support:1 software:1 checkup:1 fourth-quarter:1 thinner:1 followed:1 key:1 lawsuits:1 one:2 down:4 60:1 suspended:1 path:1 says:1 quickly:1 dream:1 market:1 size:1 '':2 law:1 would:3 their:1 top:2 been:2 cash:1 pharmaceuticals:1 expected:1 energy:1 500:4 systems:1 flat:1 ``:2 buy:1 tax:1 company:4 billion:1 lower:2 rejected:2 99:2 ended:1 demand:1 true:1 lawmakers:1 glad:1 case:1 10:2 13:1 15:2 shielded:1 wish:1 up:1 late-stage:1 n't:1 remain:1 growth:1 those:2 ruling:3 were:5 under:1 plaintiffs:1 country:1 study:4 slid:3 climbed:1 1.2:1 1.3:1 cents:2 blood:1 mind:1 sales:2 hardware:1 pushed:1 highlighted:1 against:1 have:3 return:1 technology:2 sell:1 different:1 court:3 generic:1 make:1 fears:1 ideas:2 makers:1 1:1 application:2 causing:1 earnings:1 products:1 you:1 many:1 stock:1 sued:1 used:2 pain:2 escalate:1 overall:1 after:1 halted:2 fell:4 moving:1 but:3 countering:1 services:1 such:1 stocks:11 fiscal:1 discourage:2 2009:1 off:2 move:1 consumer:1 alleging:1 roughly:1 traditional:1 more:1 chief:1 points:9 so:3 time:1 banks:3 overseas:1 typical:1 corporate:1 divided:1 profits:1 latest:2
stock_PFE r_up	rocket:1 glut:2 soon:1 trade:2 session:4 through:2 talks:1 its:6 rundown:1 whose:4 giant:1 group:1 $:3 23:1 merger:1 rose:6 delays:2 had:2 unleashed:2 disclosed:3 premarket:1 might:1 bid:1 watch:1 did:2 warned:2 companies:6 morning:1 --:4 after-hours:1 popular:2 including:3 speculation:3 significantly:2 actively:4 trading:2 result:1 year:2 's:9 lead:2 shares:8 research:2 current:2 version:2 boosted:1 medicine:2 after:1 notable:1 hours:1 takeover:2 regulatory:2 approval:2 100:2 declining:2 gained:2 32:1 could:3 climbed:4 drug:2 statements:2 encouraging:2 strategic:1 market:1 pharmaceutical:1 8.5:1 8.7:1 9.8:1 asset:1 expected:2 inhaled-insulin:2 500:2 more:3 firm:1 flat:1 ``:1 complete:2 form:2 rejected:2 biggest:2 than:3 10:1 versions:2 also:1 n't:2 while:2 89:1 were:2 making:1 called:2 acquisition:1 biotech:1 '':1 partner:2 moves:1 4.1:1 provide:2 make:1 treatment:4 application:2 concerns:4 details:2 which:1 rallies:2 performance:2 stock:1 gaining:2 pain:2 mulling:1 consistency:2 treatments:2 fell:1 letter:2 stocks:5 data:2 response:2 diabetes:2 transaction:1 well:1 daily:1 points:6 time:2
stock_PFE r_up	control:1 biotech:1 raised:1 broader:2 session:1 100:1 over:1 alongside:1 engaged:1 results:1 strategic:1 tiny:1 actively:1 trading:2 35:1 questions:1 during:1 talks:1 hit:1 federal:1 its:1 declined:1 whose:1 $:1 bullish:1 merger:2 rose:1 since:1 shares:2 day:1 rally:1 52-week:1 market:2 closed:1 rallies:2 doubling:1 effectiveness:1 into:1 500:1 higher:1 144:1 rise:1 's:3 which:1 means:1 could:1 company:1 after-hours:1 possible:1 possibility:1 effect:1 volume:1 were:1 109:1 peak:1 entering:1 head:2 news:1 asset:1 stocks:4 revealed:1 than:2 ``:1 gained:1 changing:1 has:1 prescription:1 have:1 study:1 climbed:1 companies:1 up:1 drug:4 more:2 points:3 afternoon:1 evaluating:1 cholesterol:1 north:2 transaction:1 12:1 stock:1 filing:1 acquisition:1
stock_PFE r_up	biotech:1 financial:1 help:1 investors:1 headed:1 trading:3 broader:3 market:3 collapse:1 note:1 needed:1 passed:1 developer:1 has:1 gains:2 head:2 parliament:1 north:3 avert:1 measures:1 news:1 stocks:4 afternoon:1 gainer:1 were:1
stock_PFE r_down	help:2 just:1 over:2 expects:2 years:2 previous:1 blow:2 late:1 add:1 premarket:1 details:1 has:1 2013:1 take:2 hit:2 expirations:1 therapy:1 soften:2 condition:1 treating:1 increasing:1 --:6 medicines:2 facing:1 did:1 testing:1 year:1 out:2 comments:1 medicine:1 new:2 falling:1 before:1 standard:1 expire:2 key:1 franchise:1 dividend:1 beginning:2 stage:1 reaction:1 prospects:1 drug:1 trial:1 products:1 maker:1 patents:2 late-stage:1 number:1 lung:1 per-share:1 total:1 come:2 5th:1 least:1 next:2 clinical:1 more:1 ``:2 drugs:5 company:2 but:2 smoking:1 worked:1 analyst:1 10:1 include:1 target:1 showed:1 sees:1 backing:1 sales:2 '':2 have:1 linked:1 information:1 end:1 patent:1 earnings:1 several:2 development:2 's:3 track:1 quote:1 4th:1 70:1 off:1 well:1 experimental:1 executives:1 profits:2 8th:1
stock_PFE r_up	prevent:1 session:1 actively:1 trading:1 whose:1 21:1 rose:1 shares:1 1:1 new:1 500:1 added:1 's:1 clots:1 blood:1 stocks:1 approved:1 gained:1 10:1 climbed:1 companies:1 drug:1 points:2
stock_PFE r_up	sector:1 among:1 managers:1 cancer:1 shortened:1 companies:1 testing:1 back:1 pair:1 likely:1 growth:1 including:1 long:1 have:1 news:1 pain:1 headlines:1 orders:1 returned:1 gains:2 blue:1 mutual:1 investors:2 data:1 factory:1 been:1 looking:1 may:1 hot:1 pared:1 4:1 holiday:1 sluggish:3 stand-out:1 afternoon:1 week:1 earlier:1 's:2 plans:1 extend:1 far:1 funds:1 jumps:2 after:1 watch:5 chips:1 fund:1 regulators:1 breast:1 ask:1 during:1 stocks:4 weekend:2 developments:1 look:1 ahead:2 largely:1 --:1 2011:1 futures:1 well:1 say:1 drug:1 morning:2 continue:1 so:1 analysts:1 were:1 mixed:1 trading:1 stock:1 approve:1 massage:1
stock_PFE r_down	fueling:2 focus:2 divestitures:4 session:2 including:2 spinoff:3 follow:1 aggressive:2 its:13 whose:2 giant:4 20:1 $:2 graph:1 pursuing:2 include:3 worth:2 animal:2 far:2 rise:2 updates:2 background:1 one:1 look:2 buyouts:1 spinoffs:2 --:5 companies:2 after-hours:1 businesses:7 stock:4 shed:2 because:2 financial:1 deal:1 talks:1 actively:2 trading:2 result:2 animal-health:5 portfolio:2 close:1 operation:2 said:4 decision:1 since:1 shares:2 health:5 business:4 each:3 group:2 strong:2 beginning:1 care:2 39:1 brand-name:2 could:3 climbed:2 according:1 keep:2 products:1 analysts:1 rose:2 onto:2 options:5 road:1 year:2 strategic:2 down:1 ties:2 throughout:2 crisis:1 unit:4 pharmaceutical:4 disappointment:2 additional:1 would:4 2:2 500:2 more:6 nutrition:6 buy:1 company:2 diversified:2 but:2 91:1 multi-month:1 93:1 hold:2 those:1 13:1 has:4 14:1 19:2 up:1 n't:2 matter:1 making:1 drops:2 1.4:1 months:2 hoping:2 investors:3 exploring:5 health-care:4 sales:2 disappointing:2 say:1 proceeds:1 built:2 leveraged:1 potential:1 5:1 details:3 which:3 largest:1 units:2 disappoint:1 several:2 higher:2 added:2 's:4 generic-drug:2 transactions:1 may:3 price:4 hang:1 such:2 stocks:2 recent:2 billion:2 third:1 traded:2 sale:3 person:1 points:4 so:2 consumer:7 review:2
stock_PFE r_down	shine:3 candidate:1 their:1 drug-stocks:2 drug:1 fueled:1 trading:2 positive:1 news:1 diabetes:1
stock_PFE r_down	because:1 increasingly:1 into:1 spinning:1 broader:1 year:1 market:2 debt:1 lead:3 concerns:1 units:1 you:1 markets:1 public:1 more:1 them:1 selling:1 's:1 far:1 becoming:1 slides:1 job:1 they:2 stocks:1 than:1 lower:1 off:1 faster:1 drug-stocks:2 companies:1 drug:1 pace:1 slide:2 're:1 common:1 situation:1 think:1
stock_PFE r_down	sector:2 operations:2 all:2 help:2 innovative:2 its:1 increase:1 overhaul:2 21:2 other:2 has:3 2010:2 noncore:2 around:1 big:2 bid:1 nearly:2 cushion:2 during:2 continued:2 --:1 medicines:2 companies:4 deals:2 quarter:2 shedding:2 significantly:2 opting:2 some:2 challenges:2 second:2 year:2 makers:2 closer:2 said:1 bottom:2 research:2 looking:2 new:2 public:1 bought:1 specialist:1 marketing:3 million:1 20:2 approaches:2 regulatory:2 approval:2 improve:2 many:2 industry:1 drug:4 amount:1 products:2 faces:2 major:2 own:2 tough:2 presence:1 licensing:2 initial:1 been:2 their:10 firm:1 relations:1 pipelines:4 cope:2 company:1 hurt:2 effort:2 up:4 steep:2 scramble:2 health-care:2 sales:2 have:4 alliances:2 patent:2 threatens:2 granted:2 shore:4 also:4 internal:2 units:2 instead:2 development:2 hurdles:2 healthcare:1 such:2 approved:2 cliff:2 acquisitions:2 lines:2 savings:2 costs:4 keeps:2 drawing:2
stock_PFE r_down	saying:1 says:3 investors:1 being:1 preserving:1 narrower:1 we:1 valuable:1 defended:1 '':1 proposition:1 looks:2 still:1 any:1 short-term:1 defends:1 beyond:1 spending:2 decision:1 crucial:1 opportunities:1 research:2 looking:1 start:1 interview:1 growth:1 generics:2 pursuing:1 2015:1 new:2 challenges:2 really:1 development:2 ``:1 his:1 's:5 pharmaceutical:1 drugs:1 big:1 company:2 loom:2 term:1 most:1 cutting:1 despite:1 pipeline:1 gets:1 he:1 past:2 digesting:1 short:1 success:1 --:4 deals:1 drug:1 n't:1 maintain:1 disappointment:1 long-term:1 its:1 maker:1
stock_PFE r_down	tools:1 their:1 stats:1 driving:1 showcase:1 makers:1 may:1 investigational:1 week:1 's:5 scientific:1 crashes:1 drugs:1 grandparents:1 diagnostic:1 imaging:1 burden:1 developments:1 car:1 companies:1 disease:1 block:1 latest:1
stock_PFE r_up	ethical:1 help:1 people:1 0.3:1 reduce:1 number:1 disease:1 affected:1 medical:1 have:1 formally:1 its:2 said:1 sodium:1 decision:1 three:1 application:1 according:1 authorized:1 medicine:1 's:3 hurdles:1 hit:1 journal:1 million:1 active:1 market-beating:1 injection:1 stocks:1 lifestyle:1 extension:1 --:2 up:1 could:1 solution:1 healthy:1 indication:1 withdraw:1 published:1 study:1
stock_PFE r_down	restore:1 help:2 agreed:2 four-year:2 dollar:2 outlook:1 rest:1 session:2 including:1 research:2 its:6 impact:1 whose:2 giant:2 antipsychotic:1 disorders:2 23:1 rose:2 late:1 economy:1 add:1 under:1 has:7 2011:1 remaining:2 updated:1 boxed:1 government:1 big:1 possible:1 soon:1 nearly:2 performance:1 own:2 investor:1 channels:2 several:1 name:2 lost:3 --:4 medicines:1 56:4 companies:2 50:4 toughest:1 discussing:1 page:2 prevent:1 deal:2 bleeding:1 series:1 activists:1 some:1 play:2 past:1 see:1 actively:2 trading:2 doses:1 pain:2 declined:2 said:2 profit:2 spokesman:1 anticlotting:1 shares:2 forecast:1 content:2 outside:1 does:3 above:1 internet:1 falling:1 sluggish:1 collaboration:2 body:2 recently:1 prescriptions:1 targeted:3 sold:1 million:2 agencies:1 reported:2 incident:2 focused:2 key:1 offset:1 put:1 100:1 beginning:1 unauthorized:2 $:6 hacked:1 attacks:1 study:1 months:1 drug:5 important:2 traded:2 maker:1 patents:1 raised:1 already:4 revenue:2 year:1 down:1 corporations:1 picking:2 pharmaceutical:2 working:3 best-selling:1 5th:1 citing:1 been:4 spike:2 500:2 expiring:1 describe:1 drugs:4 reduce:1 company:7 acquire:2 took:1 site:1 understand:1 gain:3 known:1 second-quarter:2 11:3 13:1 12:1 developing:4 official:1 up:3 n't:3 while:2 growth:2 values:2 risks:1 believed:2 1.5:1 weaker:2 hoping:1 health-care:1 tax:2 sales:3 helped:2 full-year:1 warning:1 have:2 seen:1 blockbuster:1 again:1 generic:1 stake:4 also:2 costs:2 role:2 earnings:2 which:4 continued:2 9:2 commentary:1 effectiveness:1 brand:1 stock:1 development:2 product:2 's:14 price:1 after:1 ion:2 fell:2 date:1 stocks:2 approved:2 recent:1 lower:2 happening:1 slightly:1 points:5 biotechnology:2 latest:1
stock_PFE r_up	all:1 shot:1 increasingly:1 consolidated:1 over:1 fall:1 results:2 drug-price:1 focusing:1 manager:1 including:1 fear:1 its:3 but:1 $:3 merger:1 failed:1 charge:1 bank:1 increased:1 income:1 medicine:1 effects:1 despite:2 bigger:1 apart:1 lost:1 --:6 drop:1 companies:1 facing:1 bad:1 through:1 side:1 because:1 deal:1 some:1 past:1 pricing:2 first-quarter:1 slew:1 best:1 said:1 profit:1 +:1 shares:1 increase:1 discounts:1 enough:1 goes:1 capital:2 affecting:1 new:1 net:1 across:1 noise:1 rebates:1 pressure:2 looming:1 put:1 strong:1 prescription:1 8.7:3 reported:1 could:1 firing:1 drug:1 bow:1 planned:1 efforts:1 already:1 revenue:1 feel:1 clout:2 unexpected:1 licensing:1 pharmaceutical:1 soothe:1 raise:1 would:1 remains:1 positive:1 top:1 been:1 their:1 pharmacy-benefits:1 ``:1 sessions:1 drugs:4 company:1 negotiating:1 hurt:1 prices:1 behalf:1 '':1 12:1 rival:1 clients:1 n't:1 convince:1 were:1 balance:1 greater:1 heart:1 investors:2 high:1 have:2 rally:1 negotiations:1 if:1 confirmed:1 patent:1 makers:3 which:1 largest:1 higher:1 gaining:1 analysts:1 's:5 may:2 expirations:1 eight:1 blood:1 spelling:1 29.1:1 recent:1 billion:1 purchase:1 relief:1 biotechnology:1 paced:1
stock_PFE r_down	among:1 says:1 played:1 reductions:1 series:1 cited:1 years:1 past:1 hiring:1 have:1 hires:1 cites:2 unit:1 staff:1 cut:1 factors:1 contributed:1 two:1 virtual:1 freezes:2 also:1 behind:2 difficulties:1 role:1 medicine:2 new:1 over:1 damaging:1 independent:1 ``:2 's:5 may:1 company:1 problems:1 said:1 investigation:1 internal:1 report:3 freeze:1 headcount:1 recent:1 '':2 off:1 integrating:1 --:3 avoiding:1 employees:1 laying:1 directors:2 costs:1 recalls:3 efforts:1 led:1 consumer:1 acquisition:1
stock_PFE r_down	less:1 being:1 issued:1 brain:2 spinoff:1 its:1 $:1 compelling:1 4:1 caused:1 health:1 has:2 worth:1 casting:1 which:1 loss:1 continues:1 condition:1 aggressively:1 --:4 warned:1 companies:1 stopped:1 common:1 heavy:1 shunned:1 because:1 antibiotic:1 deal:1 some:1 year:1 safety:1 between:1 approach:1 earlier:1 business:1 confusion:1 reported:1 approaches:1 takeover:1 acquisitions:2 both:1 interaction:1 many:1 could:1 larger:1 drug:4 maker:2 communication:1 memory:1 bill:1 more:2 building:1 drugs:2 specialty:1 scrutiny:1 failure:1 doctors:1 cases:1 reel:1 than:1 made:1 antitrust:1 up:1 value:1 n't:1 patients:1 can:1 leaning:1 toward:1 treated:1 called:1 sees:1 tax:1 high:1 moves:1 if:1 syndrome:2 agency:1 chemical:1 fatal:1 potentially:1 animal:1 antidepressants:1 's:2 reportedly:1 after:1 problems:1 viewing:1 levels:1 types:1 billion:1 cause:1 older:1 sale:1
stock_PFE r_up	advisory:1 over:1 executive:1 appeals:1 including:1 innovative:1 exclusivity:1 its:2 whose:1 votes:1 group:1 $:1 rose:1 has:1 march:1 get:1 report:1 affect:1 spur:1 lost:1 cholesterol:1 requirement:1 trend:1 some:1 competition:1 growth:2 year:2 cast:1 ways:1 compensation:1 find:1 health:1 medicine:1 new:2 slight:1 reported:1 restructuring:1 advance:1 last:2 drug:1 controversy:1 products:1 long-term:1 thinner:1 revenue:1 stalling:1 rising:1 market:1 decline:1 working:1 top:3 acquired:1 drugs:1 but:3 stem-cell:1 technologies:1 second-quarter:1 buying:1 posted:1 14:1 record:1 while:1 future:1 ruling:1 start-ups:2 example:1 investors:1 sales:2 sought:1 generic:1 earnings:1 which:1 higher:1 's:1 expires:1 problems:1 paid:1 helping:1 blood:1 coming:1 device:1 such:1 brass:1 law:1 billion:1 peers:1 off:1 charges:1 medical:2 counter:1 face:1 patent:2 solve:1 2009:1 starting:1
stock_PFE r_down	obligations:1 over:2 expects:4 research:2 its:8 giant:2 cut:2 $:12 guidance:2 2015:2 8:2 lawmakers:1 2011:2 increased:1 government:1 big:1 competing:1 bit:1 now:4 14:1 coping:1 positions:2 benefit:2 continue:2 quarter:1 reduced:2 week:1 says:1 budget:1 likely:1 growth:2 year:2 substantially:1 said:2 federal:1 forecast:2 eliminate:1 cost-cutting:1 jobs:1 million:2 reported:2 key:2 100:2 strong:2 come:1 last:1 items:2 drug:1 maker:2 raised:2 12,000:2 revenue:2 13,000:5 world’s:1 another:4 force:1 post:1 pharmaceutical:3 8.3:2 debt:1 spending:2 top:2 per-share:2 next:1 2:3 expected:1 meeting:1 wants:1 ceiling:1 posting:2 drugs:2 company:2 but:3 sales:5 year’s:1 effort:1 second-quarter:3 must:1 target:2 work:1 up:1 while:2 cents:2 tax:2 eyes:1 seen:2 if:1 aging:1 end:6 also:4 other:2 earnings:4 which:1 largest:1 higher:3 development:2 product:1 's:2 plans:3 tied:1 payment:1 soared:2 billion:4 lower:5 profit:3 lineup:1 latest:1
stock_PFE r_down	all:2 forget:1 over:1 executive:7 dicker:1 major:1 trade:1 session:1 including:2 higher:2 pitch:1 debt-ceiling:2 its:5 one:2 whose:1 group:1 rose:1 had:1 has:2 2010:1 surprised:2 earnings:1 versus:1 do:1 watch:2 background:2 years:2 14:1 aggressively:2 --:12 companies:3 doubled:2 large:2 team:2 small:2 through:1 quarter:2 harm:2 says:2 acquired:4 see:1 result:1 year:2 further:1 acquisitive:2 said:4 parent:4 profit:2 shares:1 new:2 net:1 dominate:1 ever:1 public:1 comparable:2 jobs:3 business:1 wrangling:2 marketing:1 million:2 latest:1 active:1 benefits:2 limits:2 created:2 could:4 changed:1 contract:1 maker:1 named:4 formerly:2 headed:2 within:2 period:2 two:1 down:1 upgrades:1 financial:1 throughout:2 unit:1 size:2 pharmaceutical:2 little:2 would:1 strictly:1 three:2 relations:1 pitching:1 expected:1 final:1 firm:1 head:2 company:5 formed:2 incoming:2 last:1 19:3 n't:4 were:1 numbers:1 sees:2 sales:1 helped:1 drug:1 accounting:1 if:2 1:1 concerns:2 details:2 largest:1 interview:2 economy:1 product:2 's:5 after:2 effect:1 forecasts:1 president:2 billion:1 borrowing:2 stand-alone:2 chief:5 push:2 2009:1 once:2
stock_PFE r_down	265:2 over:2 results:1 trade:1 divestitures:2 session:7 including:3 shares:5 years:1 research:2 its:9 bunch:1 whose:5 giant:2 patent:2 $:3 took:1 personal:1 rose:2 had:2 expectations:1 analyst:1 late:1 source:1 potential:2 tape:1 quarterly:1 8:1 has:2 2011:2 pill:2 sent:1 details:1 hit:1 than:2 auto:1 continues:2 watch:3 focus:1 early:1 streak:1 cutting:2 small:2 updates:1 background:1 own:2 world:2 aiming:2 continued:2 day:3 nearly:1 drugmaker:2 outweigh:1 lost:4 --:6 drop:2 companies:6 fewer:2 morning:1 deals:2 affiliate:1 cholesterol:2 worries:3 through:2 economy:5 straight:2 investors’:1 shed:4 financial:2 billion:1 deal:1 medical-device:1 back:2 competition:5 rate:5 actively:5 trading:4 53:1 animal-health:2 exceeded:1 2.2:1 2.6:1 out:1 fuels:1 index:3 said:1 adds:1 lead:1 broad:1 2.38:1 comments:1 forecast:1 increase:5 health:1 closed:1 progress:1 firms:1 attention:1 business:1 pharmaceutical:2 lose:2 seventh:2 acquisition-related:5 reported:3 protection:2 key:2 hurts:2 losing:1 100:2 strong:2 beginning:1 vaccine:2 reaction:1 prospects:1 38:2 2.8:1 concerns:1 32:1 losses:5 drug:2 costs:2 products:1 advisers:1 traded:3 maker:2 nutrition:2 among:1 benefited:2 revenue:4 app:1 offset:2 down:3 5.25:1 licensing:2 another:3 nursing-home:1 throughout:1 open:1 market:2 bolster:2 decline:2 debt:3 heads:1 investors:1 prepare:2 spending:3 leading:2 three:1 2:2 compromise:1 low:1 way:1 expected:1 squeezing:1 500:6 more:4 exploring:2 ceiling:1 drugs:5 company:3 pipeline:2 second-quarter:4 those:2 13:2 stumbling:3 bill:2 likely:1 while:5 growth:5 ongoing:1 closing:1 2012:1 spotlight:2 1.4:1 slid:3 1.2:1 1.3:1 reaffirmed:1 tax:5 sales:5 13th:1 pushed:4 full-year:1 dropped:6 limit:2 hospitals:1 any:3 again:1 5.5:17 generic:3 fears:3 1:3 also:3 other:4 earnings:7 fourth:1 income:1 units:2 insurers:1 completed:1 stock:6 development:2 draw:1 's:15 track:1 price:2 after:2 includes:1 fell:3 stocks:7 data:2 approved:2 acquisitions:2 lower:13 third:1 charges:5 amid:2 futures:8 sale:1 antidepressant:3 5.8:2 points:12 relief:3 reduced:1 consumer:1 came:2 longest:1
stock_PFE r_up	saying:1 financial:1 ad:1 deal:1 less:1 acquired:1 communication:2 36:1 high:1 across:1 earnings:1 defects:1 reports:1 doses:1 pregnancy:1 's:1 unit:1 scientific:1 whose:1 giant:1 said:2 group:1 $:1 area:1 provide:1 surprises:2 agency:1 future:1 three:2 advisories:2 spread:1 health:1 treatment:1 has:1 cause:1 worth:1 seeks:1 details:1 activities:2 recently:1 tried:1 get:1 familiar:1 million:1 rejected:1 markets:1 most:1 part:1 umbrella:1 but:1 birth:1 become:1 based:1 100:1 cleared:1 than:1 expand:1 roundup:1 both:1 organization:1 --:3 might:1 medical:1 companies:1 according:1 drug:1 times:2 n't:1 communications:1 person:1 quarters:1 healthcare:2 long-term:1 did:1 2008:1 latest:1 corporate:1 acquisition:1 first:1
stock_PFE r_down	emerging:1 help:1 expects:1 years:2 brain:1 fear:1 decisions:1 its:2 before:1 should:1 symptoms:1 only:1 has:1 decades:1 pill:2 ...:2 his:1 government:1 familiar:1 rebound:1 introduce:2 reimbursements:1 world:1 bit:1 pare:1 sources:1 --:4 loses:1 cholesterol:3 popular:2 view:1 people:1 scared:1 back:1 competition:1 out:1 even:4 consumers:2 research:1 enough:1 version:3 new:2 ground:1 explosion:1 expire:1 let:1 news:1 reports:1 prescription:3 could:4 according:1 drug:4 prior:1 protection:1 diagnosed:1 phase:1 market:1 standing:1 silent:1 would:1 best-selling:1 their:1 wants:2 ``:1 buy:2 drugs:2 bolsters:1 sales:1 properly:1 bull:3 squeeze:1 effort:1 begins:1 versions:1 bids:1 n't:1 matter:1 patients:2 convince:1 can:1 guide:1 investors:1 haunt:2 '':1 battered:1 have:1 need:1 seek:1 if:1 sell:1 doctor:2 generic:1 rout:1 fears:2 successful:1 twitching:2 take:1 week:1 polar:1 's:7 may:1 after:1 rejected:1 haunting:1 stocks:3 natural:1 maybe:1 life:1 disease:1 patent:1 without:2 triggering:1
stock_PFE r_up	agreed:1 some:1 against:1 moves:1 court:1 hunting:1 provide:1 make:1 tax-loss:1 fight:1 other:1 ammunition:1 smart:1 2012:1 his:1 's:2 lab:1 stem:1 fall:1 now:1 potential:1 created:1 cells:1 devices:1 premiums:1 tweaking:1 harvesting:1 medical:1
stock_PFE r_down	look:1 investors:1 getting:1 should:1 thrashed:1 select:1 stocks:1 market:1 high-yielding:1
stock_PFE r_down	increasingly:1 actively:1 through:1 farther:1 such:1 market:1 whose:1 use:1 5.3:1 leverage:1 rose:1 4:1 shares:1 only:1 attractive:1 way:1 500:1 closed:1 's:1 gains:1 offer:1 4.7:1 but:1 not:1 dividend:1 stocks:1 those:1 gained:1 --:1 climbed:1 companies:2 skittish:1 session:1 yields:1 after-hours:1 trading:1 higher:1 options:1 thanks:1
stock_PFE r_up	directly:1 campaign:1 adviser:1 acquired:1 certain:1 sales:1 '':2 against:1 have:1 discussions:1 information:2 said:3 campuses:1 government:1 question:1 outside:2 potentially:1 board:1 which:1 unseat:1 firms:1 has:2 activities:1 ``:2 his:1 's:1 provided:2 company:1 drug:1 resolve:1 shareholder:1 members:1 authorities:1 law:1 improper:1 hire:1 made:3 four:1 companies:1 begun:1 filing:1 matter:1 connection:1 important:1 compete:1 payments:3 were:1 voluntarily:1 2009:1 maker:1
stock_PFE r_up	``:1 month:1 improper:1 seen:1 strategy:1 investment:1 market:1 even:1 provided:1 said:1 should:1 outside:1 potentially:1 take:1 has:1 smart:1 we:1 enable:1 advantage:1 information:1 long-term:1 swings:1 authorities:1 107:2 '':1 kind:1 made:1 us:1 've:1 payments:1 wild:1 voluntarily:1 maker:1
stock_PFE r_up	proposed:2 allegations:2 ninth:2 communities:1 session:3 exclusivity:4 its:3 whose:3 giant:2 disorders:1 rose:3 had:2 won:2 2019:14 weeks:1 pill:6 pending:2 ingredient:2 infringement:2 cheaper:2 background:2 judge:6 ruled:2 regarding:2 --:6 companies:6 after-hours:1 stock:2 16th:2 financial:2 challenged:2 back:1 actively:3 trading:3 2.2:1 said:4 federal:8 decision:2 shares:3 version:2 volatile:1 closed:1 receiving:2 boost:2 preserve:2 patient:1 seventh:2 protection:2 active:2 approval:2 beginning:2 gained:3 could:2 drug:10 infringe:2 faces:2 traded:2 other:2 appeals:2 into:6 one:3 market:4 dysfunction:2 use:2 would:2 removing:1 give:2 copies:2 upheld:4 treat:2 statement:2 until:2 500:3 ``:2 much-needed:2 form:2 started:1 erectile:2 prices:2 effort:2 case:2 prevents:2 barring:2 ruling:2 industry:2 history:1 1.4:2 1.6:1 1.2:1 1.3:1 certain:1 preserving:4 1.9:2 covers:2 '':2 against:4 blockbuster:6 sell:2 different:1 court:4 patent:20 detail:2 same:2 1:1 valid:2 details:2 which:2 several:2 higher:3 added:3 's:19 most:1 stocks:3 pages:1 cliff:2 calls:2 generic:6
stock_PFE r_down	cancer:1 give:1 low-cost:1 detection:1 violent:1 economic:1 lung:1 's:3 contributions:1 scrutinizing:1 riots:1 suburbs:1 2019:2 boost:1 scans:1 week:1 affected:1 government:1 rebates:1 worst:1 down:1 last:1 --:1 drug:1 efforts:1
stock_PFE r_up	help:2 through:2 exclusivity:2 its:8 giant:2 $:2 had:2 controls:2 signals:1 investigational:2 treatment:3 premarket:2 enthusiasm:1 has:2 tears:1 anticipated:2 accepted:4 like:2 --:2 tumors:1 52:2 did:2 lose:2 popular:2 successful:2 prolong:1 resubmitted:2 trading:2 year:2 close:2 makers:2 skin-cancer:1 n't:2 said:6 shares:2 won:1 new:7 therapies:1 decline:2 targeted:1 leukemia:2 regulators:3 expire:2 offset:2 approval:1 manufacturing:2 come:1 rare:2 drug:10 s:1 speedy:1 due:2 experimental:4 first:2 cancer:4 one:2 down:2 chronic:2 lung:2 pharmaceutical:2 two:2 genetic:3 2:4 treat:2 clinical:2 happy:1 form:2 drugs:2 company:2 lives:1 he:1 case:2 up:2 submitted:2 regulator:2 patients:1 were:2 more:2 promises:1 sales:2 crusade:2 have:4 blockbuster:2 5.01:2 information:2 needs:2 end:3 patent:2 trials:2 4.8:2 application:4 other:4 products:2 shrink:1 stock:2 requested:2 's:10 treatments:2 applications:2 such:1 data:2 recent:2 disease:2 patents:2 time:2 chemistry:2 latest:1
stock_PFE r_down	n't:3 done:1 yet:1
stock_PFE r_down	pharmaceutical:1 plant:1 business:1 shortages:1 drugs:1 caused:1 some:1 drug:1 exit:1 faces:1 ban:1 supplies:1 has:1 its:1
stock_PFE r_up	results:2 high:1 good:2 market:1 raise:2 trials:2 current:1 clinical:2 ``:2 buy:1 boosted:2 after:2 encouraging:2 reported:2 designed:2 stocks:1 volatility:1 '':2 uncertain:1 --:1 drug:4 options:1 high-yielding:1 were:2 cholesterol:2 maker:2
stock_PFE r_up	hip:1 good:1 's:1 raise:1 cancer:1 trial:1 positive:1 implants:1 metal-on-metal:1 drug:2 results:1 phase:1 pricing:1 cholesterol:1 complaints:1 has:1
stock_PFE r_up	adviser:1 informed:1
stock_PFE r_up	set:1 economists:1 unemployment:1 sales:1 rate:1 year:1 makers:1 new-vehicle:1 strength:1 projected:1 forecast:1 increase:1 bracing:1 which:1 then:1 9:1 9.1:1 expected:1 website:1 flat:1 's:1 gains:1 released:1 report:1 barrel:1 ago:1 --:1 later:1 according:2 remain:1 residents:1 toward:1
stock_PFE r_up	summer:1 emerging:1 gold:3 being:1 developed:1 agreed:1 month:1 own:1 identify:1 touch:1 its:1 whose:4 giant:1 $:4 rose:3 should:1 board:1 premarket:1 has:2 remaining:1 tests:1 increased:2 rebound:1 continues:1 watch:2 consolidation:1 miners:1 not:1 trade:2 like:2 56:1 companies:4 bird:1 benefit:2 session:4 thinners:1 small:1 served:1 significantly:1 deal:1 testing:1 some:2 likely:2 actively:4 trading:4 2.2:2 2.7:1 shown:1 while:1 shares:5 does:2 254:2 new:2 teens:1 ire:1 therapies:1 notice:1 recently:2 targeted:1 million:1 drew:1 diagnostic:1 boosting:1 active:1 cities:1 gained:2 prospects:1 last:1 study:1 drug:4 trial:1 traded:2 among:1 major:2 already:2 market:1 shareholders:1 light:1 fair:1 support:1 relatively:1 start:1 2:1 treat:1 6:1 expected:2 proposal:1 final:1 500:2 firm:1 box:1 mining:1 buy:1 offer:2 drugs:1 share:1 company:3 acquire:1 but:2 wake:1 prices:1 afflicting:1 valued:1 14:1 flu:1 up:1 value:1 n't:2 record:1 patients:2 can:1 were:4 3.2:1 could:1 acquisition:2 1.7:1 1.8:1 1.9:1 fellow:1 say:1 numbers:1 blockbuster:1 diseases:1 make:1 stake:2 warfarin:1 highlighted:1 also:1 reminder:1 insurers:3 offered:1 gains:1 higher:2 week:1 over:1 's:13 may:1 approves:1 outperformed:1 reflect:1 blood:1 stocks:2 rallied:1 assets:1 amid:1 roughly:2 relief:1 biotechnology:1 affirmed:1
stock_PFE r_up	session:1 health-care:1 2.8:1 trading:1 3.3:1 2.3:1 's:1 poll:1 scrutinizing:1 whose:1 overhaul:1 rose:1 shares:1 preventing:1 closed:1 500:1 higher:1 do:1 premium:1 increased:1 clots:1 after-hours:1 increases:1 know:1 stocks:1 gained:1 benefits:1 companies:1 n't:1 suggests:1 patients:1 actively:1 were:2 uninsured:1
stock_PFE r_down	required:1 just:1 cited:1 shareholders:1 some:2 one:1 four:1 extended:1 adding:1 complete:1 allowed:1 tender:1 blockbuster:1 wo:1 its:2 before:1 information:1 confirmed:1 deal:2 million:1 provide:1 56:1 acquire:1 offer:2 two:1 day:1 1:2 start:1 version:1 assets:1 board:1 7:1 6:1 new:1 valued:1 has:1 offered:1 announced:1 2012:1 selling:1 's:6 risk:1 web:1 drugs:1 share:1 company:4 expires:1 giant:1 drew:1 reflect:1 ire:1 short:1 value:1 members:1 own:1 month:1 pages:1 fair:1 $:2 patent:1 last:1 14:1 --:2 failing:1 roughly:2 drug:3 remaining:1 n't:3 generic:1 directors:1 minimum:1 does:2 stake:2 already:2 biotechnology:1 maker:1 acquisition:1 proposal:1
stock_PFE r_down	emerging:1 high-risk:1 just:1 chances:4 over:1 results:2 ninth:1 session:1 higher:1 talks:1 its:9 impact:1 whose:1 giant:1 $:2 failed:5 fuel:1 has:1 remaining:1 hurting:4 hit:1 goes:4 beat:4 big:1 showing:1 income:1 own:1 world:5 day:1 lost:1 relied:1 --:9 shy:1 56:1 companies:1 settle:1 yields:1 after-hours:1 worries:2 anti-cholesterol:4 multinational:1 says:1 significantly:1 deal:1 some:2 added:1 trading:1 seal:2 tender:1 2.2:1 employment:1 2.6:1 2.5:1 out:1 adds:1 review:1 shares:1 does:2 closed:1 medicine:8 boost:4 measuring:1 jobs:1 extend:1 slumped:1 sixth:1 million:1 weak:1 drew:1 invest:1 imaging:1 key:2 dividend:1 vs.:1 study:1 losses:1 funded:1 drug:7 trial:5 fell:1 maker:2 proxy:1 comment:2 already:3 one:1 ultrasound:1 shareholders:1 fair:1 best-selling:4 top:7 been:1 attack:1 noting:1 growth:1 change:1 6:1 clinical:4 proposal:1 markets:4 500:1 low:1 partnership:1 complete:1 form:1 offer:2 drugs:1 offered:1 acquire:1 released:1 assets:1 effort:1 than:1 must:1 13th:1 valued:1 14:1 rival:3 value:1 n't:2 patients:1 minimum:1 can:4 were:2 10th:1 called:2 acquisition:1 heart:1 slid:2 weaker:1 tap:1 best:2 measure:1 share:1 sales:4 disappointing:1 itself:1 have:2 close:2 technology:1 risk:2 again:1 marking:1 generic:4 stake:2 detail:2 also:1 concerns:1 potentially:1 declined:1 largest:1 company:8 economy:1 product:1 extended:1 's:28 generic-drug:1 after:2 reflect:1 most:1 important:1 complaints:1 stocks:6 data:2 purchase:1 lower:4 longer:1 amid:1 required:1 roughly:2 time:1 biotechnology:1 latest:1 blue-chip:1 came:1 head-to-head:2
stock_PFE r_up	prevent:1 storms:2 setback:1 down:3 weather:1 drug:2 markets:1 further:1 fibrillation:1 staff:1 atrial:1 writes:1 anticlotting:1 same:1 batten:1 recommended:1 potential:1 treatment:1 boost:1 head:1 's:1 strokes:1 today’s:1 immediate:1 market:2 valuable:1 approval:1 true:1 weathering:1 extreme:1 prospects:1 tactics:1 assets:1 level:1 rival:1 could:1 hatches:3 against:1 keep:1 patients:1 choppy:1
stock_PFE r_down	associated:1 according:1 thin:1 certain:1 product:1 pile:1 rate:1 including:2 drug:1 may:1 prompt:1 alternative:1 blockbuster:1 its:2 relatively:1 use:1 said:2 adverse:1 trials:1 make:1 also:1 clinical:2 health:1 rates:1 across:1 higher:1 poor:1 comparable:1 's:1 drugs:1 big:1 arthritis:1 problems:1 treatments:1 but:1 reported:1 death:1 performance:1 hopes:1 line:1 analyst:1 those:1 treating:1 pipeline:1 acquisition:1 showed:1 oral:1 cash:1 analysis:1 pill:1 large:1 trial:1 can:1 were:1 serious:1 rheumatoid:1 other:1 experimental:1
stock_PFE r_down	advisory:1 says:1 give:1 some:1 sales:2 one:1 see:1 committee:1 its:1 issues:1 seemed:1 abstention:1 $:1 2.6:1 voted:1 forces:1 ammunition:1 week:1 's:3 drugs:1 peak:1 approval:1 approved:1 billion:1 dim:1 prospects:1 rival:1 could:2 drug:2 rivaroxaban:1 approve:1
stock_PFE r_down	disease:1 50:1 times:1 likely:1 without:1 have:1 artery:1 man:1 than:1 more:1
stock_PFE r_up	next:1 own:1 sees:1 just:1 revenue:1 list:1 low-priced:1 within:1 reduce:1 '':1 services:1 beneficiaries:1 research:1 newsletter:1 hospitals:1 makers:1 unit:1 pharmaceutical:1 said:1 $:2 hospital:1 opportunities:1 insurance:1 their:1 deficit:1 which:1 biggest:1 angels:1 editor:1 firm:1 ``:1 's:2 big:1 company:1 its:1 plan:1 not:1 10:2 calls:1 18:3 months:1 companies:1 drug:1 savings:1 wringing:1 biotechnology:1 fallen:1 chairwoman:1
stock_PFE r_up	all:1 money:1 over:1 including:1 coli:1 spinoff:1 alternative:1 its:4 partners:1 giant:1 conclusions:1 sugar:1 better:1 platform:3 extends:1 equity:1 has:2 might:1 real:1 them:1 evaluate:1 rise:1 report:1 world:1 drugmaker:1 list:1 continue:1 team:1 financial:1 choosing:1 further:1 out:1 delivered:1 said:5 network:1 mortgage:2 increase:1 boost:1 across:1 we:2 business:3 corn:1 deliver:1 use:1 agreement:1 explore:1 extend:1 benefits:1 contract:2 strains:1 planned:1 maker:1 tax-free:1 reached:3 your:3 pharmaceutical:1 shareholders:2 would:1 leading:1 question:1 cloud-based:1 their:2 structures:2 ``:3 partnership:1 company:2 buying:1 case:1 whether:1 dangerous:1 cash:1 value:1 n't:2 baby-formula:2 delaying:1 sales:7 '':3 drug:1 have:1 home:1 any:2 court:1 goal:1 pay:3 internal:1 take:1 answer:1 you:1 effectiveness:2 channel:1 conclusion:1 added:1 's:4 says:1 separate:1 allowing:1 stocks:3 structure:1 short:1 off:1 sale:1 chief:1 greatest:1 after-tax:1 spend:1
stock_PFE r_down	said:1 certain:1 antidepressant:1 symptoms:1 application:1 hot:1 declined:1 flashes:1 such:1 approve:1 market:1 treatment:1
stock_PFE r_down	prospects:1 takeover:1 's:1 target:1 according:1
stock_PFE r_up	global:1 sales:1 tablets:1 withdrawn:1 pharmaceutical:1 cut:1 administration:1 its:2 application:1 only:1 largest:1 new:1 has:1 specialist:1 jobs:1 plans:1 company:2 said:2 world:1 225:3 supplemental:1 reorganization:1 --:2 drug:2 spokeswoman:1 patients:1 part:1 maker:1
stock_PFE r_down	1000:2
stock_PFE r_down	prevent:1 one-year:1 1,800:1 results:1 two:1 assess:1 included:1 tissue:1 have:1 doses:1 hysterectomy:1 complex:1 its:1 osteoporosis:2 pharmaceutical:1 lining:1 had:1 hot:1 symptoms:1 also:1 investigational:1 potential:1 safety:1 treatment:2 new:1 more:1 's:1 ability:1 efficacy:1 3:1 company:1 safe:1 selective:1 known:1 than:1 women:2 effective:1 developing:1 study:2 according:1 n't:1 vaginal:1 following:1 flashes:1 prevention:1
stock_PFE r_down	lands:2 says:1 willingness:1 foul:2 authorities:1 stroke:1 include:1 its:2 shareholders:1 it’s:1 application:1 concerns:1 exit:1 ego:1 has:2 shows:1 interests:1 good:1 's:3 risk:1 extend:1 use:1 needs:1 fund:1 moment:1 shareholder:1 blood:1 put:1 received:1 territory:2 look:1 ahead:1 drug:1 patients:1 crossed:1 time:1 appraisal:1 favorable:1
stock_PFE r_up	results:1 trade:2 report:1 session:2 thumbs:2 committee:1 its:2 whose:2 giant:2 $:3 rose:1 recommending:1 late:1 board:2 premarket:1 has:1 borrowed:1 his:5 government:1 slate:2 watch:2 early:1 closely:1 front:1 chips:1 investor:2 companies:2 after-hours:1 mergers:1 deal:1 cash:1 scrutinize:1 actively:2 trading:2 makers:1 out:1 blue:1 said:1 decision:1 shares:3 current:2 nominees:2 million:1 pipeline:1 country:1 study:1 against:1 foreign:1 credit:1 involving:1 stand:1 experimental:1 down:2 reached:1 market:2 pharmaceutical:1 shareholders:3 would:2 submit:1 expected:3 disclosed:1 ``:1 company:2 acquire:1 lives:1 line:1 160:1 16:1 harder:1 doings:1 optimism:1 patients:1 spooking:1 determining:2 have:1 investors:1 give:2 household:2 purposes:1 general:1 '':1 drug:3 prostate-cancer:1 watched:1 sell:2 confirmed:1 5.5:1 perhaps:1 make:1 week:1 's:6 plans:2 after:4 fell:2 pair:1 corporate:1 well:1 position:1 pulled:2 filing:1
stock_PFE r_down	breathe:1 significantly:1 helped:1 lung:3 file:1 said:2 endurance:1 two:1 better:1 5:1 which:1 under:1 medicine:1 8:1 meeting:1 exercise:1 shows:1 function:2 's:1 increased:1 brand:1 after:1 regulators:1 compared:1 background:1 filed:1 improving:1 cough:1 data:1 condition:1 treating:1 name:1 showed:3 --:4 study:1 well:1 smoker:1 drug:2 patients:3 improves:1 placebo:1 studies:2 maker:1 experimental:1
stock_PFE r_down	operations:1 expects:1 substantial:1 likes:1 year:1 pharmacy:1 patent:1 next:1 branded:1 available:1 's:3 drugs:2 protection:1 those:1 versions:1 value:1 choices:1 supermarkets:1 generic:1 benefit:1 lose:1 become:1
stock_PFE r_down	just:1 through:2 stepping:1 world:1 exclusivity:1 its:2 anticipation:1 $:1 asking:1 systems:1 premarket:1 fatal:1 worth:1 combination:1 big:1 couple:1 immediately:1 grim:1 bigger:1 treating:2 did:1 loses:1 race:1 declines:1 past:1 trading:1 year:1 2.7:1 makers:2 out:1 said:1 affects:1 version:1 unit:1 red:1 injections:1 regulatory:1 approval:1 received:1 ahead:1 launch:1 study:1 days:1 drug:3 major:1 cancer:1 presence:1 down:1 market:2 working:1 pharmaceuticals:1 two:1 been:1 their:3 more:1 pipelines:1 drugs:2 company:2 infection:1 goals:1 trying:1 has:3 anything:1 hour:1 up:2 n't:1 patients:1 were:1 1.2:1 turned:1 have:1 partner:1 seen:1 blockbuster:2 any:1 fill:1 compromised:1 patent:1 immune:1 other:1 potentially:1 which:1 stock:1 's:6 after:1 reach:1 running:1 recent:1 generic:1 shade:1 gain:1
stock_PFE r_down	financial:1 deal:1 one:1 year:1 species:1 market:1 3.9:1 $:1 lo:1 since:1 crisis:1 endangered:1 combined:1 biggest:1 has:1 2011:2 announced:1 billion:1 's:1 far:1 felt:1 takeover:1 they:1 buyout:1 than:1 bigger:1 buyouts:1 10:3 like:1 value:2 2007:1
stock_PFE r_up	even:1 better:1 12:1 rivals:1 could:1 months:1 outperformed:1 next:1 past:1 most:1 year:1 has:1 its:1
stock_PFE r_up	raised:1 because:2 often:1 agreed:1 epilepsy:2 some:1 results:2 interim:2 questions:1 surgery:1 blockbuster:1 its:2 if:1 even:1 terminated:2 $:1 pay:1 caught:1 had:1 been:1 enough:1 settle:1 treatment:2 clinical:2 common:1 suggested:2 's:2 million:1 early:1 nearly:1 90:1 cases:1 seizures:2 case:1 financing:1 effective:2 --:1 tumors:1 stand-alone:2 drug:4 trial:2 patients:2 practices:1 can:1 treated:1
stock_PFE r_up	deck:1 money:3 over:1 exclusivity:1 its:4 weekly:1 giant:2 should:1 better:1 going:1 overbought:1 has:1 dispute:1 gains:1 seeking:1 rise:1 not:3 now:2 drugmaker:1 --:3 positions:2 large:1 predicted:1 bond:1 prevent:1 right:1 some:1 related:1 see:1 out:1 said:1 giving:1 yet:1 participants:1 version:3 before:1 tolerance:1 yield-hunting:2 we:3 expire:1 approval:2 lawsuit:1 gained:1 nonfarm:1 ahead:1 could:2 months:1 oversold:1 days:1 drug:1 faces:2 patents:1 into:1 throughout:1 market:3 pharmaceutical:1 little:1 top:1 painkiller:3 strategy:1 their:1 180:1 storm:1 suit:1 borrowers:1 ``:1 filed:3 payrolls:1 than:1 challenge:1 up:2 're:3 making:3 trader:3 acquisition:1 30:1 investors:1 give:1 head:1 '':1 unlikely:1 need:1 moves:2 any:1 risk:1 patent:2 get:1 delay:1 application:2 5:2 details:1 which:1 instead:1 several:1 bets:1 product:1 's:2 after:1 most:2 stocks:1 weekend:2 surprising:1 conscious:1 generic:3 points:1 so:1 corporate:1 came:1
stock_PFE r_up	one:1 defending:1 human:1 year:1 insurance:1 group:1 trials:1 clinical:1 scientists:1 hope:1 more:1 's:1 stance:1 exchange:1 treatments:1 stem:1 off:1 areas:1 conducting:1 join:1 limits:1 clutch:1 medical:1 drug-pricing:1 science:1 small:1 cells:1 researchers:1 first:1
stock_PFE r_down	global:1 soon:1 month:2 cuts:1 exclusivity:1 its:4 trying:3 antipsychotic:1 late:1 other:1 treatment:2 has:1 pill:1 versus:1 epilepsy:1 return:1 expirations:1 government:1 evaluate:1 break:1 report:1 loss:1 --:2 ever:1 companies:1 facing:1 cholesterol:1 quarter:1 woes:1 challenges:1 pricing:1 makers:1 closer:1 said:1 patients:1 research:1 pressures:1 behind:1 version:2 goes:1 net:1 sluggish:1 announced:1 specialist:1 jobs:1 cut:1 key:1 regulatory:1 approval:1 20,000:1 received:1 launch:1 industry:1 according:1 drug:3 trial:1 faces:2 patents:1 major:2 benefited:1 plethora:1 put:1 landscape:1 combines:1 their:2 spending:1 next:1 start:1 more:1 expiring:1 company:1 formed:1 attempt:1 line:1 hold:1 than:1 regimen:1 15:1 monopoly:1 recall:1 pace:1 while:1 health-care:1 tax:1 blockbuster:2 sell:1 end:1 generic:2 potential:1 which:1 economy:1 draw:1 's:3 most:1 changing:1 off:1 third:1 patent:3 block:1 2004:1 overseas:1 profits:1
stock_PFE r_down	prevent:2 months:1 boosting:1 knocking:1 one:1 manager:1 result:1 begun:1 year:2 partner:1 its:2 osteoporosis:1 pharmaceutical:1 said:3 court:1 district:1 generic:1 plans:1 marketing:1 two:1 application:1 version:1 treatment:1 suit:1 best-performing:1 has:2 presentation:1 final:1 week:1 product:1 's:4 around:1 offering:1 commercial:1 company:1 stop:1 new:1 stay:1 designed:1 filed:3 misuse:1 approval:1 line:1 stocks:1 lawsuit:2 approved:1 entire:1 patent:1 last:1 ahead:1 launch:1 could:1 30:1 companies:1 up:1 drug:4 filing:1 prior:1 expiration:2 cholesterol:1 maker:1 patents:1 pain:1
stock_PFE r_up	giant:1 third:1 markets:1 encouraging:1 sales:1 released:1 other:1 dairy:1 demand:1 following:1 quarter:1 data:1 surge:1
stock_PFE r_down	operations:2 they:1 move:2 allegations:1 years:1 hopes:2 businesses:2 settlement:1 decisions:1 its:8 $:3 dividing:1 spin:4 charge:2 other:1 remaining:2 divergent:1 customers:1 global:1 risk:1 government:1 very:1 possible:1 updates:2 background:2 new:1 world:1 unauthorized:1 --:10 companies:1 each:1 economy:1 rheumatoid:1 trend:1 successfully:1 separated:1 investment:1 out:1 said:5 potential:1 recorded:1 while:1 comments:1 investigation:1 adapt:1 formula:2 approach:1 footprints:1 arthritis:1 continuing:1 add:1 diagnostics:1 generates:1 rises:2 planned:1 industry:1 positioning:1 drug:3 products:6 analysts:1 named:1 revenue:3 into:1 down:2 throughout:1 unit:5 pharmaceutical:4 shareholders:3 would:1 breakup:1 create:1 two:2 pharmaceuticals:2 stock:2 more:2 wants:1 ``:1 company:6 but:2 baby:2 valuation:2 analyst:1 '':1 devices:2 probe:1 remain:2 promoted:1 history:1 1.5:3 proprietary:2 investors:3 diversification:1 health-care:1 weighed:2 sells:1 blockbuster:1 check:1 sell:2 different:2 things:1 make:1 45:1 able:1 complex:1 stemming:1 details:2 which:2 higher:2 's:2 plans:3 separate:2 price:2 sets:1 most:1 levels:1 uses:1 plan:1 recent:1 billion:1 off:4 assets:1 charges:1 medical:7 later:1 cover:1 command:2 allow:2 healthcare:1
stock_PFE r_down	'':1 drug:1 blockbuster:1 makers:1 market:1 closer:1 said:1 antipsychotic:1 generic:1 finally:1 version:1 authorized:1 new:1 edging:1 fibrosis:1 ``:1 's:1 after:1 agreement:1 treatments:1 protection:1 signed:1 loses:1 patent:1 cystic:1
stock_PFE r_up	among:1 accuse:1 agreed:1 health-care:1 overbilling:1 medical:1 officials:2 have:1 its:1 improperly:1 pharmaceutical:1 giant:1 $:3 whistle-blower:2 pay:1 began:1 marketed:1 use:1 two:1 makers:1 their:1 state:1 other:1 accusations:1 under:1 stepped:1 several:1 million:1 's:1 government:1 after:1 agreement:1 uses:1 they:1 filed:1 off-label:1 lawsuit:1 former:1 14.5:3 especially:1 programs:1 employees:1 companies:1 up:1 drug:2 federal:2 settle:1 lawsuits:1
stock_PFE r_up	increase:1 ``:1 's:1 version:1 3rd:1 follows:1 corrected:1 p.m.:1 '':1 63:3 program:1 published:1 repurchase:1 stock:1
stock_PFE r_down	outlook:1 outdoor:1 force:1 help:1 people:1 efforts:1 cited:1 revamp:2 soften:1 prices:1 third-quarter:1 cuts:1 hurt:1 close:2 throughout:1 its:2 drugs:1 emerging:1 cut:1 vitamins:1 studying:1 decision:1 played:1 three:1 1:1 pressures:1 role:1 strong:1 under:1 new:1 workforce:1 save:2 markets:1 minor:1 main:1 may:1 price:2 keeps:1 results:1 giant:1 expects:1 pressure:1 reason:1 said:1 axe:1 not:1 factories:2 continued:1 grow:1 kids:1 impact:1 healthy:1 amid:1 work:1 drug:2 --:6 remain:1 costs:2 activity:1 franc:2
stock_PFE r_up	because:1 features:1 people:1 photo:1 over:1 some:1 ``:1 days:1 '':1 remove:1 have:1 go:1 seen:1 its:1 ad:1 said:2 asks:1 also:1 tube:1 offensive:1 tight:1 behind:1 online:1 shows:1 website:1 picture:1 balm:2 woman:1 do:1 reaching:1 jeans:1 back:1 bloggers:1 hand:1 blasted:1 recent:1 pull:1 search:1 graphic:1 would:1 lost:1 sofa:2 up:1 can:1 planned:1 leaning:1 found:1
stock_PFE r_up	thinner:2 help:1 cancer:2 revenue:1 contributed:1 executive:1 sales:3 outcomes:1 high:1 regulatory:1 growth:1 year:1 its:2 braces:1 string:1 $:1 patent:1 positive:1 had:1 third-quarter:1 comments:1 research:1 2:3 fourth:1 approvals:1 quarterly:1 commentary:1 has:2 boost:1 stock:1 rise:1 increased:1 received:1 drugs:3 sixth:1 price:1 million:1 121:1 blood:2 hopes:1 beginning:1 analyst:1 11:1 loss:1 reported:1 --:3 drug:2 profit:1 while:1 maker:2 updates:1
stock_PFE r_down	ago:1 again:1 new-vehicle:1 largest:1 --:1 auto:1 year:1 sales:2 month:1 increase:1 report:1 according:1 each:1 expected:2 post:1 website:1 makers:1 gains:1
stock_PFE r_up	saying:1 words:1 less:3 over:4 move:2 $:8 quarters:1 session:3 shares:2 broader:1 during:2 exclusivity:1 settlement:1 its:9 fifth:1 whose:2 giant:1 renewed:2 police:1 catastrophe:1 million:1 also:1 surprises:2 point:1 had:1 expectations:6 late:1 austerity:1 advisories:2 4:1 premarket:1 're:1 2011:7 pill:1 details:1 do:2 them:1 seized:1 rescue:1 food:1 rattled:2 watch:2 focus:2 early:3 were:1 breast-cancer:1 know:1 background:1 fall:5 trade:4 asset-sale:1 bit:2 difference:1 new:1 day:2 apart:3 prime:1 loss:2 heightened:1 lost:1 --:13 boost:1 drop:5 companies:4 loses:1 default:2 55:1 counterfeit:1 15th:1 activity:2 worries:3 quarter:3 sank:2 heavy:1 sugary:1 set:1 financial:1 significantly:1 higher:2 series:1 30:1 hard:1 competition:2 euro-zone:5 unexpectedly:1 second:3 actively:2 trading:1 third-quarter:5 favorable:3 exceeded:1 led:2 11th:1 targets:3 declined:2 drinks:1 index:2 said:2 banking:1 profit:3 consecutive:1 decision:4 opening:1 recorded:1 months:1 comments:1 increase:1 bailout:11 6.9:2 7:2 surprise:2 strategist:1 public:1 participation:1 could:1 core:2 we:3 full:2 recently:1 2.9:1 adding:2 300:1 marketing:1 cholesterol:1 renews:1 reported:1 reason:1 operating:1 buyback:1 recent:1 repurchase:2 overhaul:1 100:1 debt:4 manufacturer:1 roundup:1 worth:1 last:1 world:2 package:2 starts:1 region:1 uncertainty:1 reports:1 recession:1 147:1 analysts:3 pick:1 efforts:1 retail:1 makes:1 maker:1 executives:1 among:1 outlook:1 economists:2 revenue:4 22.50:1 around:2 pharmaceutical:1 commitment:1 referendum:14 down:1 production:1 1.7:1 raises:1 female:1 wider:1 says:1 stirred:1 throughout:1 open:1 market:3 risk:1 decline:2 manufacturing:2 would:1 pharmaceuticals:1 dropped:1 top:4 they:1 sovereign:1 long:1 work:1 share-repurchase:1 start:1 much:1 rates:2 too:1 expected:3 call:3 expanded:1 final:2 500:2 asset:1 buybacks:1 ``:1 big:1 insurer:2 month:1 going:1 company:3 due:1 lower:5 but:2 understand:1 minister:1 sharply:2 beat:1 improved:1 hold:2 posted:2 than:1 those:1 women:1 calls:1 publicly:1 monopoly:2 whether:1 might:3 spill:1 show:1 up:2 measures:1 war:1 n't:4 below:2 future:1 further:1 country:2 growing:1 gave:1 auto:1 called:1 numbers:1 bell:1 program:2 slid:1 losses:5 investors:1 1.3:1 year:2 share:2 1.9:4 '':1 currency:3 unit:1 curb:1 drug:6 have:2 home:1 anger:1 blockbuster:2 230:2 surgery:1 if:1 tumbled:3 information:1 moves:1 end:1 goal:1 generic:3 imminent:2 fears:4 stayed:1 while:1 stock-market:2 another:1 other:1 5:1 earnings:8 which:2 largest:1 9:1 headlines:1 out:1 brand:1 stock:7 week:1 200:1 oil:1 's:24 plans:4 see:1 boosted:5 price:2 after:4 red:1 tied:1 regulations:1 fueled:3 fell:4 plan:6 significant:2 authorities:1 stocks:8 why:2 soared:3 derail:1 billion:6 stress:1 roiled:2 third:1 traded:2 average:1 futures:5 sale:2 face:1 their:2 person:1 competitors:1 points:7 does:2 gain:3 push:1 joining:1 corporate:2 updates:2 latest:3
stock_PFE r_up	low-end:2 sees:2 campaign:1 revenue:3 sales:3 executive:2 some:2 results:4 product:2 full-year:4 growth:3 comments:2 year:2 sharp:3 forecast:2 makers:1 down:3 if:2 decline:3 said:1 end:2 longstanding:1 profit:5 mounting:1 guidance:2 third-quarter:5 legal:1 its:8 also:2 listed:1 pitching:1 largest:2 company:2 stock:2 disappointed:2 them:1 's:2 fourth:2 generic-drug:5 top:2 earnings:2 price:2 overall:3 delayed:2 falls:2 regulations:1 reported:2 weighed:3 fell:3 uses:1 updates:2 not:1 world:2 overturn:1 beginning:2 past:2 13:11 3rd:2 launch:2 --:6 reduces:2 maker:2 range:2 lowered:2 analysts:2 bottle:1 quarter:2 medicines:1 view:2
stock_PFE r_up	managers:1 pushes:1 over:3 alternatives:1 manages:1 drug:2 dividend:1 battle:1 says:1 pharmacy:1 debate:1 decade:1 giant:1 believe:1 group:1 $:1 consumers:1 employers:1 system:1 next:1 industry:1 health:2 underestimate:1 generics:1 medicine:1 insurers:1 boost:1 them:1 drugs:1 some:1 continues:1 treatments:1 but:1 cheaper:1 pricey:1 fat:1 adds:1 promote:1 coupons:2 billion:1 benefits:1 --:3 hike:1 could:1 brand-name:1 according:1 aims:1 keep:1 patients:1 costs:3 can:1 32:1 cards:2 eases:1 study:2
stock_PFE r_up	pharmaceutical:1 thinner:1 prevent:1 strokes:1 rose:1 after:1 its:1 conglomerate:1 blood:1 sharply:1 authorities:1 approved:1 treatment:1
stock_PFE r_up	urinary:1 significant:1 investors:1 sales:1 number:2 month:1 episodes:2 been:1 cholesterol:1 exclusivity:1 its:2 preparing:1 has:1 said:1 patent:1 leading:1 endpoint:1 long:1 concerns:1 safety:2 treatment:1 mean:1 weeks:1 effectiveness:1 pill:1 his:1 's:2 after:1 primary:1 met:1 compared:1 mouth:1 effects:1 letter:1 not:1 world:1 investor:1 day:1 change:1 dry:1 kind:1 12:1 most:1 study:1 lose:1 drug:2 side:1 trial:1 maker:1 common:1 were:2 found:2 placebo:1 reduced:1 urgency:2 latest:1
stock_PFE r_down	heart:2 antibiotic:1 pharmaceutical:1 deal:1 exposed:1 linked:1 certain:1 agreed:1 related:1 one:1 tide:1 selling:1 businesses:1 treat:1 another:2 asthma:1 crisis:1 vulnerable:2 out:1 information:2 said:4 painkiller:1 $:1 grant:1 giving:1 pay:1 lawsuits:1 class-action:1 brand:1 struggles:1 legal:1 its:2 continental:1 strokes:1 risk:1 other:1 market:1 which:1 issued:1 products:1 firms:2 has:2 2010:1 subpoena:1 development:1 activities:1 product:1 million:1 's:1 increased:1 maker:1 government:1 drugs:1 marketing:2 equivalent:1 after:2 ailments:1 delivery:1 generic:3 additional:1 teeters:2 former:1 platform:1 manufacturer:1 received:1 develop:2 washing:1 look:2 rights:2 attacks:1 region:1 drug:2 leaving:1 recession:1 2003:1 settle:1 used:1 three:1 2004:1 represents:1 addition:1 requests:1 struck:1 filing:1 investigators:1
stock_PFE r_up	outpaces:1 biotech:1 seven:1 results:1 years:1 produced:1 growth:1 its:4 increased:1 confidence:1 said:2 positive:1 their:1 clinical:1 earnings:1 7:2 which:1 quarterly:1 pay:1 tests:1 's:2 mid-stage:1 business:1 demonstrates:1 much:1 sharply:1 preliminary:1 dividend:2 novel:1 --:2 industry:1 drug:3 spend:1 n't:1 does:1 time:1 anti-cholesterol:1 maker:2 first:1
stock_PFE r_up	tap:1 omega-3:1 increasingly:1 fish:1 global:1 high:1 dietary:1 acid:1 its:1 market:1 sell:1 pharmaceutical:1 said:1 develop:1 consumers:1 pharmaceuticals:1 only:1 health:1 build:1 has:1 division:1 product:1 regulators:1 demand:1 approved:1 both:1 prescription:1 being:1 conscious:1 drug:1 healthcare:1 growing:1 become:1 consumer:1 having:1
stock_PFE r_down	reviewers:2 agreed:1 brain:1 including:2 its:2 young:1 passive:1 failed:1 disclosed:1 under:1 has:4 apixaban:1 showing:1 during:1 bank:1 name:1 entire:1 like:1 --:3 eased:1 50:1 benefit:1 unstable:1 become:1 quarter:1 wrote:1 prevent:2 says:1 people:1 blood-thinning:1 year:1 close:1 surgery:1 investment:1 out:1 index:1 said:1 anticlotting:1 patients:2 research:1 looking:1 new:1 cause:1 sold:2 met:1 regulators:1 article:1 vaccine:1 both:1 last:1 study:2 drug:4 exiting:1 involving:1 published:1 think:1 'd:1 heart:4 retailer:1 children:1 another:1 better:1 use:3 holdings:3 support:1 been:2 attack:1 clinical:1 way:1 expanding:1 treatment:1 function:1 ``:1 meningitis:1 hospitalized:2 company:1 fund:2 known:1 ear:1 pain:1 than:2 he:1 13:5 fraud:1 showed:1 up:1 while:1 can:1 meet:1 website:1 adults:1 certain:2 '':1 have:1 apparently:1 documents:1 requirements:1 goal:1 technology:1 brand:1 preventing:1 application:1 chest:1 strange:1 which:1 largest:1 short-term:1 clots:2 failure:2 stock:3 's:10 undergoing:1 screenings:1 assessing:1 blood:2 significant:1 contractors:1 stocks:2 data:1 approved:1 expand:1 posted:1 third:1 older:1 age:1 infections:2 position:1 athletes:1 incomplete:1
stock_PFE r_up	emerging:2 able:1 results:1 session:1 controversial:2 alternative:1 its:2 previous:1 setbacks:2 adding:1 renewed:1 good:1 gains:1 broadly:1 inflation:1 fall:2 during:1 --:6 morning:1 bad:1 yields:1 activity:1 worries:2 become:1 reduced:1 bond:1 prevent:1 financial:2 estimates:1 euro-zone:4 economic:1 doses:1 slumped:1 slew:1 decision:2 while:1 shares:1 research:4 cell:2 exit:2 7:1 new:1 boost:1 scientific:2 cholesterol:2 stem:2 manufacturing:1 ahead:1 attacks:1 study:1 losses:1 according:1 drug:1 trial:1 disappointment:1 retail:1 safely:1 experimental:1 one:1 miss:3 decline:1 debt:1 top:1 sovereign:1 clinical:1 way:1 taken:1 markets:1 lowering:1 releases:1 drugs:2 slump:1 than:2 disappointing:1 kind:1 showed:1 patients:1 could:1 heart:2 tap:1 investors:1 sales:1 high:1 any:2 rather:2 fears:2 field:2 earnings:3 constraints:2 stock:1 's:13 strokes:1 involving:1 data:3 class:1 lower:1 futures:2 plaque:1
stock_PFE r_down	reversing:2 significantly:2 tougher:1 sales:1 growth:1 moderating:1 seen:1 hit:1 throughout:1 market:1 sell:1 generic:1 make:1 due:1 better:2 clinical:2 details:1 comparable:1 's:8 enter:1 cheaper:1 volume:1 background:1 than:2 versions:2 --:3 rival:2 could:1 30:1 drug:2 n't:2 trial:2 cholesterol:2 outcome:1 reduced:1 plaque:3
stock_PFE r_down	his:2 's:3 prolific:1 career:1 highs:1 work:1 been:1 relative:1 cut:1 enters:1 lows:1 has:1 out:1 spotlight:1 filled:1 successor:1
stock_PFE r_up	right:1 over:1 one:1 year:1 blockbuster:1 expensive:1 generic:1 copies:1 recommending:1 next:1 encourage:1 health:1 largest:1 insurers:1 more:2 customers:1 's:3 business:1 drugs:1 after:1 stop:1 pharmacy-benefit:1 nation:1 protection:1 members:1 using:1 than:1 covering:1 30:1 drug:1 loses:1 patent:1 continue:1
stock_PFE r_down	control:1 biotech:1 deal:2 weighs:1 win:1 into:2 probe:1 sign:1 alive:1 headquarters:1 global:1 growth:1 trading:1 hepatitis:2 have:1 further:1 technology:1 its:3 best:1 move:1 foster:1 story:1 curse:1 $:4 sector:1 bribes:1 pay:1 revenue:1 shares:1 yet:1 10.4:3 does:1 health:1 goes:1 expected:1 government:1 care:1 million:1 announced:1 more:2 sinking:1 settling:1 buy:1 's:4 resolve:1 business:2 city:1 drugs:1 becomes:1 company:4 after:1 debate:1 treatments:2 but:1 early:1 dealings:1 pricey:1 kids:1 paid:1 boosting:1 maker:1 foothold:1 than:1 recent:1 billion:1 60:1 12:1 jobs:1 success:1 developing:1 whether:1 harder:1 roughly:1 drug:1 keep:1 n't:1 costs:1 75:1 probes:1 overseas:2 latest:1 example:1 comes:1 software:1
stock_PFE r_down	among:1 agreed:3 move:1 trade:1 known:1 session:1 through:1 looks:2 skin:2 exclusivity:1 its:6 previous:1 planning:1 whose:1 giant:2 death:1 $:3 capex:1 unemployment:1 better:1 economy:1 premarket:1 400:1 criminal:1 pill:1 achieve:1 first:1 his:1 risk:1 bonds:1 weakness:1 handling:1 preparing:1 they:2 world:1 month:1 continued:1 drugmaker:1 lost:1 --:1 companies:2 've:1 deals:1 settle:1 mode:1 cholesterol:2 quick:1 quarter:2 better-than-expected:1 shed:1 product:2 sign:1 likely:1 actively:1 video:1 happen:1 loses:1 out:1 said:1 profit:1 since:1 below:1 shares:1 research:1 content:1 health:1 boost:3 announced:1 core:1 focuses:2 turning:1 business:2 licensing:1 million:2 confidence:1 small:1 outlays:1 protection:1 after:1 buck:1 pipeline:3 last:1 completely:1 drug:1 analysts:1 efforts:1 fallen:1 comes:1 executives:1 prices:1 fourth-quarter:1 own:2 civil:1 into:1 owned:2 privately:2 directly:1 reducing:1 crisis:1 expensive:1 pharmaceutical:2 aiming:1 raise:1 leading:1 been:2 their:1 pessimistic:1 treat:2 lot:1 expected:1 patients:1 today:1 more:1 lowest:1 acquisitions:1 selling:1 faith:1 drugs:2 funds:1 company:4 exactly:1 proving:1 part:1 91:1 fighter:1 hold:1 effort:1 former:1 has:4 14:1 developing:2 cash:1 n't:1 while:1 're:1 can:1 promoted:1 gave:1 sentenced:1 later:1 painkiller:1 sales:2 helped:1 healthcare:1 dropped:4 write-downs:1 seen:1 sell:1 5.1:1 patent:2 pay:1 drivers:1 also:1 earnings:2 which:3 stock:2 development:1 illegally:1 acquire:3 's:9 though:1 time:1 helping:1 fell:1 eight:2 services:1 segment:1 cliff:1 fiscal:1 off:1 happening:1 charges:1 onto:1 lose:1 drive:1 generic:1 points:3 truck:1 950:1 2009:1 corporate:1 nearly:1
stock_PFE r_down	heart:2 sees:1 high-risk:1 11-year:1 revisit:1 reassure:1 ``:1 technicians:1 years:1 past:1 say:1 promise:1 medicines:1 have:1 such:1 vessel:1 statin:1 cutting:2 involved:1 one:1 pharmaceutical:2 shown:1 said:1 limited:1 pharma:1 indices:1 trials:1 there:1 bad:1 lowering:1 should:1 industry:2 attack:2 lows:1 scientists:1 you:2 fight:1 them:1 never:2 risk:1 drugs:1 could:1 hazardous:1 after:1 stop:1 but:4 back:2 reported:1 death:1 effects:2 underway:2 using:2 construction:2 evidence:1 producing:1 those:1 '':1 days:2 benefits:1 would:2 --:4 statins:1 study:1 disease:1 know:2 keep:1 these:2 patients:2 without:1 cholesterol:2 long-term:2 reduces:1 blood:1
stock_PFE r_up	do:1 we:1 's:1 patent:1 coming:1 question:1 days:1 us:1 your:1 expiration:1 our:1 answer:1 'll:1 you:1 tell:1 best:1 confusing:1
stock_PFE r_up	generic:1 brand:1 version:1 word:1 same:1
stock_PFE r_up	emerging:1 30:1 stores:1 significantly:1 warfarin:1 agreed:1 indicating:1 sales:1 two:1 ended:1 stroke:1 another:1 fibrillation:1 173:1 tomorrow:1 market:2 one:1 adding:1 said:1 $:1 generic:4 positive:1 review:2 anticlotting:1 patients:1 its:3 preventing:1 application:2 version:3 health:1 treatment:2 stable:1 products:1 posted:1 approach:1 pill:2 cited:1 dispute:1 product:1 's:8 apixaban:2 million:1 outperformed:1 prospects:1 boosting:1 results:1 most:1 regulators:1 blood:1 new:2 approval:2 accepted:1 data:1 women:1 regarding:1 12:1 wait-and-see:1 showed:1 launch:1 taking:1 months:1 companies:1 eve:1 drug:5 called:4 large:1 patent:1 accelerated:1 speedy:1 victory:1 birth-control:2 atrial:1 heartbeat:1 studies:2 granted:2 thinners:1
stock_PFE r_up	stock:1 exclusive:1 all:1 unclear:1 says:1 help:1 deal:1 supply:1 sales:1 switching:1 ca:1 distribute:1 blockbuster:2 product:1 '':1 surrounding:1 including:1 reports:1 another:1 terms:2 exclusivity:1 still:1 its:1 market:2 priority:1 marking:1 throughout:1 adds:1 giant:1 generic:7 began:1 long-awaited:2 remain:1 supplied:1 spokesman:1 their:1 varies:1 version:2 disclosed:1 authorized:1 marks:1 health:1 net:1 strengths:1 pill:1 details:1 status:1 gives:1 ``:1 selling:2 's:7 plans:2 pharmaceutical:1 afford:1 share:1 company:1 under:1 confirmed:1 first:1 agreement:1 protection:1 plan:1 background:1 prices:1 world:1 five-year:1 receive:1 approved:1 begins:1 loss:2 lost:1 launch:1 --:3 uncertainty:1 drug:4 dosage:1 n't:2 patent:1 patients:1 were:1 timeline:1 providing:1 changes:1 review:1 praises:1
stock_PFE r_down	exclusive:1 dollar:1 years:1 four:1 ended:1 session:1 through:1 aggressive:1 also:1 treatment:1 has:3 pill:2 loss:2 like:2 --:1 deals:2 birth-control:1 recommendations:1 popular:1 higher:1 weight:1 some:1 related:1 second:1 growth:3 trading:1 2.2:2 makers:1 said:2 shares:1 version:4 slash:1 new:1 specialist:1 agreement:1 aftermath:1 generate:1 manufacturer:1 central:1 launch:1 healthy:1 could:1 against:1 credit:1 acquisition:1 action:1 makes:1 patents:1 buoyed:1 rivals:1 threatening:1 their:3 returns:1 suit:2 wants:1 drugs:1 took:1 but:1 filed:2 straight:1 shelves:1 following:1 launched:1 investors:1 taste:3 drug:3 rally:1 counseling:1 confirmed:1 generic:5 began:1 application:1 performance:1 several:1 stock:1 's:4 generic-drug:1 after:1 most:1 ago:1 shipping:1 blood-pressure:1 off:1 face:1 costs:1 comes:1 banks:1
stock_PFE r_down	pharmaceutical:1 scientific:1 big:1 studying:1 medical:1 published:1 results:1 mounting:1 billions:1 research:2 n't:1 drug:1 companies:1 community:1 promising:1 new:1 ca:1 spends:1 therapies:1 shows:1
stock_PFE r_up	results:2 trade:2 facilities:2 episodes:1 session:2 incontinence:1 agrees:1 fifth:1 whose:2 rose:1 version:1 treatment:1 weeks:1 has:1 pill:1 hope:1 2012:2 seized:1 rescue:3 finish:2 number:1 endpoint:1 month:1 day:2 advanced:3 countries:1 --:12 companies:2 yield:1 52:2 found:1 reduced:1 shed:1 leaders:1 people:1 warns:1 elderly:1 euro-zone:2 second:1 actively:2 trading:1 out:1 index:2 said:3 lead:3 blue-chip:3 patients:2 shares:3 its:3 sites:1 participants:1 bailout:2 closed:3 after:11 recently:1 downgrades:1 agreement:1 stem:3 drug:2 109:1 put:1 debt:4 come:1 gained:1 last:3 met:1 could:3 35:1 significantly:1 credit:1 published:1 mixed:1 efforts:3 traded:1 maker:2 among:2 slipped:1 primary:1 two:4 65:1 reducing:1 crisis:7 1.1:1 bolster:3 industrials:2 additional:1 sovereign:1 authorized:1 expected:1 12-week:1 mostly:2 sessions:1 funds:3 bladder:1 spectrum:1 part:1 gain:1 stems:1 12:2 15:1 double:2 up:1 nations:1 while:1 frequency:1 following:1 other:1 study:3 launched:1 seven:1 medication:1 hoping:3 investors:2 0.3:1 0.4:1 reports:5 aged:1 gains:2 sell:1 trial:1 generic:1 42:1 1.39:1 summit:4 details:1 higher:6 week:3 added:1 's:9 plans:3 combat:3 separate:4 may:2 reporting:2 forecasts:2 action:1 stocks:6 blood-pressure:1 older:1 paces:2 later:3 points:7 review:1 urgency:1
stock_PFE r_up	advisory:1 just:1 show:1 ended:1 session:1 6.2:1 committee:1 participate:1 exclusivity:1 settlement:2 its:2 fifth:1 whose:1 $:1 eligible:1 justice:1 rose:1 28:1 bailout:2 extends:1 disclosed:1 under:1 pill:1 2012:2 family:1 seized:1 gains:2 finish:2 birth:1 new:1 now:1 advanced:3 drugmaker:1 facilities:2 did:1 companies:1 52:1 --:7 after-hours:1 shed:1 right:1 doing:1 second:1 actively:1 trading:1 year:1 substantially:1 out:2 even:1 index:2 lead:2 blue-chip:3 high-stakes:1 shares:2 research:1 waiting:1 version:2 closed:3 shared:1 reporting:2 sold:1 million:1 stem:2 separate:2 approval:1 along:1 debt:3 gained:1 last:2 could:2 30:1 days:1 drug:1 headline:1 mixed:1 efforts:2 first:1 1.4:1 cancer:1 had:1 sovereign:1 crisis:4 market:2 bolster:2 industrials:1 additional:1 two:3 submit:1 next:1 180:1 much:1 ``:1 complete:1 sessions:1 funds:2 overwhelmingly:1 0.4:1 lives:1 gain:1 case:1 double:2 n't:2 while:2 were:1 following:1 called:1 launched:1 control:1 seven:1 hoping:2 investors:1 sales:1 '':1 reports:4 kidney:1 rescue:2 1.39:1 generic:3 application:1 recommended:1 summit:2 details:1 higher:4 week:2 added:1 's:16 plans:2 combat:2 though:1 may:2 after:5 forecasts:2 nothing:1 stocks:4 paces:2 later:2 points:6 allow:1 order:1
stock_PFE r_down	advisory:1 '':1 projections:1 happen:1 availability:1 rapid:1 would:1 generic:1 progress:1 uptake:1 ``:1 recommends:1 form:1 they:1 estimate:1 come:1 vaccine:1 panel:1 timely:1 these:1 drug:1 venture:1
stock_PFE r_up	woes:1 caused:1 contamination:2 agent:2 due:1 contract:1 have:1 throughout:1 batches:1 cancer:2 two:1 recommended:1 potential:1 details:1 certain:1 medicine:1 advises:1 's:1 drugs:1 inspect:1 diagnostic:2 recalled:1 background:1 doctors:1 manufacturer:1 made:2 --:3 recall:1 drug:1 risks:1 shortage:1
stock_PFE r_down	actions:1 month:2 ended:1 stepping:1 go:1 yet:1 current:2 giant:3 enters:1 20:1 $:16 22:1 winner:1 had:2 program:6 pile:1 board:2 quarterly:3 2011:2 ingredient:1 return:1 greater:2 payouts:2 overall:1 lucky:1 early:1 nearly:1 background:1 day:1 14.6:5 --:3 list:2 joined:2 names:1 some:1 cash:1 year:1 its:5 looking:2 7:4 new:2 firms:2 boost:2 shows:1 dividends:1 deliver:1 here:1 following:1 repurchase:8 dividend:5 come:1 last:2 could:2 30:1 days:2 drug:2 efforts:1 maker:1 first:1 comment:1 raised:5 active:1 raises:1 another:1 throughout:1 market:2 pharmaceutical:2 shareholders:1 additional:2 their:1 next:1 hitting:1 few:1 2:1 expected:2 authorization:1 buybacks:2 started:1 company:5 volume:1 prescription:1 10:16 15:2 announcing:1 versions:2 these:1 hike:1 expanded:1 up:4 value:2 n't:1 era:1 growing:2 2012:2 cents:1 share:6 gains:1 capture:1 containing:1 goal:2 generic:2 drugs:1 5:2 details:1 9:2 stock:2 week:1 added:2 's:9 plans:1 information:1 after:1 buyback:2 most:1 shareholder:2 data:2 approved:2 billion:12 cover:1 headquarters:1 without:1 corporate:1
stock_PFE r_up	sector:1 concept:1 being:1 over:1 raised:2 existing:1 held:2 paper:1 businesses:2 committee:1 world:2 years:2 chair:1 debate:1 succeeding:2 group:2 21:1 22:1 title:2 writes:1 auditors:2 operational:2 late:1 pile:2 board:2 under:1 quarterly:1 details:1 has:9 2010:2 2012:2 do:3 his:1 return:2 dividend:3 continues:1 overall:1 early:1 nearly:1 they:1 not:1 immediately:3 rotation:1 defended:2 term:1 like:1 lost:2 --:3 positions:2 companies:5 standards:1 good:3 duties:1 cholesterol:2 found:1 audited:1 wrote:1 ahead:2 harm:1 expanded:2 mandatory:1 stepping:2 swept:1 independent:2 doing:2 some:2 cash:2 likely:1 audits:2 exclusivity:2 fails:1 said:3 bullish:1 served:4 investing:2 since:4 research:2 current:2 500:1 health:2 new:2 issue:1 public:2 we:1 after:2 recently:1 rug:1 appointments:2 authorization:1 enhance:1 hobble:2 chairman:4 post:1 beginning:1 $:3 cautious:1 last:2 limits:1 could:2 days:1 drug:4 prior:2 products:2 month:2 skepticism:1 undergo:1 maker:3 comment:2 disclosure:1 named:3 formerly:1 public-company:1 period:1 one:1 repurchase:3 raises:1 president:6 financial:1 quality:1 market:2 pharmaceutical:1 shareholders:2 would:1 spending:2 leading:2 been:4 strategy:2 accountant:1 too:1 biggest:1 proposal:2 today:1 questionable:1 billion:3 ``:2 collapse:1 drugs:2 company:3 pursuing:2 but:1 scrutiny:1 unreliable:1 former:1 he:2 10:7 15:1 effective:3 versions:1 cap:1 up:4 pill:2 n't:1 while:2 limit:1 can:1 were:1 problem:1 industry:1 investors:2 ...:1 cents:1 share:3 sales:2 '':2 2nd:1 warning:2 curb:2 have:1 accounting:1 any:1 information:1 end:1 provide:1 make:1 directors:1 also:1 other:2 take:2 which:1 wanting:1 stepped:1 several:3 events:1 worldwide:2 requested:1 added:3 's:5 plans:2 capture:1 reporting:1 director:2 moving:2 demise:1 changing:1 stocks:1 efforts:4 audit:2 lead:2 calls:1 vice:2 average:1 well:3 2002:1 patent:2 chief:1 points:1 auditor:7 tenure:2 professional:1 senior:2 joining:2 its:9 latest:1
stock_PFE r_up	unemployment:1 high:1 cost:1 year:1 confidence:1 said:1 weakened:1 patent:1 due:1 rash:1 next:1 low:1 2012:2 expirations:1 government:1 pressure:1 significant:1 demand:1 amid:1 companies:1 face:1 containment:1 consumer:1
stock_PFE r_up	chain:1 money:1 retire:5 outlook:2 quarters:1 four:1 session:1 through:2 managers:1 its:2 boosts:1 giant:2 it’s:1 same-store:1 29:3 program:1 board:1 chairman:1 executive:2 rise:1 results:1 updates:1 background:2 despite:1 three-day:1 loss:1 --:7 wellness:1 officer:1 12th:1 stock:1 16th:1 highs:1 lifted:1 doing:1 some:1 second:1 economic:1 year:1 out:1 said:2 bullish:2 since:2 bearish:2 research:2 longtime:2 consecutive:1 leader:2 sixth:1 succeed:2 operating:1 losing:1 dividend:1 gained:1 last:1 drug-store:1 days:1 times:2 thing:2 whole:1 first:1 named:1 elect:1 one:1 retires:1 another:1 narrowed:1 throughout:1 crisis:1 market:1 conference:1 additional:1 third-quarter:1 least:1 their:1 call:1 store:1 head:2 funds:3 apparent:1 heir:1 took:1 but:1 finished:1 improved:1 these:1 three:1 2012:3 streak:1 heart:1 investors:1 snapping:1 sales:3 full-year:1 warning:1 have:1 information:1 end:1 rosier:1 make:1 2000:1 also:1 intends:1 details:2 higher:1 exactly:1 's:7 that’s:1 price:1 after:3 loyalty:2 helping:1 biotechnology:2 president:1 data:1 eighth:1 fiscal:1 off:1 programs:1 stronger:1 chief:3 position:1
stock_PFE r_down	all:2 chain:1 show:1 sights:1 focus:1 broader:2 exclusivity:2 its:9 profitable:1 resisting:1 just:1 spin:1 same-store:1 has:4 gains:1 seeking:2 continues:1 wring:2 bigger:1 loss:1 lost:2 always:1 companies:2 morning:1 trimmed:1 higher:2 lifted:1 set:1 restless:2 burst:1 narrowed:1 acquisitive:1 out:3 said:2 current:2 everything:1 3:2 new:1 increasing:1 public:1 business:1 leg:2 takeover:1 franchise:1 cautious:1 benefits:2 industry:2 drug-store:1 drug:4 action:1 top:2 copes:2 tone:1 revenue:2 into:1 primary:2 one:2 refill:2 pharmaceutical:2 pharmaceuticals:1 addition:2 support:2 third-quarter:1 been:5 their:2 way:2 meeting:2 more:3 pipelines:2 drugs:2 company:1 but:1 else:1 overture:1 line:2 effort:2 target:1 showed:2 patients:2 three:2 making:2 endpoints:2 study:4 sales:2 have:3 blockbuster:2 saw:1 syndrome:2 patent:4 medical-devices:1 also:2 which:3 gate:1 nice:1 product:2 's:6 plans:1 uses:2 such:2 stocks:1 expand:2 cliff:2 fiscal:1 off:1 programs:1 stand-alone:1 push:2
stock_PFE r_up	sector:1 serving:1 proposed:1 global:1 data:1 its:2 poorly:1 setbacks:1 $:3 poorest:1 recommending:1 late:1 charge:1 treatment:1 2011:2 into:1 2012:1 pay:1 return:1 fourth:1 meanwhile:1 wave:1 therapy:1 effects:1 despite:1 now:1 --:1 drop:1 facing:1 predicted:1 small:1 quarter:1 side:1 deal:1 penalties:1 dead:1 growth:1 year:1 makers:1 said:1 forecast:1 provider:1 doggy:1 officially:1 approvals:1 million:2 standard:1 reported:1 unwanted:1 put:1 stage:1 prospects:1 38:1 benefits:1 pressure:1 industry:1 according:1 drug:2 range:1 context:1 long-term:1 vets:1 pre-tax:1 revenue:1 pot:1 two:1 wider:1 pharmaceutical:1 use:1 breakup:1 due:1 clinical:1 too:1 4:1 drugs:1 company:1 pipeline:1 cresting:1 cases:1 rival:1 flu:3 risks:1 more:1 acquisition:1 challenging:1 investors:1 states:1 warning:1 performed:1 hit:1 hospitals:1 halt:1 forced:1 confirmed:1 end:1 trials:1 get:1 take:1 which:1 largest:1 development:1 product:1 added:1 's:6 may:1 after:1 most:1 revealed:1 billion:1 lower:1 charges:1 yielding:1 time:1 push:1 profits:1
stock_PFE r_up	aided:1 all:1 help:3 chain:7 sentence:2 trade:2 identify:2 looks:1 7.5:2 its:2 issues:1 previous:1 $:4 1.11:2 had:2 capabilities:2 pharmacy:2 add:3 treatment:2 details:2 poised:3 dispute:6 tests:2 gains:1 weakness:1 rise:1 background:2 updates:2 they:2 despite:2 progresses:2 day:1 --:23 fewer:2 benefit:2 steps:6 predicted:1 economy:2 expanded:2 says:10 back:1 maintain:6 second:4 trading:2 expect:6 year:5 's:12 margins:2 detect:2 lead:2 shares:4 access:6 health:7 new:5 sluggish:2 available:2 business:1 seventh:2 agreement:8 diagnostic:4 although:2 news:2 manufacturing:1 beginning:2 rare:2 many:6 taking:6 months:2 contract:11 analysts:2 settled:1 first:2 comment:2 secure:8 appeared:2 powerful:1 down:2 intraday:1 conference:2 additional:4 would:1 5th:2 been:2 genetic:2 much:2 call:2 stock:4 drugstore:7 offer:2 drugs:1 company:2 gain:6 last:4 13:2 made:4 clients:6 up:4 regulator:1 patients:6 can:2 were:4 2012:3 could:1 losses:1 share:6 sales:1 have:2 recover:1 4.5:19 generic:3 lung-cancer:2 1:2 concerns:2 earnings:8 test:2 commentary:2 higher:7 week:4 begin:3 first-quarter:6 plans:8 undergoing:2 may:4 quote:2 price:2 after:2 fell:7 eight:2 stocks:1 eighth:2 recent:5 fiscal:6 peers:6 attempt:8 light:2 without:3 costs:7 latest:4
stock_PFE r_down	medication:4 painkiller:2 headwinds:1 health-care:1 voluntarily:2 related:2 stability:2 chronic:2 likely:1 identify:2 performed:2 another:2 year:1 pain:2 protein:2 next:1 targets:2 acceleration:1 symptoms:2 said:3 potential:2 lead:2 patent:1 since:2 two:2 research:2 better:2 concerns:3 potentially:2 then:2 6:2 taken:2 new:2 moderate:2 patients:4 therapies:2 fiscal:1 's:10 expirations:1 than:2 inhaled:2 crushed:2 fund:2 abuse:2 recalled:2 key:2 half:2 affect:2 abroad:1 stresses:1 both:2 showed:2 third:2 fully:2 studies:4 industry:1 disease:2 remaining:2 n't:2 remain:1 either:2 withdrawal:4 study:4 efforts:2 placebo:2 its:2 could:2 address:2 late-stage:2
stock_PFE r_up	said:1 did:1 survival:1 overall:1 drug:1 n't:1 trial:1 patients:1 clinical:1 late-stage:1 its:1 experimental:1 improve:1
stock_PFE r_down	all:1 close:1 navigate:1 some:1 through:2 performed:1 have:1 year:2 need:1 's:6 technology:1 its:1 out:2 industrials:1 group:1 lead:1 managing:1 top:1 rounds:1 scenarios:1 cue:1 health:1 folks:1 2011:3 sent:1 more:3 gaming:1 them:1 pain:1 business:1 night:1 20:1 five:1 doctors:1 hopes:1 highlighting:1 than:2 care:1 intriguing:1 12:3 last:1 19:1 involved:1 taking:1 30:1 companies:1 up:3 picks:1 pace:1 patients:1 components:1 social:1 release:1 2012:1 start-ups:1 31:1 executives:1
stock_PFE r_down	prevent:2 now:1 least:1 says:1 adults:1 clinical:1 expanding:1 over:1 global:1 ages:1 infections:2 rest:1 years:2 certain:1 already:1 looks:1 year:2 been:1 blockbuster:1 its:1 meningitis:1 agency:1 use:5 said:2 data:1 granted:1 flying:1 had:1 accelerated:1 40:1 approved:2 supported:1 can:1 won:1 which:1 under:1 new:1 poised:1 cause:1 more:2 program:1 buy:1 's:5 diseases:1 ear:1 treatments:1 fell:1 approval:3 along:1 one:1 investor:1 than:1 vaccine:3 panel:1 13:3 last:1 turbulence:1 older:1 industry:1 expanded:1 children:1 50:4 disease:1 face:1 large:1 patients:1 airline:1 time:1 serious:1 2012:1 review:1
stock_PFE r_up	meant:1 dividend-paying:1 's:1 look:1 success:1 classic:1 banner:1 30:1 year:2 one:1 consecutive:1 second:1 yields:1 promising:1 known:1 dividend:1 technicals:1 stocks:2 2011:2 best:1 strategies:1
stock_PFE r_down	named:2 financial:1 classic:1 over:1 back:1 second:1 have:1 year:1 's:3 its:1 unit:1 previous:1 heads:1 underperforming:1 decade:1 new:1 2011:2 his:1 run:1 de:1 consecutive:1 known:1 post:1 former:1 after:1 success:1 companies:1 reports:1 chief:1 officer:1 strategies:1
stock_PFE r_down	search:1 set:1 bar:1 finance:1 took:1 why:1 high:1 chief:1 land:1 which:1 new:1 years:1 's:1 its:1
stock_PFE r_down	large-cap:1 just:1 decent:1 companies:1 identified:1 yield:1 few:1 4:2 has:1 than:1 more:1
stock_PFE r_up	medication:1 just:1 physicians:1 sales:2 '':1 likely:1 nicotine:1 such:2 go:1 cold:1 makers:1 turkey:1 quit:1 patches:1 over-the-counter:1 tightly:1 their:1 acting:1 asking:1 treatment:1 new:1 effectiveness:1 more:1 supporting:1 ``:1 casting:1 doubt:1 after:1 pitches:1 cigarette:1 fresh:1 using:1 now:1 relapse:1 resource:1 like:1 study:1 suggests:1 switch:1 products:1 smokers:2 making:1
stock_PFE r_up	streak:1 heart:1 associated:1 generation:1 companies:1 stroke:1 market:1 increased:1 said:1 generic:1 takeovers:1 hepatitis:1 winning:1 attack:1 holding:1 new:2 's:1 risk:2 cholesterol:1 lower:1 treatments:1 fund:1 part:1 blood:1 approval:1 hedge:1 competes:1 38:1 versions:1 study:1 developing:1 37:1 drug:2 thinners:1 first:1 onto:1 comes:1 gain:1
stock_PFE r_down	function:1 use:1 off:1 scales:1 pot:1 older:1 people:1 lung:1 assessment:1 block:1
stock_PFE r_down	prospective:1 weight:1 over:1 2,000:1 period:1 see:1 drug:1 's:1 partners:1 said:1 would:1 pet:1 announces:1 300:1 brand:1 more:1 we:1 jobs:1 business:2 food:1 company:2 after:1 but:1 cut:1 than:1 three-day:1 loss:1 lower:1 created:1 value:1 team:1
stock_PFE r_up	development:2 's:6 clinical:1 ending:1 study:1 after:2 watch:1 results:1 drug:2 morning:1 disappointing:2 trial:1 potential:1 treatment:1 another:1 partner:1 include:1 yet:1 late-stage:1 more:1
stock_PFE r_up	praising:1 's:1 pharma:1 deal:1 branding:1 require:1 n't:1 actors:1 industry:1 execs:1
stock_PFE r_down	said:1 especially:1 business:1 generic:1 saw:1 stronger:1 results:1 than:1 growth:1 sales:1 generics:1 were:1 expected:1 new:1 strong:1 2011:1 its:2
stock_PFE r_up	fourth-quarter:1 outlook:1 issued:1 fortunes:1 cuts:1 hit:1 medications:1 46:1 5:2 earnings:1 net:1 boost:1 2012:3 franc:1 's:2 price:1 reported:1 restructuring:1 strong:1 continued:1 write-offs:1 cautious:1 like:1 could:1 drop:1 companies:1 drug:1 profit:1 costs:1
stock_PFE r_down	talked:1 classic:1 looks:1 have:2 still:1 any:1 would:1 prevented:1 only:1 version:1 which:1 rookie:1 we:1 's:2 approached:1 far:1 bid:1 agreement:1 v.:2 early:1 but:1 hostile:1 made:1 standstill:1 like:1 days:1 without:1 so:1 first:1 mistake:1
stock_PFE r_down	treating:1 's:1 cancer:1 drugs:1 disease:1 drug:1 years:1 regulators:1 kidney:1 recent:1 several:1 approved:2 advanced:1 latest:1
stock_PFE r_up	developed:1 over:1 results:1 skin:1 alternative:1 its:1 before:1 $:1 tape:1 has:2 ...:1 diseases:1 government:1 preparing:1 world:1 trouble:1 wipe:1 advanced:1 runs:1 clutch:1 companies:1 've:1 small:1 shed:1 seats:1 some:1 year:1 morning:1 out:2 cell:1 attracted:1 health:1 new:3 therapies:1 measuring:1 we:1 pose:1 business:1 million:1 little:1 agencies:1 pressure:1 leadership:1 regulatory:1 approval:1 both:1 dollars:1 annual:1 drug:4 times:1 confidence:1 partnerships:1 checkup:1 major:1 cancer:1 supply:1 into:1 billions:1 pharmaceutical:1 story:1 housing:1 question:1 arms:1 tropical:1 much:1 treat:1 biggest:2 more:2 firm:2 company:1 took:1 cases:1 than:1 10:3 bill:1 2020:1 aid:1 toward:1 could:1 biotech:1 surprisingly:1 heard:1 seek:1 increased:1 sell:1 corporation:1 get:1 backs:1 's:8 may:1 includes:1 blood:1 data:1 approved:1 booster:1 ago:1 older:1 corporate:1 clean:1 push:1 model:1 800:1 consumer:1 investments:1 nearly:1
stock_PFE r_down	high-risk:1 yen:1 over:1 move:1 outlook:1 ending:1 session:1 legal:1 signs:1 talks:1 protecting:1 research:1 its:2 seemed:1 envy:1 thinking:1 risk:1 rules:1 watch:4 five:1 new:1 trade:1 during:1 years:2 advanced:1 volatility:1 companies:2 each:1 higher:3 round:1 investors’:1 still:1 tougher:1 declines:1 competition:1 likely:1 economic:1 trading:1 further:1 insurance:1 skin-cancer:1 said:2 profit:2 shares:1 forecast:1 weapons:1 favor:1 progress:1 red:1 we:1 after:1 handful:1 agreement:1 reported:1 active:1 debt:1 quarter:1 successes:1 could:1 drug:2 slightly:1 maker:1 fourth-quarter:1 major:1 see:1 cancer:1 point:3 into:1 long:1 unit:1 strong:1 prepare:1 start:1 data:1 there:1 due:1 least:1 next:1 few:1 themselves:1 cliff:1 ``:1 drugs:1 but:1 hurt:2 lowered:1 posted:1 '':1 15:1 look:1 rival:1 budget:1 were:1 strategies:1 associated:1 figure:1 life:1 disappointing:2 full-year:1 against:2 have:1 need:1 string:1 again:1 generic:1 patent:1 indexes:1 also:2 earnings:1 which:2 largest:1 gains:1 stock:4 scored:1 's:1 combat:1 reporting:1 forecasts:1 weighed:1 fell:2 device:1 drought:1 stocks:3 prostate:1 approved:1 pool:1 recent:1 fiscal:1 third:1 amid:1 futures:3 disease:1 reports:1 costs:1
stock_PFE r_up	saying:1 they:1 show:1 dollar:1 expects:1 competitive:1 month:1 course:1 including:2 cuts:1 its:1 impact:1 zone:1 surprises:2 guidance:1 advisories:2 weakening:1 2012:3 has:1 hope:1 take:1 good:1 unplanned:1 gains:1 government:1 weakness:1 continues:1 closely:1 report:2 breast-cancer:1 quarters:1 day:2 entire:1 --:1 always:1 companies:3 consensus:1 slide:1 birth-control:2 recalls:1 dealing:1 some:3 jump:1 see:1 growth:1 year:1 jobs:1 surgery:1 employment:1 pills:2 out:2 index:1 said:2 funding:1 pattern:1 section:1 outside:1 future:1 international:1 boost:1 million:1 recently:1 predicting:1 packaged:1 affiliates:1 reported:1 become:2 put:1 manufacturing:1 improve:1 roundup:1 last:1 ahead:1 getting:1 could:1 in-depth:1 reports:2 spending:1 products:1 slightly:1 first:1 fourth-quarter:1 raised:1 puzzle:1 retailer:1 rolling:1 such:1 throughout:1 miss:1 crisis:1 market:1 monthly:2 bite:1 their:2 much:1 expected:4 recent:1 markets:1 today:3 more:1 ``:1 much-needed:1 packs:1 but:2 recalled:1 '':1 look:1 n't:3 're:1 were:1 pressure:1 piece:1 weaker:1 sales:2 disappointing:1 currency:1 numbers:1 have:1 our:2 watched:1 risk:1 huge:1 compared:1 no:1 get:1 other:1 earnings:3 which:1 auto:1 higher:1 week:1 repeat:1 's:8 warnings:1 most:1 coming:1 nothing:1 positives:1 euro:6 surprising:1 stronger:2 edge:1 position:1 corporate:2 profits:1 latest:1
stock_PFE r_down	revenue:1 surgery:1 regulate:1 fee:1 profit:1 sugar:1 increase:1 also:1 call:1 swung:1 agreement:1 acquisition-related:1 reported:1 restructuring:1 user:1 charges:1 amid:1 modest:1 fewer:1 future:1 maker:1 medical-device:1
stock_PFE r_down	fiscal:1 lower:1 austerity:1 gains:1 investors:1 wrangling:1 over:1 focus:1 their:1 five:1 broader:1 putting:1 weeks:1 hold:1 market:1
stock_PFE r_up	'':1 planning:1 pills:1 expensive:1 millions:1 generic:1 shortcut:1 favor:1 complex:1 market:1 biosimilar:1 ``:1 's:1 insurer:1 stop:1 versions:2 members:1 made:1 covering:1 medicines:1 created:1 matter:1 first:1
stock_PFE r_up	qualms:1 over:1 hypertension:1 universities:1 partners:1 no:1 their:2 treat:1 new:1 has:1 form:1 chancellor:1 hands:1 schools:1 such:1 approved:1 increasing:1 medical:1 glaucoma:1 drug:1 n't:2 wringing:1 corporate:1
stock_PFE r_up	...:1 share-price:1 estimates:1 potent:1 trade:1 session:1 whose:1 informed:1 shares:1 returns:1 continue:1 earnings:1 expected:1 beating:1 adviser:1 's:1 delivering:1 companies:1 drug:1 while:1 actively:1 can:1 maker:1
stock_PFE r_down	fourth-quarter:1 harm:1 costly:1 cancer:2 revenue:1 simple:1 over:1 offset:1 agents:1 fakes:1 rising:1 year:1 controlled:1 pills:1 declined:1 counterfeit:2 done:1 much:1 distributors:1 rather:1 highlights:1 distributed:1 legal:1 its:1 increase:1 version:2 biggest:1 if:1 therapies:1 higher:1 showdown:1 's:3 any:1 but:1 nation:1 acquisition-related:1 fueled:1 found:2 such:1 one:1 than:2 purchase:1 has:1 last:1 warned:1 clear:1 sale:1 drug:4 34:3 n't:1 profit:1 costs:1 threat:1 injectable:1 more:1 heading:1
stock_PFE r_up	tough:1 over:1 year:1 attract:1 use:1 said:2 $:1 profit:1 claiming:1 version:1 damages:1 expected:1 new:1 heartburn:1 dispute:1 customers:1 's:1 million:1 reported:1 960:1 drop:1 drug:1 patent:1 products:1 generic:1
stock_PFE r_up	acquisitions:1 's:3 morning:1 banking:1 biggest:1 news:1 more:1 mergers:1 bankruptcy:1
stock_PFE r_up	up:1 named:1 code:1 just:1 do:1 28:1 health-care:1 tax:1 resistance:1 rip:1 years:1 challenges:1 rate:1 minimum:1 eliminating:1 our:1 foreign:1 yet:1 its:1 giant:1 documents:1 overhaul:1 offering:1 reform:1 top:1 administration:1 detail:1 should:1 few:1 finally:1 setting:1 rates:1 earnings:1 slash:1 proposal:1 dozens:1 today:1 lowering:1 levy:1 move:1 business:1 exchange:1 immediate:1 deductions:2 preparing:1 groups:1 day:1 corporate-tax:2 past:1 last:1 ahead:1 many:1 your:1 faced:1 limiting:1 n't:1 time:1 first:1 corporate:1 plan:1
stock_PFE r_down	weaker:1 consolidated:1 sales:1 related:1 another:1 wider:1 settlement:1 city:1 court:2 decision:1 trademark:1 fourth:1 net:1 pending:1 dispute:1 's:3 halt:1 rejected:1 hurt:1 reported:1 regulators:1 sharply:1 loss:1 amid:1 rupee:1 costs:1 efforts:1 quarter:1
stock_PFE r_up	advisory:1 would:1 proposed:1 marketed:1 disease:1 drug:1 chronic:1 lung:1 treat:1 backed:1 approval:1 panel:1
stock_PFE r_up	proposed:1 being:1 developed:1 guided:1 executive:1 results:1 bapineuzumab:2 helm:1 its:1 25:2 $:1 28:1 should:1 platform:1 treatment:1 has:3 agreed:1 get:1 very:2 maritime:1 therapy:1 not:1 success:2 harbor:1 companies:1 financially:1 either:1 become:1 approaching:1 provided:1 said:1 decision:1 since:1 anticlotting:1 profitability:1 research:1 3:1 asking:1 new:2 regulators:1 key:1 could:1 months:1 drug:2 experimental:1 powerful:1 three:1 down:1 publication:1 would:1 transform:1 least:1 expected:1 until:2 ``:1 delayed:1 but:1 hopes:1 pilot:1 '':1 while:1 revenues:1 biotech:1 share:1 dash:1 fortunes:1 have:1 blockbuster:1 occur:1 information:1 trials:1 agency:1 any:1 1:1 which:1 stepped:1 arrives:1 's:2 huge:1 after:1 stay:2 changing:1 data:2 billion:1 2003:1 chief:1
stock_PFE r_down	use:1 stats:1 delays:1 anticlotting:1 drug:2 age:1 sleep:1 decision:1
stock_PFE r_up	tough:1 expanding:1 animal-health:2 recently:1 still:1 considers:1 unit:1 bankruptcy:1 $:1 spurned:1 lawsuits:1 access:1 much:1 too:1 biggest:1 approach:1 more:1 billion:1 buy:1 's:2 business:1 offer:1 drugs:1 bid:1 valued:1 low:1 preliminary:1 news:1 drug-company:1 coupons:1 acquisitions:1 made:1 target:1 16:1 many:1 medical:1 rebuffed:1 morning:1 banking:1 bills:1 mergers:1
stock_PFE r_up	advisory:1 unanimously:1 continue:1 federal:1 developed:1 companies:1 should:1 drugs:1 said:1 other:1 class:1 experimental:1 panel:1
stock_PFE r_up	poor:1 decline:1 financing:1 have:1 amid:1 weak:1 offerings:1 returns:1 venture:1 seen:1 firms:1 stock:1 economy:1
stock_PFE r_down	announcement:1 statistics:1 's:1 largest:1 payer:1 guru:1 crunches:1 some:1 second:1 numbers:1 dividend:2 aftermath:1 now:1 concludes:1 500:3
stock_PFE r_down	trade:1 its:1 end:1 would:1 top:1 opening:1 shares:1 offered:1 higher:1 exchange:1 company:1 after:1 priced:1 services:1 world:1 strong:1 made:1 debut:1 range:1 without:1 were:1 stock:1
stock_PFE r_down	help:1 some:1 site:1 euro-zone:1 n't:1 slowed:1 initiative:1 connect:1 slip:2 corporations:1 go:1 small:1 large:1 fears:1 factory:1 vendors:1 does:1 firms:1 markets:1 stock:1 led:1 enough:1 far:1 after:2 weak:3 but:1 fueled:1 sharply:1 stocks:2 data:2 resource:1 launch:1 drop:1 say:1 recession:1 while:1 activity:1 banks:1
stock_PFE r_up	set:1 's:1 trial:1 see:1 favorable:1 result:1
stock_PFE r_up	highest:1 driving:1 support:1 after:1 labor:1 four:1 needed:1 market:1 500:1 rates:1 low:1 interest:1 years:1 still:1 its:1 advanced:1 nearly:1
stock_PFE r_down	seven:1 costly:1 have:1 proposed:1 best:1 hard:1 some:1 disappointing:1 economic:1 investors:1 fifth:1 tumbled:1 overhaul:1 $:1 would:1 merger:1 administration:1 29:1 been:1 access:1 treat:1 health-care:1 week:1 used:1 's:3 diseases:1 drugs:1 fell:1 impede:1 eyed:1 stocks:1 data:1 day:1 debates:1 billion:1 look:1 performers:1 whether:1 taking:1 commodities:1 patients:1
stock_PFE r_up	's:1 like:1 decent:1 into:1 sales:1 shares:1 dividends:1 put:1 stocks:1 quality:1 ease:1
stock_PFE r_down	financial:2 chain:1 doing:1 private:1 years:1 past:1 persuade:1 its:1 $:1 broad:1 veteran:1 grocer:1 9:1 new:1 unless:1 stay:1 discount:1 hired:1 five:1 post:1 billion:1 leaves:1 experience:1 chief:1 so:1 can:1 lose:1
stock_PFE r_up	sector:1 control:1 sees:1 help:1 people:1 one:2 rising:1 opportunities:1 year:2 close:2 its:2 said:1 $:2 would:2 leading:1 least:2 largest:2 9:2 selling:2 business:2 far:2 familiar:1 investor:1 billion:2 companies:1 deals:2 matter:1 costs:1 so:2
stock_PFE r_up	just:1 committed:1 cold:1 centers:1 relationships:1 young:1 systems:1 under:1 local:1 do:1 return:1 food:1 unveil:1 not:1 entire:1 like:2 --:1 companies:1 morning:2 banking:1 bad:1 popular:1 obesity:1 its:1 mergers:1 mean:1 because:1 says:2 people:1 some:2 year:1 our:1 've:1 makers:1 best:1 provided:1 research:1 does:1 health:1 between:1 new:1 offline:1 supporting:1 we:1 business:1 met:1 news:1 improve:1 would:1 pressure:1 many:1 drug:1 suggests:1 options:1 already:1 feel:1 community:1 services:2 set:1 1990s:1 quality:1 cloud:2 bankruptcy:1 service:1 support:1 cloud-based:1 next:1 their:2 vendors:1 biggest:1 until:1 more:2 offering:1 tool:1 but:1 link:1 cases:1 those:1 challenge:1 created:1 n't:1 can:1 piece:1 my:1 file:1 site:1 need:1 have:2 ready:1 work:1 functions:1 productivity:1 no:1 generic:1 make:1 storage:2 you:1 's:8 may:3 collaboration:1 most:1 brands:1 acquisitions:1 remember:1 well:1 traditional:1 perform:1 consumer:1 having:1 came:1
stock_PFE r_up	financial:1 slipped:1 reeling:1 into:1 global:1 back:1 trade:1 rate:1 session:1 crisis:1 recession:1 unemployment:1 shares:1 2009:1 recommended:1 expected:1 has:1 sent:1 economy:1 's:7 after:1 rejected:1 regulators:1 approval:1 than:1 diabetes:1 14.6:1 country:2 companies:1 drug:3 regulator:1 actively:1 higher:1 experimental:1
stock_PFE r_down	infant:2 want:1 clip:1 certification:1 fish:2 global:1 buy:2 drug:1 lagging:1 need:1 scarce:1 glance:1 category:1 its:1 expensive:1 bankruptcy:1 sell:2 leader:1 27:1 $:6 would:2 certified:1 they:1 may:1 those:1 lot:1 biggest:1 formula:2 more:1 company:1 price:1 higher:1 nutrition:1 good:1 's:14 business:5 found:1 food:2 problems:1 bid:1 looks:1 but:1 finds:1 acquisitions:1 cement:1 position:1 baby:2 news:3 new:1 than:1 buying:1 billion:4 10:1 transaction:1 assets:1 third:1 industry:1 deal:1 morning:1 banking:1 expecting:1 certifications:1 sustainable:1 making:1 first:1 study:1 mergers:1 justify:1
stock_PFE r_up	infant:1 help:1 agreed:1 emerging:1 years:1 stepping:1 its:1 discipline:1 giant:1 $:5 had:1 winning:1 finally:1 equity:1 8:1 has:1 2011:1 hit:1 returned:1 sitting:1 food:1 big:1 nearly:1 half:1 during:1 now:1 entire:1 companies:1 morning:1 deals:1 benefit:1 mergers:1 billion:3 deal:1 back:1 second:1 year:1 even:1 3:2 won:1 unit:2 formula:1 boost:1 announced:1 terms:1 business:2 acquisitions:1 news:1 auction:1 climbed:1 remains:1 private:1 market:2 spending:1 leading:1 there:1 least:1 their:1 low:1 biggest:1 markets:2 today:2 more:1 nutrition:1 acquire:1 volume:1 expected:1 stick:1 prices:1 buying:1 whether:1 rival:1 up:2 baby-formula:1 process:1 share:2 seen:1 agreeing:1 pay:2 far:1 17.1:3 which:1 stock:1 's:8 cement:1 expand:1 rallied:1 so:1 buybacks:1 position:1
stock_PFE r_up	grabbing:1 gone:1 says:2 cancer:1 restore:1 recalls:1 sales:1 helped:1 interim:1 rising:1 $:2 's:10 priority:2 morning:3 miss:1 investment:1 no-hitter:1 decline:1 cleared:1 problems:1 takeover:1 no:1 profit:1 breakup:1 fix:1 there:1 anticlotting:1 expectations:1 been:1 increase:1 other:1 headlines:1 critical:1 health:2 chairman:1 way:2 biggest:1 revolving:1 more:1 has:2 bid:1 first:1 billion:2 head:1 door:1 airwaves:1 returning:2 drugs:1 earnings:1 becoming:1 component:1 wireless:1 reported:1 part:1 recalled:2 broke:1 offset:1 news:2 manufacturing:1 spin:1 condition:1 he:1 acquisitions:1 39:1 12:3 incoming:1 failed:1 vows:1 receive:1 fee:1 bankruptcy:1 up:1 drug:2 leaving:1 n't:2 banking:2 1:3 analysts:1 quick:1 serious:1 retail:1 consumer:1 maker:1 mergers:1 latest:1
stock_PFE r_up	help:1 into:1 some:1 sales:1 helped:1 cost:1 drug:2 67:3 's:5 slower-than-expected:1 your:1 dysfunction:1 said:1 us:1 would:1 grading:1 rose:1 section:1 system:1 controls:1 its:2 investigation:1 earnings:1 biggest:1 stories:1 weekly:1 dominance:1 treat:1 week:1 ``:1 first-quarter:1 comments:1 business:1 litigator:1 back:1 erectile:1 know:1 offset:1 approved:1 thoughts:1 abused:1 '':1 has:2 look:1 antitrust:1 whether:1 against:1 lead:1 deals:1 growth:1 compete:1 advertising:1 maker:1
stock_PFE r_down	revenue:1 into:1 trade:1 brought:1 see:1 session:1 its:1 if:1 said:1 22:3 generic:1 rose:1 boot:1 find:1 does:1 earnings:1 way:1 new:1 boost:1 higher:1 's:2 risk:1 get:1 drugs:1 becoming:1 watch:2 reported:1 sharply:1 active:1 could:2 companies:2 drug:1 n't:1 admit:1 maker:1
stock_PFE r_down	sector:1 all:1 just:1 executive:1 trade:1 stature:1 session:1 high-profile:1 headlines:1 doesn’t:1 its:3 digest:1 indicator:1 red-hot:1 should:1 quarterly:1 has:1 offense:1 do:1 good:1 gains:1 read:1 watch:2 early:2 they:1 now:1 chips:1 complain:1 aren’t:1 companies:1 mid-caps:1 manages:1 activity:1 stock:2 round:1 mean:1 because:1 people:1 estimates:1 back:1 competition:1 actively:1 election:1 picked:2 's:5 resigned:1 small-:1 declined:1 out:1 blue:1 missed:1 mortgage:1 profit:1 announces:1 bearish:1 shares:1 continent:1 3:2 stock-index:1 bullish:1 new:1 forth:1 shows:1 after:3 business:1 handful:1 bulls:1 hours:2 rises:2 cautious:1 last:1 ahead:2 country:1 could:1 drug:1 turn:1 became:1 place:1 climb:1 major:1 there:2 into:3 one:2 names:1 another:1 open:1 market:1 decline:1 manufacturing:1 top:1 rebounded:1 copies:1 their:1 secret:1 much:1 too:1 interest:1 expected:1 billionaires:2 interests:1 buy:2 insurer:1 month:2 took:1 but:2 part:2 gain:2 analyst:1 look:1 19:1 rival:1 wealthiest:1 up:1 n't:1 shift:1 squeezed:1 industry:1 investors:3 influence:1 sales:1 player:1 reports:1 have:3 further:1 politics:1 tumbled:1 4.1:1 recovery:2 no:1 generic:1 suggest:1 make:1 generally:1 also:1 interested:1 5:2 earnings:2 which:1 performance:1 higher:2 worldwide:1 closer:1 product:1 first-quarter:1 await:1 problems:2 falls:2 71:1 coming:1 stocks:3 data:3 purchase:1 kept:1 especially:1 amid:1 futures:3 ways:2 chief:1 edge:2 investments:1 latest:1
stock_PFE r_down	examining:1 surprises:2 saying:1 humans:1 related:1 quarters:1 down:1 not:1 have:1 consumer-products:1 seen:1 its:1 20:1 ambitions:1 rose:1 since:1 advisories:2 earnings:1 2007:1 roundup:1 get:1 drugs:1 some:1 company:1 part:1 prepares:1 chili:1 future:1 emerging-market:1 basics:1 last:1 corporate:1 taking:1 companies:1 reports:1 pinning:1 levels:1 risks:1 published:1 studies:1 31:1 latest:1
stock_PFE r_down	pharmaceutical:1 said:1 government:1 drugs:1 try:1 industry:1 work:1 companies:1 aside:1 been:1 large:1 cast:1 uses:1 have:1 new:1 find:1
stock_PFE r_up	1.6:3 adults:1 session:1 agreed:1 allegations:1 results:1 trade:1 actively:1 its:1 improperly:1 said:1 $:3 federal:1 positive:1 marketed:1 shares:1 state:1 expected:1 's:1 compared:1 uses:1 authorities:1 off-label:1 billion:1 showed:1 study:1 companies:1 drug:1 antidepressant:1 settle:1 pay:1 long-term:1 placebo:1
stock_PFE r_down	advisory:1 major:1 votes:1 simple:1 over:1 executive:1 purposes:1 setback:1 '':1 held:1 second:1 medication:1 have:1 year:1 choices:1 its:1 little:1 said:1 raise:1 their:3 chosen:1 pay:1 writes:1 had:1 should:1 rivals:1 high:1 setting:1 role:1 which:1 between:1 main:1 type:1 stock:2 firm:1 ``:1 good:1 high-dividend:1 business:1 big:1 cholesterol:1 shareholders:1 story:1 but:1 hopes:1 not:3 designed:1 groups:1 peer:1 trouble:1 stocks:1 appears:2 both:1 peers:1 failed:1 publicly:1 identifying:1 these:1 industry:1 study:1 companies:3 drug:1 different:1 large:1 influential:1 compensation:1 high-yielding:2 pick:2 playing:1 justify:1
stock_PFE r_up	quietly:1 because:1 consider:1 campaign:1 being:1 household:1 despite:1 alternatives:1 ending:1 including:1 reports:1 world:1 producer:1 aggressive:1 its:3 market:1 bankruptcy:1 well-positioned:1 cheap:1 rapid:1 generic-drug:1 banking:1 shares:1 earnings:1 which:1 largest:1 units:1 size:1 2012:3 begin:1 's:2 business:1 may:1 marketing:1 long:1 but:1 biggest:1 retain:1 not:1 news:1 strategic:1 continued:1 name:1 acquisitions:1 assets:1 companies:1 drug:1 morning:1 n't:1 pace:1 divest:1 share:1 more:1 mergers:1
stock_PFE r_down	fourth-quarter:1 slim:1 's:3 investors:1 profit:1 2.7:3 rise:1 mainly:1 due:1 one-time:1 charge:1 net:1 disappointed:1 its:1
stock_PFE r_down	week:1 molecular:1 releases:1 cancer:2 society:1 drugs:1 shift:1 away:1 continuing:1 treatments:1 cells:1 medical:1 clinical:1 features:1 unique:1 data:1 display:1 target:1
stock_PFE r_up	limited:3 one-year:1 investors:1 less:1 people:1 10-year:1 mistake:1 drug:1 signs:1 yet:1 hunting:1 no:1 investing:1 writes:1 it’s:1 next:1 2:1 master:1 memory:1 show:1 surprise:1 risks:2 development:1 do:1 's:3 business:1 big:2 first:1 tested:1 nothing:1 than:1 paying:1 loss:1 average:1 companies:1 yielding:1 yield:2 n't:1 trial:1 yields:1 deposit:1 time:1 higher:1 could:1 partnerships:3
stock_PFE r_down	heart:1 emerging:1 right:1 managers:1 family:1 people:1 paralyzed:1 guidelines:1 humans:1 arm:1 lung:1 against:2 another:1 tough:1 linked:1 training:2 horse:1 cancer:2 her:1 thing:1 rather:1 two:1 antibiotic:1 their:1 clinical:1 study:1 rare:1 ambitious:1 medicine:1 personalized:1 fatal:1 explains:1 moved:1 shows:1 do:2 's:1 risk:1 government:1 nutritional:1 showing:1 enroll:1 but:1 choice:1 adult:1 mom:1 meet:1 animals:1 now:1 than:1 thoughts:1 kind:1 made:1 daughter:1 largely:1 weapon:1 robot:1 drug:2 n't:1 trial:1 cancers:1 pediatric:1 promise:1 chain:1 childhood:1 restaurants:1
stock_PFE r_up	because:1 associated:1 process:1 issued:2 approved:1 blood-thinning:1 ``:1 '':1 have:1 centers:1 n't:1 said:2 bottles:2 voluntary:1 lots:1 due:1 than:1 only:1 potential:1 safety:1 caused:1 medicine:1 notice:1 more:1 week:1 product:2 recently:1 may:1 odor:2 recalled:1 650,000:3 strong:1 concerns:1 posted:1 manufacturing:1 level:1 --:1 recall:4 versions:1 stronger:1 according:1 drug:1 element:1 spokeswoman:1 generic:1 she:1 were:1 eight:1 consumer:1
stock_PFE r_down	1.5:1 companies:1 estimates:1 quarters:1 3.0:1 2.0:1 2.5:1 based:1 agency:1 anticlotting:1 per:1 current:1 recommended:1 income:1 =:5 's:2 share:1 operating:1 included:1 approval:1 expand:1 medical:1 list:1 drug:1 survey:1 analysts:2
stock_PFE r_down	because:2 says:1 developed:2 ``:2 system:2 '':2 staff:1 no:1 rare:2 decision:1 agency:3 genetic:2 been:1 recommended:2 treat:2 statement:1 inadequate:2 has:1 more:1 division:1 head:1 recommends:1 's:2 there:2 seventh:1 background:1 not:2 subsidiary:2 evidence:2 panel:1 made:1 rejection:1 --:5 disorder:2 medical:2 drug:4 nervous:2 affects:2 works:2 approve:2 review:1
stock_PFE r_down	all:1 tumble:1 over:1 health-care:1 down:1 world:1 manage:1 politics:1 rough:1 create:1 romances:1 if:1 overhaul:1 prove:1 divided:1 next:1 health:1 boardroom:1 can:1 do:1 his:1 's:2 strikes:1 job:1 part:1 news:1 hard:1 lost:1 underscores:1 morning:1 tale:1 workplace:1 making:1 maker:1 medical-device:1
stock_PFE r_up	narrowly:1 advisory:1 use:1 innovate:1 's:2 begun:1 federal:1 expanded:1 anticlotting:1 term:1 against:1 drug:1 say:1 meaning:1 voted:1 they:1 lose:1 love:1 has:1 but:1 panel:1
stock_PFE r_down	advisory:1 said:1 rare:1 treat:1 enough:1 --:1 affects:1 study:1 contains:1 consider:1 system:1 submitted:1 approving:1 information:1 genetic:1 clinical:1 drug:2 nervous:1 disorder:1 panel:1
stock_PFE r_up	1.5:1 2.5:1 3.0:1 drove:2 companies:1 shaky:2 estimates:1 sales:2 quarters:3 ended:2 per:1 have:2 seen:2 80:2 blockbuster:2 its:2 market:2 based:1 8.1:2 said:2 20:2 $:2 pressured:2 generic:4 top:2 had:2 40:2 current:1 low-cost:2 citing:2 version:2 health:2 earnings:2 income:1 has:4 =:5 economy:2 litigation:2 customers:2 's:2 receiving:2 though:2 share:1 company:2 after:2 restructuring:2 operating:1 included:1 approval:2 line:2 grow:2 recent:2 billion:2 10:2 2.0:1 12:2 31:2 months:2 list:1 drug:2 costs:2 survey:1 analysts:2 cholesterol:2 options:2 launched:2
stock_PFE r_down	operations:2 named:7 old:2 revenue:2 executive:13 ``:2 ending:7 '':2 platforms:2 growth:2 names:4 another:4 president:2 appointment:4 strategy:4 driving:2 comments:2 information:2 said:2 recently:2 $:4 million:8 record:2 restricted:4 began:11 compensation:2 shares:4 analyst:2 1:4 track:2 other:2 health:2 fourth:2 provider:7 new:4 eighth:2 has:6 resignation:7 company:2 stock:6 ends:4 buy:4 's:15 animal:2 pharmaceutical:2 successful:2 commercial:2 price:4 after:11 seventh:2 most:2 sustainable:2 background:2 group:2 along:2 years:2 former:15 he:2 received:4 search:11 1.04:4 roles:2 identifying:2 --:14 corporate:2 efficiency:2 opportunities:2 51:2 departure:4 receive:4 chief:18 abrupt:11 healthcare:2 leveraging:2 closing:4 consumer:2 options:4
stock_PFE r_down	1.5:1 says:1 cancer:1 list:1 into:1 health-care:1 share:2 treatment:1 quarters:1 62:1 drug:1 3.0:1 partner:1 2.0:1 2.5:1 said:1 20:1 $:2 three:1 per:1 should:1 current:2 investigational:1 split:1 which:1 income:1 =:5 more:1 3:1 estimates:1 price:1 men:1 conglomerate:1 76:1 operating:1 included:1 based:1 prostate:1 than:1 advanced:1 secondary:1 met:1 could:1 companies:2 up:1 value:1 survey:1 analysts:2 endpoints:1 study:1
stock_PFE r_up	among:1 investors:1 200:1 including:1 use:1 trials:1 boardrooms:1 winning:1 clinical:1 interest:1 test:2 new:1 dominance:1 more:2 independent:1 which:1 genes:1 drives:1 analyzes:1 putting:1 chairmen:1 than:1 tumors:1 early-stage:1 companies:1 drug:1 dent:1 chief:1 executives:1 attracting:1
stock_PFE r_up	sector:1 represent:1 they:1 summer:3 global:1 focus:3 through:2 human:3 its:14 fifth:2 $:4 second-quarter:3 disclosed:1 surprised:1 earnings:3 updated:2 around:1 expects:3 preparing:6 background:2 report:3 animals:3 pegs:2 name:1 --:10 companies:1 essential:1 shed:2 people:1 discover:1 growth:1 export:1 animal-health:10 year:1 2.5:1 minority:3 said:6 capacity:1 shares:3 vaccines:3 farm:3 health:3 market:3 new:1 firms:2 public:3 multinational:1 recently:1 business:4 million:1 reported:3 separation:2 manufacturing:2 standalone:3 country:2 leaves:1 drug:3 target:3 makes:4 maker:3 first:2 strategic:3 accounts:1 unit:13 size:1 pharmaceutical:6 sheer:1 create:3 initial:3 pharmaceuticals:3 2:2 which:6 expected:3 more:4 offering:3 drugs:3 company:9 part:3 valuation:2 than:1 population:1 15:2 room:1 18:2 2013:3 were:1 called:5 medication:1 1.2:1 certain:2 112:1 share:3 sales:1 file:6 seen:1 sell:3 documents:3 releases:3 provide:3 also:1 details:5 animal:3 stock:2 hone:2 's:6 plans:5 track:3 price:2 plan:3 prepares:2 such:1 eighth:2 billion:5 assets:2 filing:2
stock_PFE r_up	2,300:1 ignored:1 retired:1 can:1 evidence:1 chronic:1 including:1 have:1 news:1 lawyers:1 86:1 injuries:1 depression:1 mounting:1 alleged:1 suits:1 health:1 decades:1 more:1 complaint:1 's:2 hid:1 effects:1 such:1 than:1 morning:1 players:1 risks:1 long-term:1 making:1
stock_PFE r_down	agreed:1 move:1 quarters:1 proposition:1 looks:1 portfolio:1 its:3 whose:1 generous:1 stockpickers:1 based:1 $:6 attractive:1 life-science:1 2012:2 versus:2 good:1 gains:1 far:1 continues:1 milestone:1 trade:1 like:2 real-estate:1 pounds:1 --:2 companies:2 yield:1 large:1 popular:1 list:1 196:3 turbulent:1 global:1 see:1 actively:1 3.2:1 3.0:1 year:1 pain:1 2.0:1 investment:1 2.5:1 per:1 research:2 current:1 3:1 new:2 million:3 25:3 panelists:1 dividends:1 payment:1 maintains:1 conglomerate:1 operating:1 received:1 industry:1 drug:1 survey:1 analysts:2 into:1 one:1 down:1 trust:1 market:1 sports:1 anyone:1 2:1 expected:1 markets:1 500:1 treatment:1 successful:1 estimates:1 company:1 acquire:1 park:1 but:1 careful:1 has:2 following:1 more:1 bet:1 1.5:1 approved:1 share:1 4.6:1 media:1 shares:1 also:1 income:1 =:5 economy:1 's:6 after:1 most:1 included:1 stocks:1 grow:1 peers:1 programs:1 cover:1 disease:1 looking:1
stock_PFE r_up	life-science:1 acquire:1 's:2 $:3 million:2 pounds:1 large:1 agreed:1 196:3 park:1 research:2 investment:1 continues:1 markets:1 trust:1 portfolio:1 grow:1 has:1 its:1 real-estate:1
stock_PFE r_up	then:1 third:1 pattern:1 dive:1 time:1 back:1 early:1 rising:1 year:2 following:1 falling:1 market:1 row:1
stock_PFE r_up	charges:1 industry:1 arrested:1 sale:1 related:1 pharmacy:1 pioneer:1 authorities:1 medicines:1 counterfeit:1
stock_PFE r_up	survey:1 1.5:1 boosted:1 buying:1 developed:1 measure:1 estimates:1 primary:1 quarters:1 second:3 submitted:1 3.0:1 subsidiary:1 income:1 2.0:1 its:4 2.5:1 per:1 completion:1 said:2 receive:1 goal:1 affects:3 system:3 comments:1 investment:1 current:1 companies:1 genetic:3 clinical:1 details:1 which:3 inherited:1 new:1 has:2 type:1 treat:2 requested:2 treated:1 's:6 complete:2 efficacy:2 seeking:1 drugs:1 weakness:1 company:3 differences:1 met:1 involving:1 operating:1 goals:1 although:1 included:2 approval:1 between:1 condition:1 secondary:1 main:1 rare:3 treats:2 rights:1 --:1 approve:1 study:6 based:1 list:1 disease:1 drug:8 n't:2 did:2 patients:1 those:1 analysts:2 nervous:3 =:5 meet:1 share:1 muscle:1 disorder:3 called:2 experimental:2
stock_PFE r_up	fourth-quarter:4 significantly:2 cancer:2 up:4 appeared:4 executive:4 retailer:4 sales:4 trade:5 verdict:1 session:5 lung:2 showed:2 7.5:4 its:10 announcement:4 said:6 court:1 $:4 advantage:1 profit:4 top:4 three:4 shares:9 cell:2 previously:2 lung-cancer:2 premarket:2 expected:5 surprise:4 survival:2 movement:1 health-care:1 's:8 increased:4 triggered:4 schedule:4 company:4 after:6 priced:1 hours:2 reported:4 eight:4 benefit:1 president:4 departure:4 advanced:2 following:1 lymphoma:2 improved:2 effective:4 ahead:4 study:2 months:4 companies:5 days:4 drug:2 leaving:4 5.1:2 patients:2 actively:5 3.5:2 were:4 popular:1 treated:2 options:1
stock_PFE r_down	advisory:2 all:1 caused:1 over:1 including:1 broader:1 still:1 yet:1 seemed:1 blow:1 young:1 should:1 systems:1 exempt:1 has:1 2010:1 adviser:1 salespeople:1 increased:1 material:1 background:1 not:1 spur:1 ruled:1 companies:2 50:1 dealt:1 crushing:1 related:1 year:2 makers:1 since:1 recommendation:1 children:1 waiting:1 available:2 jobs:1 use:2 vaccine:2 panel:3 protect:1 could:1 drug:1 place:1 patents:1 another:1 wider:1 rounds:1 adults:2 pharmaceutical:2 story:1 their:1 informed:1 been:2 next:1 overtime:1 much:1 recommend:1 until:1 expiring:1 competition:1 ear:1 paying:1 13:5 pneumonia:1 were:1 have:1 certain:1 health-care:1 sales:1 ramifications:1 well:1 if:1 highlighted:1 immune:1 recommended:1 potential:1 take:1 which:1 layoffs:1 's:5 generic-drug:1 may:1 law:1 recent:1 older:1 age:1 infections:2 compromised:1
stock_PFE r_down	trade:3 session:3 suffer:2 injuries:2 its:4 giant:2 20:2 $:1 better:2 only:2 permanent:1 treatment:2 stable:1 2010:2 consolidation:1 not:2 now:2 condition:2 companies:3 morning:1 extremely:2 bad:1 quarter:4 discussing:1 hinder:2 people:2 some:2 trends:2 actively:3 further:1 said:6 since:2 patients:4 shares:5 yet:2 increase:2 bailout:1 provider:2 can:4 cord:4 marketing:1 reported:2 270,000:2 industry:1 drug:2 amount:2 efforts:2 options:2 software:2 nerve:2 outlook:1 revenue:6 into:1 number:2 spinal:4 pharmaceutical:2 use:2 positive:1 available:2 citing:1 least:1 payment:1 expected:5 percentage:2 injury:2 settling:1 ``:2 selling:1 drugs:1 company:3 but:4 collected:2 lowered:1 pain:6 than:2 16:2 batch:1 n't:2 deferred:2 below:2 future:2 risks:1 were:4 1.5:1 associated:3 sales:2 '':2 against:2 slumped:2 close:1 seen:2 concentration:1 no:2 40:2 delay:1 also:2 earnings:2 which:4 brand:1 's:12 buffer:2 after:1 possible:1 off-label:1 data:1 approved:4 probes:1 billion:1 off:1 fund:1 well:1 time:2 first:4 came:2
stock_PFE r_up	alfa:2 actively:2 trading:2 's:2 index:2 47:1 44:1 4.8:1 shares:2 their:2 recommended:2 treatment:2 9.4:1 has:2 authorization:2 higher:2 added:4 recently:2 whose:2 marketing:2 3:1 stocks:2 gained:2 18:1 companies:2 disease:2 against:2 points:6 traded:2
stock_PFE r_down	quarters:1 being:5 developed:3 reviewed:5 session:3 per:1 blocked:3 whose:2 based:1 atrial:5 treatment:2 premarket:2 has:3 multibillion-dollar:2 additional:3 trade:3 now:1 lost:3 --:6 companies:9 disorder:2 shed:3 set:2 list:1 estimates:1 back:4 actively:6 trading:7 3.0:1 2.3:2 blocks:2 2.0:1 2.5:1 index:3 said:6 decision:2 anticlotting:1 while:2 shares:8 current:1 version:1 closed:1 new:5 recently:2 hours:1 regulators:2 operating:1 approval:4 $:4 reaction:2 last:2 months:2 drug:8 trial:2 survey:1 analysts:2 studies:2 thinner:2 heart-rhythm:2 down:2 smaller:2 throughout:2 market:4 pushes:2 rejects:1 support:2 anti-clotting:5 least:3 few:2 2:1 expected:3 clinical:3 more:7 share:1 but:2 filed:1 fibrillation:5 patients:5 were:2 already:2 called:2 1.5:1 1.6:3 1.7:1 1.1:2 1.2:1 1.8:1 sales:2 stroke:5 dropped:2 further:2 seen:2 seek:2 their:2 information:10 4.6:2 no:2 generic:1 application:4 potential:4 which:7 income:1 =:5 stock:2 requested:5 used:2 's:13 after:1 fell:3 blood:2 included:1 stocks:3 data:3 approved:2 lower:3 traded:2 request:2 antidepressant:1 having:2 prevention:5
stock_PFE r_down	uncertainty:2 ramifications:1 investors:2 health-care:2 influence:1 ``:1 valuable:1 trade:2 surrounding:2 brave:1 trading:2 have:1 news:1 sought:1 moves:1 event:1 market:1 pharmacists:1 said:1 overhaul:1 tissue:1 application:1 ways:1 decision:1 enough:1 shares:1 autism:1 also:1 pickup:1 potential:1 health:2 version:1 expected:1 has:4 2010:1 play:1 experienced:1 's:5 slight:1 big:1 filed:1 cheaper:1 ranges:1 fund:1 antidepressant:1 plan:1 demand:1 president:1 safer:1 stocks:1 spur:1 fray:1 recent:1 session:1 loss:1 insurers:1 --:3 avoiding:1 months:1 companies:1 used:1 morning:1 specific:1 generic:1 good:1 actively:1 verdict:1 ruling:2 stoked:1 long-term:1 rising:1 amount:1 outcome:1 options:1 research:1
stock_PFE r_up	nicotine:1 says:1 they:1 second:1 promise:1 aimed:1 said:1 trials:1 preventing:1 run:1 wo:1 screen:1 finished:1 courts:1 vaccine:1 he:1 showed:1 companies:1 drug:1 n't:1 summit:1 addiction:1 outcome:1 studies:1 researchers:1
stock_PFE r_down	sector:1 requirement:1 cuts:1 health-care:4 some:1 all:1 billions:1 price:1 good:1 including:1 fees:1 rally:1 hospitals:1 insurance:1 even:1 law:2 uphold:2 dollars:1 hospital:2 though:1 fared:2 makers:1 mix:1 health:1 insurers:1 2010:1 gives:1 buy:1 's:1 insurer:2 survival:1 after:2 quite:1 plan:1 they:1 president:1 stocks:2 largely:1 certainty:1 shock:1 drug:1 face:1 bad:1 ruling:2 were:1 decision:2 came:1
stock_PFE r_up	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_PFE r_down	billion:1 stream:1 less:1 almost:1 guilty:1 agreed:1 sales:1 years:1 '':1 traveling:1 have:1 plead:1 door:1 open:1 pills:1 market:1 wonder:1 pharmaceutical:1 position:1 office:1 quality:1 seekers:1 any:1 their:1 3:3 safety:1 marketing:1 investors:1 government:1 criminal:1 's:1 pay:1 economy:1 illegally:1 do:1 ``:1 star:1 physician:1 drugs:1 big:1 company:1 loose:1 obtain:1 regulations:1 job:1 them:1 representative:2 doctors:1 put:1 world:1 stocks:1 data:1 than:1 $:3 ago:1 helped:1 keeping:1 monopoly:1 healthy:1 many:1 steady:1 regulators:1 drug:1 n't:1 charges:1 bad:1 can:1 behavior:1 rock:1 making:1 entertaining:1 value:1 options:1
stock_PFE r_down	saying:1 used:1 tactics:1 generic:1 joined:1 against:1 copies:1 delay:1 legal:1 retailers:1 battle:1 's:1 anticompetitive:1 pill:1
stock_PFE r_up	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_PFE r_down	control:1 sector:1 world:1 says:1 broader:1 do:1 food:1 received:2 number:1 competition:1 past:1 known:2 have:1 year:1 's:7 exclusivity:1 blockbuster:1 agriculture:1 lower-priced:1 market:1 bolster:1 consumers:1 generic:1 struggles:1 been:1 makers:1 cell:2 their:1 too:1 largest:1 raft:1 firms:1 low:1 status:2 eventually:1 head:1 pipelines:1 cope:1 drugs:1 company:1 inherited:2 therapy:2 industrywide:1 prices:1 during:1 cliff:1 loss:1 suffers:1 rare:2 commodity:1 coping:1 disease:2 drug:2 deals:1 patent:1 costs:1 so:1 entry:1 its:2
stock_PFE r_down	sector:1 caused:1 over:1 prices:1 solutions:1 broader:1 exclusivity:1 its:3 had:1 better:4 dairy:1 announce:1 weeks:1 has:1 pill:3 luxury:1 gains:1 combination:1 joint:1 accuse:1 industrywide:1 during:1 firms:1 loss:1 --:6 university:1 deals:1 did:1 superiority:1 small:1 quarter:1 energy:1 testing:1 competition:1 euro-zone:1 past:1 surrounding:1 88:1 growth:1 year:1 81:1 makers:1 concern:1 index:1 said:3 banking:1 patients:2 shares:2 crisis:1 pressures:1 safety:1 between:1 new:3 newly:1 announced:1 shows:1 felt:1 coping:1 pressure:2 along:1 beginning:1 after:1 patent:1 reported:1 study:1 losses:1 drug:7 foreign:1 trial:5 products:1 diagnosed:1 maker:2 first:1 retailer:1 number:1 ministers:1 rising:1 compared:1 100:1 market:2 bolster:1 union:1 positive:1 initial:1 two:1 been:1 lower-priced:1 their:1 clinical:4 biggest:1 raft:1 head:1 selling:1 pipelines:1 manufacturers:1 drugs:2 baby:1 than:4 applied:1 regimen:4 novel:1 showed:1 rival:1 slowed:1 while:1 venture:1 inhibitor:1 dropped:1 control:1 climbed:1 have:2 0.2:1 unsafe:1 vs:1 performed:3 triple:1 partner:3 blockbuster:4 yet:1 any:1 finance:1 containing:1 swung:1 48:1 generic:1 cope:1 struggles:1 lately:1 other:1 details:1 uncertainty:1 product:1 oil:1 's:7 reporting:1 virus:1 errors:1 phase:1 such:1 stocks:1 data:1 cliff:1 fiscal:1 older:1 implications:1 concrete:1 costs:1 entry:1 late-stage:3 oral:1
stock_PFE r_up	firm:1 short-selling:1 defended:1 broader:1 hit:1 blockbuster:1 trade:2 market:1 decline:1 unique:1 research:1 52-week:3 sixth:1 racks:1 highs:3 day:1 week:1 kicked:1 's:2 tried:1 share:1 price:1 earlier:1 heir:1 stem:1 defensive:1 report:1 stocks:3 properties:1 off:1 sectors:1 losses:1 up:1 drug:1 near:3 handful:1 its:3
stock_PFE r_up	1.5:1 force:1 3.0:1 campaign:1 biotech:1 list:1 in-house:1 estimates:1 soon:1 quarters:1 3.6:1 examine:1 underlying:1 legal:1 have:1 lawyers:1 2.0:1 its:1 2.5:1 partners:1 based:1 $:1 make:1 directors:1 per:1 current:1 their:1 causes:1 pursuing:1 firms:1 has:1 =:5 into:1 acquire:1 's:3 share:1 income:1 weak:1 treatments:1 paid:2 job:1 operating:1 know:1 address:1 included:1 market:1 ending:1 billion:1 counsel:1 task:1 off:1 hostile:1 whether:1 smartly:1 companies:1 drug:2 three-month:1 survey:1 analysts:2 recommendations:1 aid:1 efforts:1 maker:1
stock_PFE r_up	stock:1 because:1 revenue:2 bump:1 sales:1 expenses:1 down:1 currency:3 trends:3 decrease:1 comments:1 second-quarter:1 hit:1 throughout:1 speed:1 out:2 decline:1 anticipation:1 details:1 49:4 profit:2 disruptions:2 stockpicker:1 contributed:1 negative:2 legal:3 forecast:1 other:1 earnings:2 fourth:1 new:2 2012:1 's:2 slight:1 falls:1 conglomerate:1 reported:1 fell:1 background:1 hurt:1 beginning:1 expectations:1 acquisitions:1 weighed:2 short:1 calls:1 discusses:1 charges:1 amid:1 reduces:1 full-year:1 against:1 --:3 while:2 costs:2 merits:1 higher:1 acquisition-related:1 could:1 acquisition:1 names:1
stock_PFE r_up	file:1 people:2 partnership:1 sales:1 dose:1 ended:1 tablets:1 another:2 registration:1 causes:2 regulator:1 use:2 said:4 $:1 generic:3 had:1 submit:1 research:1 preventing:2 citing:1 version:2 market:1 statement:1 new:3 has:1 type:2 becoming:2 announced:1 specialist:1 them:2 's:4 receiving:1 combination:1 company:2 after:1 strengths:1 virus:2 12:1 approval:1 data:1 billion:1 fixed:1 look:2 healthy:2 study:2 months:1 funded:2 drug:5 aim:2 --:5 patients:1 31:1 public-private:1 maker:1 launched:2
stock_PFE r_up	through:1 exclusivity:1 its:10 developer:2 $:9 had:1 2018:1 has:1 local:1 2010:1 11:3 dominant:1 diseases:1 early:1 hands:1 judge:1 awaiting:1 day:2 ruled:1 --:9 trading:2 said:1 opened:1 consumers:1 federal:1 shares:4 closed:1 appeal:1 public:4 recently:1 sold:2 million:4 affiliates:1 overcharge:1 backed:1 approval:1 essentially:1 country:1 against:1 7:2 range:3 products:1 patents:1 first:2 locally:1 one:1 regulatory:1 market:2 8.1:3 pharmaceutical:2 district:1 best-selling:1 initial:2 informed:1 expected:2 minor:1 flat:1 offering:2 drugs:2 company:7 formed:1 rejected:1 priced:1 filed:1 known:1 case:1 10:1 13:2 made:2 developing:1 up:4 below:3 ruling:1 closing:1 illnesses:1 painkiller:1 preserving:1 share:2 gains:2 court:1 agency:2 1:2 which:1 9:2 subsidiaries:1 stock:3 used:1 's:8 plans:2 price:3 earlier:1 modest:1 changing:1 data:1 adviser:1 antitrust:2 position:1 2009:1 original:2
stock_PFE r_down	chain:4 less:4 trade:4 session:4 committee:2 its:7 decade:1 impact:1 $:10 had:1 expectations:5 treatment:4 premarket:2 has:4 2011:2 combination:1 12:2 traffic:4 breast:3 lymphoma:2 advanced:4 loss:1 slowed:4 --:3 drop:1 companies:4 fewer:1 annually:1 did:1 settle:1 indication:1 common:1 restaurants:8 strengthened:1 deal:1 people:4 conditional:4 some:4 second:1 actively:4 trading:4 result:4 reached:1 2.2:3 margins:1 said:5 federal:1 projected:1 shares:4 cell:4 masking:1 boost:1 filled:1 recently:4 prescriptions:1 marketing:5 possibility:4 hours:2 approval:2 received:2 last:1 larger:1 drug:8 analysts:5 opinion:2 maker:1 cancer:10 revenue:5 previously:2 into:3 down:4 lung:4 another:1 wider:1 apply:2 narrowed:1 market:2 millions:1 use:3 additional:1 would:3 positive:2 locally:2 three:1 least:1 much:1 treat:2 widens:1 expected:5 type:1 authorization:4 continents:1 fast-food:4 drugs:1 company:3 pricey:4 prosecutors:1 second-quarter:5 raising:4 customer:4 grew:1 uncertain:4 17:2 likely:1 below:5 growth:8 risks:1 treated:2 adults:2 chip:1 sales:9 middle:1 dropped:1 have:1 spanning:1 blockbuster:1 saw:1 kidney:1 counterfeit:1 tumbled:4 information:1 granted:2 1:1 economy:4 status:1 's:16 investigations:1 after:2 fell:4 approved:4 billion:2 charges:1 practices:1 so:1 enterprise:1 push:1 2009:1 starting:1
stock_PFE r_down	all:2 chain:2 dollar:2 trade:3 four:2 bapineuzumab:4 including:2 per:1 affect:2 find:2 based:1 $:2 thinking:2 same-store:2 expectations:2 analyst:2 failed:2 other:2 treatment:4 premarket:2 income:1 anticipated:2 world:2 quarters:1 --:1 list:1 did:2 session:3 quarter:2 better-than-expected:2 set:2 companies:4 estimates:1 actively:3 3.0:1 2.2:2 2.0:1 makers:2 2.5:1 said:8 memories:2 marketed:1 shares:3 its:8 current:1 3:2 new:1 continuing:2 operating:1 address:2 both:2 healthy:2 study:2 drug:5 survey:1 analysts:2 placebo:2 changes:2 first:4 revenue:2 highly:2 chronic:1 lung:1 millions:2 spending:2 underlying:2 their:4 treat:1 expected:3 function:2 fast-food:2 acquire:2 goals:2 second-quarter:2 rival:2 n't:2 patients:2 ongoing:2 behavior:2 1.5:1 share:1 sales:2 4.5:2 compared:2 develop:2 form:2 potential:2 earnings:4 which:2 largest:2 =:5 males:2 's:26 plans:2 reach:2 fell:6 designed:1 included:1 approved:1 short:2 studies:4 required:2 stronger:2 disease:3 without:2 affects:2
stock_PFE r_down	all:1 consider:1 find:1 results:2 trade:2 four:1 7.1:1 including:1 its:7 high-risk:1 whose:2 cut:2 $:1 22:1 thinking:1 guidance:1 troubles:1 29:1 bapineuzumab:3 failed:1 only:1 potential:1 somewhat:1 treatment:2 earnings:3 for-profit:1 bonds:1 weakness:1 focus:2 gloomy:1 continued:4 loss:1 runs:1 lost:3 companies:5 large:1 continue:2 activity:1 worries:2 stock:4 heavy:2 shed:3 set:1 actively:5 trading:6 slumped:1 makers:1 points:9 index:3 said:5 pressured:1 memories:1 patients:2 shares:5 forecast:1 3:1 volatile:1 closed:1 downturn:2 reading:1 red:1 recently:2 continuing:1 weak:1 hours:2 operating:1 address:1 anticipated:1 manufacturing:2 104:1 session:3 quarter:1 losses:1 reports:1 turn:1 studies:2 other:1 experimental:1 late-stage:1 outlook:1 28:1 highly:2 millions:1 debt:1 spending:1 underlying:1 their:3 genetic:1 clinical:1 which:2 expected:2 upbeat:2 territory:1 markets:1 marginally:1 selling:1 form:1 memory:1 peers:1 goals:1 sharply:2 12:1 17:1 enrollment:1 up:2 n't:1 while:1 decided:1 ongoing:1 behavior:1 were:2 drops:2 called:1 investors:2 slowing:1 tide:1 pushed:1 drug:2 partner:1 weaken:1 end:1 trial:1 also:1 edge:2 stemming:1 economy:1 fourth:1 largest:1 higher:1 's:13 plans:1 after:3 reach:1 workforce:1 76:1 fell:3 eight:1 student:1 develop:1 stocks:7 data:1 fiscal:1 lower:4 tracking:1 effective:1 downbeat:1 changes:1 futures:4 disease:1 without:1 costs:1 affects:1 weigh:1 first:2
stock_PFE r_down	anticlotting:2 fights:1 site:1 years:1 held:1 including:2 partner:2 its:4 declined:2 developer:1 said:2 profit:2 delays:1 28:4 hepatitis:2 priority:2 application:2 which:2 between:1 new:2 insurers:1 pill:2 rebuilding:1 lack:1 's:6 expirations:2 government:1 drugs:2 agencies:1 infection:2 sales:2 virus:2 construction:1 recent:2 review:2 second-quarter:2 supplemental:2 eltrombopag:2 eroded:2 treats:2 chronic:2 up:1 drug:4 patent:2 patients:2 were:2 problem:1 tenants:1 granted:2
stock_PFE r_up	emerging:2 chain:2 profits:4 results:2 years:2 brain:1 cuts:1 aggressive:1 its:3 boosts:1 24:2 looking:1 giant:1 cut:2 21:2 rose:1 guidance:3 supply:2 expectations:2 fuel:1 8:3 has:1 earnings:5 return:1 expirations:1 beat:1 big:1 overall:1 expects:1 background:1 despite:3 condition:1 governments:3 --:14 companies:1 prolonged:1 common:1 few:1 because:2 financial:1 some:1 competition:1 challenges:1 growth:5 expect:2 year:2 further:1 margins:1 said:1 pressured:1 profit:4 shares:1 forecast:1 increase:1 behind:1 does:2 net:2 marketing:1 continuing:1 reported:1 protection:2 key:3 major:1 appears:1 received:1 hits:1 cautious:1 industry:1 double-digit:2 drug:6 prior:1 expire:3 products:1 fallen:1 patents:3 comment:2 adjusted:1 via:1 cancer:1 revenue:3 rising:1 another:3 throughout:1 unit:1 pharmaceutical:1 '':1 targeting:1 their:1 top:1 stuck:3 genetic:1 much:1 way:1 markets:2 ``:1 both:1 drugs:3 company:1 slump:3 took:1 hurt:2 quarterly:6 part:1 lives:1 prices:1 cases:1 squeeze:1 second-quarter:1 case:1 past:1 handily:2 15:2 expanded:1 optimism:1 n't:2 cost:1 were:1 2012:2 investors:2 exceeded:1 sales:12 helped:1 full-year:4 dropped:2 blockbuster:1 recovery:1 patent:4 detail:1 also:2 other:1 5:1 details:1 's:4 reporting:3 problems:2 fell:2 cleared:1 cliff:1 known:1 off:1 third:1 generic:1 subpoena:1 biotechnology:1 researchers:1
stock_PFE r_up	151:3 raised:1 economists:1 unemployment:1 series:1 over:1 allegations:1 unchanged:1 29:1 states:1 report:1 examine:1 expect:1 fake:1 return:1 technology:1 out:1 result:1 terminated:1 said:1 $:4 pay:1 government:1 three:1 next:1 3:2 raids:1 last:1 has:1 markets:1 polled:1 200:1 only:1 's:3 pharmaceutical:1 month:2 company:2 million:1 specialty:1 but:1 closely:1 prices:1 using:1 years:1 net:1 jobs:1 carried:1 license:1 rate:1 drug:2 prior:1 remain:1 products:2 investigators:1
stock_PFE r_down	global:2 quarters:1 four:2 shares:3 its:2 stock-index:2 based:1 zone:2 rose:2 signals:2 do:2 possible:2 mandate:2 lost:4 stimulus:2 list:1 higher:1 gaining:2 companies:4 estimates:1 actively:3 trading:5 3.0:1 2.0:1 2.7:3 2.5:1 index:3 per:1 current:1 closed:1 preserve:2 after:3 recently:2 sparked:2 notable:1 hours:1 operating:1 hurts:1 100:2 come:2 declining:2 gained:2 pipeline:2 last:2 economic:2 analysts:2 action:2 traded:2 point:2 within:2 whatever:2 market:2 little:2 takes:2 would:2 two:1 biggest:2 500:2 more:2 roundup:1 ``:2 mostly:2 but:1 institution:2 12:2 16:2 while:2 growth:1 were:2 making:1 1.5:1 futures:6 investors:2 0.1:2 share:1 sting:1 '':2 rally:2 moves:1 six:1 40:1 potential:2 declined:4 income:1 survey:1 =:5 stock:2 week:2 added:1 's:3 obsessed:1 await:2 fell:2 immediate:2 easing:1 included:1 stocks:6 data:2 euro:2 lower:4 slightly:3 later:2 points:12 fresh:2
stock_PFE r_up	saying:1 background:1 proposed:1 results:3 ninth:1 quarters:1 ended:1 session:1 exclusivity:5 its:2 25:16 giant:3 20:2 surprises:2 expectations:2 second-quarter:6 signals:1 advisories:2 treatment:1 details:2 earnings:4 watch:2 updates:1 cushion:3 trade:1 continued:3 loss:3 --:6 companies:1 slide:3 cholesterol:2 anti-cholesterol:3 rheumatoid:1 20th:1 exceed:2 financial:1 competition:3 past:1 see:4 economic:1 animal-health:2 said:1 profit:5 blue-chip:1 comments:1 forecast:1 increase:3 pressures:2 market:6 new:1 pharmaceutical:3 seventh:1 reported:3 active:1 beginning:1 roundup:1 advance:1 ahead:1 could:1 months:1 drug:7 analysts:3 rose:3 maker:3 2nd:6 throughout:1 unit:2 better:1 monthly:1 positive:1 statement:1 expected:2 company:1 benchmark:1 but:2 reiterated:1 former:3 than:2 10:1 versions:3 up:2 future:1 were:1 2012:1 numbers:1 investors:1 sales:8 expenses:6 helped:3 full-year:1 reports:1 blockbuster:6 sell:2 generic:3 stake:2 application:1 take:1 9:2 erosion:3 stock:1 's:11 though:1 may:1 price:1 arthritis:2 fell:1 stocks:1 lower:6 longer:1 amid:3 looked:1 chief:1 corporate:1 review:1 latest:1
stock_PFE r_up	just:1 over:1 month:2 report:1 through:1 looks:1 go:1 its:1 issues:1 before:1 wraps:1 front:1 systems:1 stalled:1 policy:1 has:1 do:2 75,000:1 halt:1 wave:1 exchanges:4 not:1 now:1 investor:1 --:4 12th:1 notes:1 securities:1 small:1 economy:1 prompted:1 higher:1 some:1 past:1 slowed:1 growth:2 trading:3 yet:1 out:1 pattern:1 p.m.:1 looking:1 leap:1 roiled:1 health:1 across:1 jobs:3 business:1 sixth:1 payroll:2 confidence:2 quarter:1 technical:1 could:1 months:1 drug:1 surge:1 afternoon:1 action:3 settled:1 options:1 first:1 among:1 followed:1 into:3 private:1 down:1 another:1 cancel:1 market:1 conference:1 unusual:1 stocks:3 call:1 statement:1 suit:1 expected:1 dozens:1 meeting:1 ``:1 pretty:1 upcoming:1 company:1 but:1 depressing:1 raising:1 hints:1 '':1 bill:1 up:1 patients:1 problem:1 similar:1 collecting:1 trades:2 13th:1 canceled:1 technology:1 orders:1 weakened:1 six:1 detail:1 traders:1 concerns:1 gets:1 stock:1 play:1 's:6 plans:2 may:1 effect:1 law:1 especially:1 third:1 changes:1 average:1 dent:1 consumer:1 profits:1
stock_PFE r_down	among:1 prompted:1 into:1 some:1 13th:1 canceled:1 trading:3 looks:1 another:1 cancel:1 technology:1 orders:1 issues:1 conference:1 giant:1 six:1 detail:1 traders:1 roiled:1 call:1 systems:1 dozens:1 across:1 stock:1 halt:1 may:1 sixth:1 confidence:1 unusual:1 wave:1 discount:1 market:1 exchanges:4 report:1 stocks:2 investor:1 concerns:1 raising:1 peers:1 12:2 third:1 technical:1 12th:1 notes:1 trades:3 drug:1 dent:1 securities:1 --:3 through:1 problem:1
stock_PFE r_up	heart:1 significantly:2 number:2 episodes:2 hepatitis:1 suspended:1 patient:1 its:1 24:2 said:2 per:2 4:2 suffered:1 has:1 meeting:2 treat:1 's:2 intended:1 after:1 bladder:2 overactive:2 primary:2 hours:2 average:2 liver:1 endpoint:2 showed:2 failure:1 study:5 disease:1 drug:1 patients:2 reduced:2
stock_PFE r_down	1.5:1 list:1 estimates:1 primary:3 related:3 quarters:1 four:3 included:1 actively:1 3.2:1 per:1 3.0:1 2.0:1 its:3 2.5:1 index:1 said:3 based:1 21:1 22:1 generic:1 rose:2 shares:1 current:1 failed:3 clinical:3 treatment:3 closed:1 income:1 violations:1 =:5 law:1 higher:1 's:11 increased:1 drugs:1 share:1 after:4 possible:1 hours:1 operating:1 goals:3 they:3 investigating:1 improving:3 world:1 stocks:1 potential:3 advanced:3 manufacturer:1 off:3 largest:1 companies:2 trading:1 points:3 survey:1 analysts:2 meet:3 studies:3
stock_PFE r_down	uneventful:1 pointing:1 global:1 allegations:1 trade:1 7.1:1 shocked:1 headlines:1 settlement:2 its:4 digest:1 rundown:1 25:1 26:1 27:1 $:3 thinking:1 rose:5 had:1 failed:1 1,400:3 under:2 quarterly:1 has:1 gave:1 then:1 move:1 gains:3 prepaid:1 loss:1 could:1 watch:2 early:1 closely:1 therapy:1 tanks:2 during:1 aiming:1 continued:2 day:1 advanced:1 14.5:1 equities:1 resolve:2 stimulus:1 drop:2 companies:4 --:1 slide:1 settle:1 payments:2 towards:1 set:1 financial:1 people:1 acquired:2 51:1 testing:1 back:1 refusing:1 jump:1 3.7:1 second:1 growth:1 trading:7 out:1 index:5 said:2 sentiment:1 federal:1 jumped:3 while:1 shares:8 outside:1 investigation:1 stock-index:1 closed:1 international:2 1400:3 strategist:1 regain:1 we:1 recently:3 sinks:1 million:3 hours:4 pressure:1 takeover:2 active:1 picking:1 strong:1 come:1 reports:1 hiding:1 session:1 reaction:1 prospects:1 subdued:1 central:1 76:1 central-bank:1 months:2 against:1 34:1 trial:1 carrier:1 economic:1 act:1 climb:2 first:2 into:1 awaited:1 three:2 60:2 bribery:3 rising:1 another:1 total:2 open:1 100:1 market:2 bolster:1 derivatives:1 most:1 additional:1 prompting:2 wider-than-expected:1 two:2 been:1 their:1 clinical:1 treat:1 statement:1 cycle:1 markets:2 final:1 500:4 gained:1 ``:2 interest:1 took:1 immediate:1 wireless:1 prices:1 subsidiary:2 96:1 12:1 last:1 official:1 up:4 late-stage:1 pace:1 calamity:1 actively:4 9.2:1 were:3 abandon:1 closing:1 minutes:1 called:1 investors:2 give:1 surpassing:1 dearth:1 '':2 way:1 drug:1 have:1 ready:1 watched:1 seem:1 relatively:1 huge:1 pay:1 make:2 topped:1 traders:1 pivotal:1 earnings:1 accusations:2 units:2 gets:1 higher:3 week:1 added:3 's:7 transactions:1 may:1 after:5 update:1 director:1 push:1 but:2 coming:1 'm:1 stocks:8 data:2 repeat:1 euro:1 rallied:1 takes:1 following:1 amid:1 futures:4 well:2 dollar:1 managing:1 points:12 shade:1 time:3 banks:1 fresh:1 overseas:1 2009:2 corporate:1
stock_PFE r_up	credible:1 3,000:1 months:1 help:1 health-care:1 '':1 likely:1 identify:1 optimism:1 portfolio:1 investment:1 index:1 recovery:1 would:1 thinking:1 three:1 opportunities:1 lifts:2 1,400:3 above:4 new:1 has:1 500:3 stock:2 firm:2 ``:1 's:2 rise:3 stocks:1 closing:1 venture-capital:1 --:1 study:1 work:1 companies:1 joined:1 drug:1 continue:1 time:1 lacked:1 first:1
stock_PFE r_up	because:1 financial:1 deal:1 underscores:1 high:1 brain:1 see:1 need:1 payoff:1 partners:1 does:1 between:1 new:1 week:1 's:4 scientific:1 treatments:1 but:1 understanding:1 failure:1 potential:1 search:1 ahead:1 medical:1 companies:1 disease:1 drug:2 n't:3 disorder:1 experimental:1
stock_PFE r_up	n't:2 said:2 renal:2 combination:2 did:2 survival:2 3:6 free:2 primary:2 cell:2 extending:2 patients:2 endpoint:2 evaluating:2 meet:2 advanced:2
stock_PFE r_down	represent:3 agreed:1 half:3 focus:3 quarters:1 shares:6 human:3 headlines:1 its:12 before:3 rundown:1 20:7 $:17 over-the-counter:1 has:2 worth:1 2013:3 watch:2 early:1 royalty:1 preparing:3 background:1 milestone:1 front:1 --:4 list:1 securities:2 payments:1 popular:1 quarter:1 shed:3 because:2 companies:1 heartburn:1 estimates:1 back:1 3.6:1 animal-health:12 estimated:5 2.5:1 said:7 profit:1 per:1 yet:3 current:1 favor:1 market:2 net:1 public:4 common:3 business:6 targeted:3 million:4 regulators:2 operating:1 based:1 100:7 could:2 drug:5 times:1 range:3 survey:1 analysts:2 maker:4 first:3 number:3 strategic:3 been:3 250:1 throughout:1 unit:7 use:1 would:1 transfer:3 initial:4 one-time:1 strategy:1 pharmaceuticals:3 rates:1 low:1 interest:2 expected:3 files:1 ``:1 complete:3 offering:10 offered:3 acquire:1 part:3 gain:1 filed:5 known:1 valuation:1 paying:1 15:2 publicly:2 rights:1 18:2 up:13 value:1 n't:3 determined:3 called:2 1.5:1 3.0:1 investors:1 almost:1 certain:3 share:1 '':1 have:4 sell:6 2.0:1 stake:7 details:1 which:6 income:1 =:5 stock:3 hone:3 's:13 plans:6 price:3 eight:1 plan:3 ownership:5 included:1 soared:1 billion:5 assets:3 well:1 command:1 corporate:1
stock_PFE r_up	agreed:2 global:2 adjusted:1 trade:1 session:1 per:1 spinoff:1 headlines:1 its:8 staff:1 rundown:1 giant:1 20:1 $:12 over-the-counter:5 guidance:1 treatment:1 has:2 2012:1 gains:1 easily:1 could:1 watch:2 early:1 royalty:3 despite:1 front:3 loss:1 beating:1 --:2 16:1 companies:1 taxes:1 payments:3 popular:4 stock:1 better-than-expected:1 deal:2 heartburn:4 estimates:1 cash:1 slowed:1 growth:3 year:1 said:2 profit:3 sum:1 disease:1 shares:1 forecast:1 increase:1 health:1 unit:1 between:2 previous:1 announced:1 earns:1 marketing:3 million:3 weak:1 agreement:1 hours:1 group:1 quarter:1 prescription:1 service:1 dollars:2 drug:5 planned:1 retail:1 raised:3 slipped:1 revenue:2 coupon:1 awaited:1 down:1 250:7 market:2 pharmaceutical:1 use:2 would:3 initial:1 interest:1 6:2 expected:1 company:3 acquire:2 catalyst:1 second-quarter:2 colitis:1 posted:1 paying:4 10:1 target:2 rights:5 up:7 while:1 actively:1 were:1 following:2 study:1 investors:2 cents:1 well:3 share:1 sales:2 expenses:1 full-year:1 ulcerative:1 world-wide:1 swung:2 sell:2 also:1 other:1 earnings:2 animal:1 online:1 higher:1 's:5 milestone:3 after:1 helping:1 lay:1 data:3 lifting:1 booked:1 transaction:1 off:1 especially:1 futures:1 stronger:1 drive:1 costs:1 allow:1 corporate:1 avoid:1
stock_PFE r_up	named:2 people:1 developed:1 health-care:2 begin:1 general:2 '':1 selling:1 doses:1 need:1 watched:1 its:5 huge:1 compared:1 symptoms:1 clinical:1 mid-stage:1 new:3 leader:1 2013:1 ``:1 executive:2 's:4 business:2 replacing:2 company:1 diet:1 early:1 said:3 plan:1 closely:1 counsel:2 improved:1 target:1 oversee:2 study:1 unmet:1 disease:1 drug:2 chief:2 placebo:1 consumer:2 medical:1 experimental:1
stock_PFE r_down	prevent:1 violated:1 bribery:1 children:2 drinks:1 $:1 federal:1 had:1 their:1 2:1 accusations:1 shows:1 company:1 million:1 paid:1 designed:1 doctors:1 subsidiary:1 drinking:1 removed:1 treating:1 diet:1 warned:1 've:1 more:1 settle:1 survey:1 overseas:1 software:1 laws:1
stock_PFE r_up	1.5:1 have:1 investors:1 up:1 companies:1 estimates:1 focus:1 private:1 quarters:1 prices:1 businesses:1 been:1 3.0:1 cuts:1 our:1 2.0:1 hospitals:1 linked:1 2.5:1 help:1 based:1 hunting:1 patent:1 hospital:1 revenue:1 per:1 makers:1 current:1 going:1 worry:1 income:1 personalized:1 insurers:1 =:5 today:1 tests:1 's:5 medicines:1 share:1 genes:1 broker:1 replace:1 regulators:1 operating:1 included:1 reassuring:1 data:1 raising:1 suggested:1 off:1 like:1 lost:1 developing:1 markets:1 notes:1 list:1 disease:1 drug:1 n't:1 survey:1 analysts:2 pick:1 discussing:1 make:1
stock_PFE r_down	pharmaceutical:2 said:2 's:2 rheumatoid:2 review:2 months:2 three:2 arthritis:2 application:2 take:2 treatment:2 expected:2 new:2 company:2 than:2 market:2 more:2
stock_PFE r_up	limited:1 stocks:1 risk:1 advantage:1 taking:1 suggests:1 low:1 wager:1 quality:1 options:1 volatility:1
stock_PFE r_up	closely:1 setback:2 mild:3 signs:4 battle:2 its:3 slow:2 misses:2 failed:6 treatment:3 20-24:2 overall:3 anticipated:3 updates:1 background:1 discuss:2 condition:2 pooled:5 cognitive:6 --:6 benefit:2 steps:2 either:3 each:4 set:3 says:2 significantly:2 some:1 best:1 said:4 missed:1 expert:1 comments:1 3:3 moderate:1 regulators:2 although:3 beginning:2 both:3 industry:2 against:2 suggests:2 analysts:1 studies:9 5th:1 experimental:2 executives:1 key:1 primary:2 highly:3 throughout:1 decline:4 additional:1 positive:1 top:2 two:9 next:2 clinical:3 ``:1 efficacy:2 reaction:1 company:1 but:3 goals:6 cases:3 10:2 showed:4 work:1 patients:5 stories:2 slowing:4 '':1 drug:8 watched:1 saw:1 marking:2 trials:3 potential:3 details:1 fourth:1 stock:1 week:1 's:21 though:1 price:1 reach:3 levels:1 significant:1 data:5 disease:8 late-stage:2 latest:2
stock_PFE r_down	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_PFE r_down	comment:1 set:1 key:1 show:1 developed:1 way:1 lung:2 year:1 throughout:1 out:1 goal:2 detail:1 submit:1 failed:1 clinical:1 treatment:1 fourth:1 2014:1 main:2 2012:1 's:1 filings:1 but:1 standard:1 met:2 regulators:1 paving:1 background:1 approval:1 analyst:1 care:1 --:4 study:1 later:1 smoker:1 drug:1 vying:1 trial:1 superiority:1 planned:1 become:1 quarter:1 experimental:1 latest:1
stock_PFE r_up	lessons:2 but:1 pharma:1 investors:1 may:1 study:1 some:1 diet:1 offers:1 fizzled:1 have:1 new:1 skinny:2 stocks:1 monkeys:2 insights:1
stock_PFE r_down	1.5:1 adults:2 cancer:6 companies:1 trial:2 estimates:1 ``:2 quarters:1 '':2 known:2 growth:2 3.0:1 take:2 2.0:1 its:2 2.5:1 significantly:2 tumor:2 4.7:2 three:2 based:3 twice:2 worsen:2 treatment:2 per:1 day:2 current:3 also:2 role:2 kidney:4 which:4 income:1 6.8:2 grow:2 has:2 =:5 pill:2 authorization:2 treat:2 meant:2 do:2 play:2 extended:2 's:4 marketing:2 survival:2 free:2 period:2 compared:2 operating:1 included:1 approval:2 patient:2 standard:2 data:2 blocking:2 advanced:2 care:2 received:2 --:4 type:2 tumors:2 months:4 list:1 disease:2 drug:6 called:2 n't:6 prior:2 patients:2 survey:1 analysts:2 have:2 time:2 those:2 did:2 share:1 works:2 treated:2 responded:2
stock_PFE r_up	global:1 results:1 trade:1 session:1 find:1 25:2 giant:2 cut:2 $:2 rose:2 expectations:1 analyst:1 citing:1 treatment:2 8:1 has:2 gains:1 get:1 express:1 fat:1 therapy:2 defying:1 world:1 continued:2 companies:1 slide:2 continue:1 anti-cholesterol:2 view:1 successful:2 trend:1 competition:2 see:2 growth:1 second-quarter:2 year:1 's:5 insurance:1 said:4 profit:1 shares:1 its:8 does:1 affecting:1 new:4 led:1 business:1 weak:1 hours:1 reported:3 regulators:2 expire:2 dividend:1 resistant:2 broad-based:1 industry:1 drug:8 credit:1 products:2 kinds:2 maker:2 patents:2 software:1 fourth-quarter:1 revenue:2 offerings:1 chronic:2 wider:1 pharmaceutical:3 use:2 spending:1 treat:2 expected:1 more:1 fiscal:2 drugs:3 company:2 adult:4 known:3 surged:1 than:1 13:1 versions:2 n't:1 patients:2 actively:1 certain:2 sales:2 expenses:2 have:2 swung:1 needs:2 blockbuster:2 develop:1 prior:2 generic:2 topped:1 makers:2 also:2 other:2 earnings:3 largest:1 several:2 economy:1 first-quarter:1 after:1 leukemia:4 services:1 approved:4 billion:1 lower:2 amid:2 costs:1 lineup:1
stock_PFE r_up	billion:1 giant:1 said:1 end:1 $:1 step:1 mutual-fund:1 down:1 manager:1 longtime:1 year:1
stock_PFE r_down	litigation:2 has:2 's:8 version:2 patent:2 agreed:2 bladder:2 related:2 overactive:2 application:2 resolve:2 drug:4 new:2 settlement:2 generic:2
stock_PFE r_down	1.5:1 3.0:1 companies:1 estimates:1 quarters:1 round-up:1 2.0:1 2.5:1 based:1 $:2 per:1 current:1 income:1 =:5 around:1 share:1 operating:1 included:1 news:1 venture-capital:1 list:1 analysis:1 survey:1 analysts:2
stock_PFE r_up	shed:1 help:1 appeared:2 testing:2 some:3 have:2 further:1 11th:1 still:1 debate:1 subject:1 provide:2 beginning:1 had:1 benefit:2 research:2 targets:2 clinical:2 meaningful:2 's:9 any:2 effect:3 but:3 its:2 data:1 reaction:1 --:3 light:1 could:1 disease:2 drug:3 n't:3 did:3 patients:3 officer:1 release:1 similar:1 experimental:2
stock_PFE r_up	pharmaceutical:4 said:2 's:4 $:6 million:2 has:2 company:2 global:2 investment:2 joint:2 products:2 venture:2 develop:2 295:6 markets:2 its:2
stock_PFE r_down	comment:2 health-care:2 ninth:2 replace:3 past:1 throughout:2 its:2 fifth:1 24:2 index:2 little:2 one:1 blue-chip:1 been:1 shorter:1 health:2 fourth:2 has:1 more:2 's:1 business:2 insurer:2 importance:1 company:1 healthcare:1 marking:1 but:2 background:2 stays:1 years:1 eighth:2 10:1 grocery:2 off:2 name:2 --:8 comes:2 time:1 growing:1 become:2 spins:2 first:2
stock_PFE r_up	sector:1 1.5:1 investors:1 navigate:1 health-care:1 estimates:1 quarters:1 3.0:1 still:2 2.5:1 signals:1 2.0:1 based:1 prognosis:1 per:1 current:1 companies:1 income:1 flashing:1 =:5 can:1 good:1 bargains:2 share:1 but:1 operating:1 risks:1 included:1 stocks:2 list:1 survey:1 analysts:2 mixed:1
stock_PFE r_up	sector:1 good:1 investors:1 navigate:1 health-care:1 but:1 signals:1 prognosis:1 can:1 mixed:1 flashing:1 risks:1
stock_PFE r_up	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_PFE r_up	even:1 feel:1 consumer:1 continues:1 labor:1 confident:1 struggle:1 bit:1 economy:1 starting:1 market:1 more:1
stock_PFE r_down	says:1 bleeding:1 one:2 way:1 shares:1 year:2 still:1 market:1 said:1 positive:1 two:1 comments:1 next:1 application:1 potential:2 treatment:3 which:1 expected:1 details:2 updated:1 's:2 plans:1 form:1 price:1 treatments:1 met:1 goals:1 key:2 half:1 bigger:1 rare:1 hemophilia:4 --:3 disorder:1 study:3 late-stage:1 stock:1 studies:1 experimental:1 first:1
stock_PFE r_up	says:1 background:1 bleeding:1 one:2 way:1 likes:1 year:2 still:1 market:1 throughout:1 positive:1 two:1 next:1 application:1 potential:2 treatment:2 which:1 expected:1 paving:1 details:1 's:2 plans:1 form:1 treatments:1 met:1 said:1 goals:1 key:2 half:1 bigger:1 rare:1 hemophilia:4 --:3 disorder:1 study:3 while:1 late-stage:1 studies:1 experimental:1 first:1
stock_PFE r_up	operations:1 1.5:1 companies:2 into:1 estimates:1 quarters:1 bribery:1 3.0:1 2.0:1 2.5:1 based:1 per:1 current:1 income:1 has:1 =:5 lawyers:1 business:1 big:1 possible:1 operating:1 included:1 delve:1 overseas:1 regarding:1 list:1 survey:1 analysts:2 become:1 share:1
stock_PFE r_up	now:1 concepts:3 settlements:2 alternatives:1 years:2 four:2 signs:1 settlement:1 its:3 bribes:1 $:2 guidance:1 better:1 asking:1 4:2 has:1 do:1 good:2 government:2 workout:1 seemingly:1 know:2 not:1 world:2 trade:2 comply:1 companies:2 individuals:1 filled:1 affect:1 notorious:1 security:1 sank:1 harm:1 creation:1 700:1 nearing:1 cost:2 investment:1 out:2 federal:1 shares:1 find:1 does:1 new:1 announced:1 shows:1 we:3 stepped-up:1 terms:1 million:1 paid:1 alone:1 news:1 safer:1 simpler:1 compliance:2 beta:3 drug:1 ignoring:2 promotion:1 among:1 previously:1 market:1 shareholders:2 law:1 investors:2 ordering:1 long-awaited:1 been:1 cooling:1 much:1 pains:1 taken:1 structures:1 more:1 enforcement:2 formally:1 offer:1 but:1 part:1 investigation:1 than:1 present:1 look:1 whether:2 're:2 stories:1 can:3 were:1 history:1 sentenced:1 1.6:1 false:1 figure:1 give:1 have:2 sense:1 court:1 no:1 pay:1 make:1 struggles:1 also:1 hedging:1 internal:3 announcements:2 stock:1 's:3 investigations:4 may:2 price:1 bundle:1 react:1 most:1 drag:1 end:1 off-label:1 recent:1 billion:1 off:2 investing:1 costs:1 so:1 correlation:1 left:1 corporate:1 preparing:1
stock_PFE r_up	sentenced:2 1.6:2 1.7:1 unemployment:1 previously:2 700:2 worsening:1 evidence:1 jobs:1 settlement:2 its:4 court:2 $:4 federal:2 pay:2 yet:1 looking:1 joblessness:1 troubled:1 announced:2 economy:1 formally:2 some:1 million:2 nation:1 part:2 peak:1 off-label:2 abroad:1 billion:2 has:1 drug:2 ordering:2 rose:1 promotion:2
stock_PFE r_up	adults:2 win:2 results:2 registration:1 its:6 pharmaceutical:1 use:2 said:3 group:2 49:4 positive:2 support:2 initial:1 3:2 clinical:1 vaccine:2 has:1 completed:1 company:1 13:6 regulators:2 approval:2 data:2 expand:2 younger:2 showed:2 package:1 --:1 18:4 trial:2 efforts:2
stock_PFE r_up	cancer:1 seen:1 its:1 unit:1 said:1 $:1 expert:1 patent:1 two:1 been:1 few:1 turnaround:1 chairman:1 under:1 new:1 has:2 local:1 details:1 his:1 's:1 valuations:1 sold:1 notable:1 leadership:1 former:1 revoked:1 companies:1 drug:2 maker:1
stock_PFE r_down	loss:1 's:3 showed:2 positive:1 study:1 signs:1 patients:1 drug:1 one:1 trial:1 slowed:1 treatment:1 another:1 memory:1 new:1 data:1 experimental:1
stock_PFE r_down	control:2 major:2 annual:2 says:2 investors:1 over:1 move:6 reduce:2 sales:2 strategic:2 3.6:1 likely:2 diverse:1 including:2 yield:1 telecoms:1 exclusivity:2 blockbuster:2 makers:2 market:2 giant:4 cut:2 $:2 3rd:4 provide:2 beginning:2 watching:2 attractive:1 shares:1 its:14 signals:2 favor:1 downgraded:1 program:2 location:4 inherited:2 expected:2 new:2 shrink:2 details:2 cost-cutting:4 billion:2 global:4 's:1 cope:2 drugs:4 completed:2 continues:4 expenses:2 site:2 property:2 said:2 operating:2 newer:2 footprint:2 dividend:1 part:2 existing:4 continued:2 former:2 recent:2 campus:2 pipeline:1 2009:2 real-estate:2 third:4 --:8 should:1 losses:2 companies:3 headquarters:10 drug:7 remain:1 costs:4 ongoing:2 following:2 strategies:2 efforts:8 quarter:2 utilities:1 acquisition:2 50:2
stock_PFE r_down	injections:1 illnesses:1 use:1 12:1 rare:1 meningitis:1 form:1 prompting:1 type:1 119:1 created:1 some:1 tied:1 pharmacy:1 their:1 deaths:1 reassess:1 doctors:1 outbreak:1 specialized:1
stock_PFE r_down	detailed:1 restore:1 required:2 painkiller:2 image:1 period:2 criticism:1 three:2 chronic:2 experienced:2 aims:2 395:2 pain:4 extended:2 technology:2 its:2 painkillers:2 information:1 said:1 would:1 clock:2 trials:1 make:1 had:2 investigational:4 least:2 secret:1 clinical:1 safety:2 available:1 used:2 's:2 around:2 drugs:1 discourage:2 deflect:1 includes:2 met:2 long:2 important:1 goals:2 included:4 using:2 data:1 day:2 received:2 keeping:1 12:2 --:4 study:4 months:4 drug:1 called:2 twice:2 patients:4 abuse:2 agent:2 works:1 12-month:2 maker:1 researchers:1 once:2
stock_PFE r_up	named:3 financial:1 have:1 presidents:1 executive:2 month:1 least:1 animal-health:1 year:1 spinoff:1 its:1 out:1 said:1 lead:1 directors:1 been:1 research:1 regions:1 other:1 various:1 board:1 has:1 officer:1 development:1 earlier:1 team:1 leadership:1 years:1 areas:1 several:1 vice:1 well:1 round:1 chief:2 nine:1 planned:1 were:1 filing:1 executives:1
stock_PFE r_up	saying:2 help:4 caused:3 allegations:2 results:4 mental-health:1 including:2 its:7 principal:2 giant:2 suicide:3 failed:1 treatment:4 them:2 his:2 seeking:2 evaluate:2 psychiatric:2 judge:2 investigator:2 --:10 facing:3 depressed:2 common:2 disorder:4 set:2 people:2 past:2 surrounding:3 second:1 275:1 adequately:1 denies:2 said:8 federal:3 p.m.:1 safety:4 denied:1 new:4 newly:1 seeks:2 pharmaceutical:2 seventh:1 beginning:1 study:6 according:1 experience:1 trial:7 important:2 commit:1 product-liability:6 placebo:2 maker:1 first:4 comment:1 major:4 because:1 quit:4 use:2 start:3 positive:2 lawsuits:3 needed:3 clinical:3 alleges:2 more:5 ``:3 efficacy:2 company:2 warn:1 released:1 smoking:4 than:3 present:2 counsel:1 these:1 patients:6 risks:1 were:2 called:2 general:1 '':3 drug:7 have:2 containing:1 denial:1 court:3 delay:7 also:2 other:1 accusations:1 begin:2 's:7 users:1 problems:1 compared:2 assessed:2 data:3 eighth:1 man:2 request:2 options:2 diagnosis:2 time:2 weigh:2
stock_PFE r_up	oncology:2 set:1 cancer:1 surrounding:1 caused:1 begin:1 allegations:1 primary:4 '':2 medical:2 because:1 analyzing:2 newly:1 determine:2 further:2 11th:1 15,000:1 its:5 narrowly:2 affairs:2 use:2 said:6 missed:2 would:2 start:1 federal:1 cell:4 whether:2 clinical:3 treatment:2 denied:1 --:3 alleges:1 evaluation:2 seeks:1 first:1 development:2 modestly:1 ``:4 his:1 's:9 risk:1 business:2 denial:1 company:1 men:1 new:1 results:1 released:1 needed:1 suicide:1 nearly:1 weigh:1 judge:2 president:2 data:1 product-liability:2 advanced:2 man:1 reaction:1 endpoint:4 renal:4 vice:2 did:2 study:6 request:1 findings:2 drug:4 n't:2 trial:4 patients:2 delay:3 common:1 specific:2 long-term:1 meet:2 senior:2 denies:1 reduced:1 researchers:1 late-stage:2
stock_PFE r_up	resolved:1 have:1 people:1 being:1 caused:1 over:1 doctors:1 begin:1 '':1 say:1 questions:1 reached:1 pain:2 its:1 litigation:1 use:1 said:1 would:1 desperation:1 remains:1 seeking:1 been:2 spokesman:1 safety:1 disclosed:1 dismissing:1 outbreak:1 has:1 's:1 2007:1 injections:1 ``:1 woman:1 patient:1 meningitis:1 offer:1 plaintiff:1 but:1 district:1 wake:1 demand:1 suicide:1 immediately:1 lawsuit:3 him:1 case:1 brought:1 northern:1 resolution:1 could:1 alleging:1 according:1 drug:1 n't:2 trial:2 her:1 relief:1 scheduled:1 commit:1 product-liability:1 settled:1 order:1 husband:1 first:1
stock_PFE r_down	creating:1 provide:1 medical:1 global:1 machines:1 drugs:1 other:1 knives:1 boom:1 cholesterol:1 biggest:1 new:1 firms:1 ever:1 its:1 market:1
stock_PFE r_down	saying:1 low-priced:1 us:1 deal:5 agreed:3 option:2 700:9 competition:1 quarters:1 held:2 buy:1 drug:2 have:1 seen:1 its:2 market:1 developer:2 pharmaceutical:2 said:1 $:9 million:3 surprises:2 privately:2 had:1 firm:2 also:1 advisories:2 potentially:3 treatment:4 fourth:1 which:1 biggest:1 details:1 more:1 branded:1 's:2 into:1 exercise:2 deficit:3 ingredient:1 gives:1 acquire:4 recently:3 plans:1 drugs:2 earnings:1 attention:3 specialty:2 but:1 includes:3 valued:3 acquisitions:1 bankruptcy:1 entry:1 active:1 news:1 2nd:1 beginning:1 approved:3 generics:1 roundup:1 quarter:1 success:1 liquid:5 --:5 disorder:4 companies:1 up:1 reports:1 face:1 banking:1 future:1 found:1 closing:1 latest:1 corporate:1 other:1 mergers:1 first:3
stock_PFE r_down	venture-capital:1 around:1 analysis:1 round-up:1 news:1
stock_PFE r_up	loss:1 costly:1 pushed:1 overall:1 drop:1 anti-clotting:1 third-quarter:1 hepatitis:1 sales:1 down:1 failure:1 while:1 revenue:1 drug:2 swung:1 experimental:1
stock_PFE r_up	among:1 20:1 work:1 years:1 other:1 650:1 celebrate:1
stock_PFE r_down	among:1 draw:1 heads:1 roster:1 releasing:1 watch:2 results:1 scrutiny:1 quarterly:1 likely:1 earnings:2 others:1 high-profile:1 corporations:1 investor:1 drugmaker:1
stock_PFE r_down	shortened:3 investors:5 bell:3 into:3 some:1 back:1 closures:2 trade:3 four:2 say:1 economic:2 trading:5 sense:1 loaded:2 out:1 again:3 busy:2 market-moving:3 sit:1 stretch:2 leading:2 it’s:1 rings:3 chaos:1 havoc:2 next:1 traders:1 few:1 going:1 earnings:2 markets:2 opening:3 stock:2 week:7 begin:2 's:2 releases:2 get:1 may:1 company:2 time:1 but:1 early:2 normalcy:1 haul:1 barrage:3 two:2 somewhat:1 during:2 strategists:1 trying:1 data:5 restart:2 stock-market:2 --:4 many:1 could:1 days:5 reports:2 face:3 without:2 a.m.:3 including:2 amid:1 making:2
stock_PFE r_down	saying:1 help:1 caused:1 over:2 focus:3 quarters:1 ended:1 through:2 exclusivity:13 settlement:2 its:8 weekly:1 impact:1 note:1 giant:8 $:12 surprises:2 expectations:2 analyst:2 better:1 advisories:2 combine:1 board:6 quarterly:1 2012:2 has:6 pending:2 details:3 do:1 updated:2 good:1 increased:1 rise:3 results:1 updates:2 they:2 not:1 month:2 chips:1 day:2 string:1 look:1 loss:6 term:1 excluding:2 lost:9 --:18 12th:2 drop:1 companies:2 continue:6 cholesterol:9 including:4 higher:2 soft:1 better-than-expected:1 heavy:2 weighs:1 some:1 sign:1 elected:1 second:1 growth:1 year:6 slumped:1 calendar:1 slew:1 awaits:2 blue:1 opened:1 profit:6 comments:4 investigation:8 health:2 new:1 jobs:2 business:1 pharmaceutical:8 seconds:1 marketing:6 million:6 agreement:6 reported:10 host:1 base:1 news:1 along:1 manufacturing:1 roundup:1 reaction:2 last:6 met:2 broad-based:1 taking:1 months:1 job:1 drug:11 keep:1 barrage:1 survey:2 analysts:2 view:1 traded:1 maker:8 executives:2 among:1 adjusted:2 unclear:1 revenue:2 two-day:1 improving:1 names:1 shutdown:1 gave:1 open:1 market:11 conference:1 late:6 authorizes:6 jobless:4 third-quarter:9 one-time:2 next:1 share-repurchase:6 program:6 opposed:1 storm:2 markets:1 more:1 company:1 line:1 but:2 hurt:6 sharply:8 sustained:1 payrolls:3 upstarts:1 former:3 10:6 14:27 showed:1 getting:1 up:3 future:1 items:2 following:1 10th:2 battered:1 private-sector:2 investors:3 health-care:1 mind:1 sales:15 cluster:2 reports:2 need:1 rally:1 blockbuster:3 if:1 information:2 equities:1 six:1 damage:1 1:3 shifts:1 other:2 earnings:18 which:8 out:1 stock:7 settle:6 's:27 price:4 after:1 clearer:1 includes:1 moment:1 fell:10 pair:2 president:1 stocks:4 data:6 eighth:2 billion:6 lower:8 short:2 calls:1 third:2 futures:3 well:1 drive:3 newcomers:1 think:1 principle:6 claims:4 corporate:1 latest:1
stock_PFE r_up	among:1 seven:1 regulated:1 economic:1 trading:1 136:2 rally:1 jobs:1 7.9:2 packed:1 industries:1 moves:1 instrument:1 managing:1 positive:1 top:1 troubles:1 testify:1 strategy:1 vendor:1 their:1 biggest:3 weeks:1 company:1 painful:1 stock:1 customers:1 kicked:1 's:3 risk:1 big:1 jumps:2 trending:1 report:1 such:1 data:1 day:1 distraction:1 off:1 ahead:1 movers:2 medical:1 worried:1 while:1 can:1 making:1 tickers:1 operate:1 maker:1 software:1
stock_PFE r_up	successful:1 heart:1 round-up:1 widely:1 ca:1 successfully:1 around:1 up:2 high:1 way:1 have:2 risk:1 cardiovascular:1 most:1 20:1 their:1 suggest:1 people:1 been:1 strokes:1 ideal:1 researchers:1 which:1 new:1 lowered:1 cause:1 either:1 lowering:1 increased:1 do:1 drugs:1 but:1 released:1 involving:1 news:1 estimate:1 venture-capital:1 lower:1 developing:1 --:1 statins:1 medicines:1 tolerate:1 disease:1 analysis:1 n't:2 attacks:1 patients:1 levels:2 can:1 cholesterol:5 called:1 experimental:1
stock_PFE r_up	being:1 through:2 its:4 decade:1 before:4 cut:1 20:1 $:6 had:4 late:1 treatment:8 weeks:6 hit:2 risk:1 big:4 early:1 they:2 anticipates:2 four-part:1 level:1 did:1 list:2 morning:1 large:1 --:17 predicted:4 cholesterol:2 become:4 rheumatoid:6 bond:1 because:1 deal:3 successfully:1 back:2 cost:2 spokeswoman:1 multibillion-dollar:1 decision:6 marketed:1 comments:1 seller:4 unit:1 new:12 available:2 sixth:1 seventh:1 regulators:2 pharmacies:2 approval:8 21:4 received:8 attacks:1 study:1 months:2 37:3 according:1 drug:6 analysts:4 retail:2 experimental:1 supply:2 within:2 three:4 market:2 pharmaceutical:4 additional:2 working:1 initial:2 two:5 been:2 call:4 way:1 expected:6 more:1 ``:1 interest:1 30-day:2 drugs:1 company:4 specialty:2 released:1 than:1 target:2 wholesale:2 n't:1 could:6 acquisition:2 heart:1 investors:2 moved:2 bankers:1 '':1 examine:2 have:4 orders:1 suggest:1 make:4 which:4 requested:2 's:12 plans:4 strokes:1 approves:2 arthritis:6 delayed:1 involving:1 date:6 data:2 billion:2 lower:1 transaction:1 lasted:1 daily:1 so:2 time:2 came:1
stock_PFE r_down	just:1 money:2 expects:2 years:1 anticipates:1 through:2 questions:1 its:2 before:1 impact:1 overhaul:3 $:5 supply:1 storms:1 analyst:1 list:1 add:2 complex:2 treatment:4 quarterly:1 volatile:1 weeks:2 has:2 details:1 activities:2 fourth:2 big:3 cutting:1 not:1 now:2 formal:1 term:1 countries:2 --:8 revert:2 public:1 large:1 slide:1 predicted:1 pharmacies:1 bills:1 automatic:1 because:1 cost:1 people:1 companies:4 second:1 legacy:1 variety:1 slumped:2 said:2 decision:1 benefit:1 comments:2 seller:1 won:2 health:4 sixth:1 new:5 firms:1 re-election:3 available:1 24:2 marketing:2 million:4 seventh:1 pressure:3 become:1 regulatory:2 path:1 received:2 quarter:2 benefits:2 ahead:1 rheumatoid:2 industry:1 drug:2 unpaid:1 extensions:1 stand:1 94:2 retail:1 other:2 first:1 revenue:2 within:1 one:1 down:1 put:2 submit:1 approval:2 your:2 pharmaceutical:1 stocks:3 few:1 three:1 deadlines:1 their:3 call:1 recognize:2 expected:1 harrowing:1 damaging:1 more:2 30-day:1 company:3 specialty:1 but:1 approves:1 gain:1 date:2 surged:2 than:3 places:1 rights:2 wholesale:1 spokeswoman:1 deferred:4 while:2 future:2 promising:1 following:2 could:1 acquisition:1 due:1 promises:2 investors:1 give:1 certain:2 health-care:3 reports:1 have:1 impacted:1 end:2 no:2 make:1 mix:2 costs:2 earnings:1 which:5 9:2 insurers:2 analysts:1 's:10 plans:2 may:2 collaboration:4 arthritis:2 prepared:1 most:2 two:1 device:1 president:1 law:5 destruction:1 amid:1 later:2 cover:1 disease:2 points:2 responsibility:2 menace:1 filing:1
stock_PFE r_down	among:2 says:2 version:1 certain:2 alternatives:2 its:2 expensive:2 sell:1 court:1 generic:1 away:2 other:2 low:2 conditions:2 available:2 division:1 's:5 business:2 drugs:2 pharmacy-benefit:2 treatments:2 produce:1 members:2 ruled:1 testosterone:2 --:1 taking:2 glaucoma:2 drug:1 aim:2 can:1 push:2 top:1 steer:2 latest:2
stock_PFE r_up	over:1 global:1 years:1 '':1 plead:1 offense:1 settlement:1 its:1 unit:1 estimated:1 $:2 federal:1 least:1 than:1 vaccines:1 investigation:1 market:1 which:1 under:1 biggest:1 leader:1 more:1 wants:1 ``:1 's:5 plans:1 government:1 company:1 million:1 five:1 next:1 part:1 lucrative:1 half:1 law:1 grow:1 billion:1 30:1 guilty:1 drug:3 become:1 promotion:1 maker:1
stock_PFE r_down	says:1 adults:1 reasons:2 encouraged:2 results:1 combining:2 multiple:1 its:2 developer:1 said:1 potential:1 generic:2 investigational:1 citing:2 version:2 widely:2 has:2 pill:2 therapies:1 development:2 used:2 run:1 business:2 arthritis:1 resistance:1 halted:2 class:1 diabetes:2 fighter:2 --:1 study:1 drug:2 evaluating:1 cholesterol:2 inhibitor:1 rheumatoid:1
stock_PFE r_down	all:1 210:3 agreed:2 allegations:2 major:1 its:2 $:9 treatment:1 stable:1 has:2 2010:1 do:1 get:1 big:1 they:1 investor:1 day:1 advanced:1 volatility:1 resolve:3 like:1 --:6 companies:1 deal:1 people:1 doing:1 cash:1 growth:1 discussions:1 said:1 investing:1 marketed:2 emotions:1 new:1 approach:1 focuses:1 creating:1 million:3 water:1 deadly:1 focused:1 strong:1 38:2 prosecutors:2 spill:1 many:1 uncertainty:1 drug:3 thing:1 connection:1 biting:1 maker:1 late-stage:1 raised:1 alliance:1 into:1 pharmaceutical:2 would:1 caught:1 returns:1 clinical:1 rates:1 markets:1 ``:1 forming:1 company:4 but:1 you:1 fund:2 accident:1 90:6 than:1 '':1 criminal:1 look:1 up:1 value:3 n't:1 economic:1 emotional:1 states:2 reports:1 need:1 roiling:1 end:1 suggests:1 pay:2 mix:1 struggling:1 picture:1 illegally:2 oil:2 's:4 flows:1 claims:1 stocks:1 grow:1 diabetes:3 charges:1 steady:1 without:1 trials:1 biotechnology:1
stock_PFE r_up	said:2 showed:2 did:2 study:2 epilepsy:2 primary:2 seizure:2 n't:6 3:2 potential:2 frequency:2 treatment:2 meet:2 endpoint:2 its:2 change:2
stock_PFE r_up	results:4 chronic:2 partner:2 its:6 said:6 positive:4 granted:2 had:2 hepatitis:2 also:2 3:2 treatment:4 top-line:2 has:2 low:2 them:2 's:4 evaluating:2 company:2 time:2 effect:2 compared:2 therapy:2 blood:2 significant:2 known:2 approval:2 pain:2 response:2 condition:2 count:2 loss:2 fibromyalgia:6 --:4 study:4 drug:2 initiate:2 patients:4 maintain:2 common:2 allow:2 were:2 placebo:2 late-stage:2
stock_PFE r_up	heart:1 says:1 have:1 founder:1 implicated:1 manager:1 officials:1 higher:1 276:1 insider-trading:5 need:1 multiple:1 dividend:1 avoided:1 its:1 little:1 said:1 $:1 puts:1 doctor:1 alleged:2 hedge-fund:1 largest:1 alleges:2 scheme:5 ever:2 more:1 's:2 than:1 may:1 million:1 given:1 fat:1 largest-ever:2 regulators:1 lucrative:1 know:1 they:1 news:1 stocks:1 you:1 cliff:1 pipeline:1 most:1 these:1 losses:1 say:1 drug:1 securities:1 deserves:1 nine:1 time:1 charged:1 maker:1 profits:1 first:1
stock_PFE r_up	saying:1 would:1 's:2 proposed:1 business:1 give:1 big:1 company:1 share:1 rejected:1 regulators:1 too:1 domestic:1 formula:1 baby:1 market:1 acquisition:1
stock_PFE r_up	boss:1 turn:1 his:1 prosecutors:1 tried:1 founder:1 get:1 against:1 former:1 insider:1 trading:1 they:1 year:1 before:1 him:1 charged:1
stock_PFE r_down	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_PFE r_down	venture-capital:1 around:1 analysis:1 round-up:1 news:1
stock_PFE r_up	comment:1 downgraded:1 requiring:1 over:1 some:2 device:1 say:1 rule:7 have:3 year:1 fear:2 makers:3 relationships:1 information:2 giant:1 said:1 bracing:2 spending:1 broad:2 overly:2 restrained:1 spokesman:1 potential:1 prices:1 medicine:1 new:5 falling:1 issue:1 public:2 more:1 them:2 around:1 government:3 drugs:1 could:2 overall:1 pharmacy-benefit:1 although:1 doctors:3 report:4 last:1 surged:1 concerns:1 improve:1 prescription:1 --:5 require:2 brand-name:1 companies:3 manager:1 drug:2 generics:1 mislead:2 payments:1 transparency:1 popular:1 10th:1 scope:1 medical-device:2
stock_PFE r_up	larger:1 presence:1 caused:1 over:2 some:2 month:1 past:1 production:1 manager:1 have:2 year:1 its:2 before:1 said:1 bottles:3 appear:1 generic:2 three:1 tiny:1 restrained:1 report:1 version:2 generics:1 medicine:1 falling:1 pill:1 more:2 drugs:1 popular:1 company:1 earlier:1 overall:1 pharmacy-benefit:1 glass:2 recalled:1 nearly:1 although:1 prices:1 surged:1 than:1 potential:1 prescription:1 brand-name:1 --:1 recall:2 months:1 drug:2 large:1 spending:1 stopped:1 small:1 investigates:1 mix-up:1 triggering:1
stock_PFE r_up	force:2 bidding:1 people:1 taste:1 certain:1 agreed:1 move:1 sales:2 makers:1 '':1 bring:1 market:1 slice:1 cuts:1 consumer-products:1 our:3 its:1 best:1 ability:1 said:2 vitamins:1 would:1 efficient:1 things:1 segments:1 limit:1 strategy:1 spokesman:1 jostle:1 health:1 allocate:1 statement:1 between:1 scope:1 recent:1 shrink:1 resources:1 more:1 cost-cutting:1 ``:1 war:1 's:1 plans:1 drugs:1 evaluate:1 were:1 serve:1 vitamin:1 but:1 growing:1 we:2 part:1 hear:1 they:1 article:1 investments:1 come:1 grab:1 areas:1 case:1 consumers:1 effective:1 did:1 could:2 alleging:1 companies:1 drug:2 maker:2 n't:1 generic:1 patients:1 lawsuits:1 customers:1 can:1 published:1 further:1 product-liability:1 reduced:1 latest:1
stock_PFE r_up	saying:1 year-end:2 testing:1 results:1 want:1 further:1 its:1 terminated:1 riskier:1 away:1 far:1 clinical:1 treatment:1 has:1 might:1 until:3 development:2 's:3 efficacy:1 beat:2 caps:3 end:1 stay:1 did:1 disease:1 n't:1 so:1 small:3 writes:1 experimental:1 justify:1
stock_PFE r_up	seven:1 significant:2 cancer:2 caused:1 into:1 shed:1 one:1 produced:2 added:1 trading:2 together:1 another:2 breast-cancer:2 recently:1 its:3 universities:1 index:1 suspects:1 said:2 banding:1 23:1 generic:1 rose:1 make:1 tiny:1 improvement:2 equipment:1 investigational:2 points:3 study:2 largest:1 got:1 ingredient:1 actively:1 used:1 's:3 diseases:1 combination:2 stem:1 glass:1 therapy:2 adult:1 key:1 tackle:1 world:1 stocks:1 advanced:2 11:1 recall:1 cells:1 companies:2 drug:4 order:1 patients:2 130:1 massive:1 were:1 mixed:1 investigating:1 create:1 breast:2
stock_PFE r_down	because:1 deal:2 manage:2 its:2 trials:2 drugs:2 clinical:2 treatment:2 which:2 under:2 new:1 struck:2 has:2 more:1 development:1 track:1 speeding:1 most:1 eight:1 relating:2 than:1 industry:1 30:1 disease:2 continue:2 ongoing:2 approve:1 experimental:1
stock_PFE r_down	pharmaceutical:1 ``:2 sure:1 police:1 $:1 gold:1 missing:1 not:1 lost:1 700,000:1 giant:1 lab:1 research:1 '':2 telling:1 stolen:1 whether:1 dust:2 's:1 worth:1
stock_PFE r_down	10:2 roiling:1 big:1 uncertainty:1 question:1 up:2 but:1 next:1 go:2 2013:2 year:1 not:1 stocks:1 market:2 more:1
stock_PFE r_down	antibiotic:2 gold:1 doing:1 agreed:2 allegations:2 unfair:2 states:2 regulatory:1 settlement:2 seek:1 deceptive:2 $:7 pay:2 conduct:1 few:1 practices:2 combined:2 time:1 medicine:2 instead:1 worth:1 treatment:1 used:2 's:3 missing:1 wo:1 marketing:2 company:1 million:2 lab:1 reported:1 but:1 dust:1 approval:1 precious:1 additional:1 --:2 32:2 study:1 metal:1 disease:1 drug:3 maker:3 n't:1 750,000:1 leading:1 speculation:1 other:2 experimental:1
stock_PFE r_down	initial:1 adults:2 exists:2 effective:2 two:2 chronic:2 offer:2 animal-health:1 alternative:2 improvement:2 unit:1 considering:1 given:2 compared:2 $:1 no:2 provide:2 positive:2 review:2 marketed:4 three:2 approved:2 application:2 program:2 4:1 which:2 under:2 has:2 '13:2 public:1 more:2 accelerated:2 billion:1 may:2 diseases:2 offering:1 schedule:2 drugs:2 safe:2 leukemia:4 provides:2 therapy:4 blood:2 significant:2 approval:4 than:2 treating:2 advance:2 rare:2 treats:2 ahead:2 launch:1 months:2 roughly:1 drug:6 expedited:2 six-month:2 placed:2 patients:2 products:2 bone:2
stock_PFE r_up	1.5:1 based:1 list:1 estimates:1 per:1 quarters:1 current:1 companies:1 operating:1 analysts:2 3.0:1 income:1 included:1 survey:1 share:1 2.0:1 =:5 2.5:1
stock_PFE r_up	sharp:1 raised:1 cents:2 commitment:1 month:1 '':1 cost:1 looks:1 year:1 return:1 its:2 24:1 pharmaceutical:1 shareholders:2 said:1 $:1 22:1 profit:1 demonstrates:1 third-quarter:1 increase:1 board:1 which:1 capital:2 quarterly:1 9.1:3 higher:1 ``:1 's:4 increased:1 business:1 returning:1 our:2 company:2 million:1 confidence:1 sales:1 reported:1 fell:1 dividend:3 continued:2 payout:1 59:1 14:1 lost:1 amid:1 drop:1 drug:1 cholesterol:1 more:1
stock_PFE r_down	sharp:1 raised:1 cents:2 commitment:1 month:1 '':1 cost:1 looks:1 year:1 return:1 its:2 24:1 pharmaceutical:1 shareholders:2 said:1 $:1 22:1 profit:1 demonstrates:1 third-quarter:1 increase:1 board:1 which:1 capital:2 quarterly:1 9.1:3 higher:1 ``:1 's:4 increased:1 business:1 returning:1 our:2 company:2 million:1 confidence:1 sales:1 reported:1 fell:1 dividend:3 continued:2 payout:1 59:1 14:1 lost:1 amid:1 drop:1 drug:1 cholesterol:1 more:1
stock_PFE r_up	distributors:1 parties:2 allegations:1 ``:1 '':1 nothing:1 subsidiary:1 high-profile:1 its:2 millions:1 pharmaceutical:1 little:1 said:1 $:2 chosen:1 pay:1 failed:1 agreements:1 accusations:1 marketing:1 offshore:1 knowing:1 complaint:1 used:1 which:1 government:1 reduce:1 company:1 despite:1 included:1 29.4:2 those:1 deny:1 third:2 did:1 study:1 drug:1 n't:1 admit:1 customers:1 risks:1 cholesterol:1
stock_PFE r_down	1.4:1 1.1:1 1.2:1 into:2 allegations:1 number:1 trade:2 four:1 agreed:1 actively:3 trading:3 dropped:1 year:1 investment:2 declined:2 index:2 believe:1 develop:2 investors:1 their:1 ideas:2 43:1 shares:3 pharmaceuticals:2 potential:2 combine:2 money-making:2 expected:2 entered:2 has:2 collaboration:2 2013:3 stock:1 worldwide:2 pay:1 settle:1 's:4 company:4 million:1 agreement:2 affiliates:1 treatments:2 market:1 fell:2 124:1 sharply:2 bull:2 29.4:3 stocks:2 $:3 session:2 10:2 lower:2 lost:1 license:2 16:1 turns:1 average:1 companies:3 bribery:1 lucky:1 points:3 products:2 historical:1 were:2 overseas:1
stock_PFE r_up	building:1 run:1 deal:1 family:1 company:2 three:1 makers:1 brands:1 including:1 into:1 's:1 powerhouse:1 investment:1
stock_PFE r_up	criticism:1 prevent:1 there:1 says:1 heart-rhythm:1 less:1 developed:1 wave:1 move:1 domestic:1 reignited:1 trade:2 stroke:1 session:2 rising:1 7.4:1 seats:1 fibrillation:1 operation:1 picks:1 its:1 considering:1 marking:1 8.2:1 actively:2 $:1 analyst:1 few:1 effort:1 initial:1 anti-clotting:1 two:1 shares:3 approved:1 also:1 carrier:1 treatment:1 closed:1 months:1 expected:2 hold:1 holiday:1 markets:1 public:1 higher:1 available:1 adviser:1 his:1 's:3 premarket:1 offering:1 year:1 month:1 than:1 company:1 said:2 reiterated:1 next:1 regulators:1 jumping:1 approval:1 favorite:1 investor:2 potential:1 hired:1 atrial:1 ago:1 has:1 third:1 17:1 thwart:1 meeting:1 drop:1 companies:2 drug:1 overblown:1 n't:2 hikes:1 patients:1 continue:1 strategic:1 worries:1 disorder:1 called:1
stock_PFE r_down	comment:1 exceed:1 annual:1 heart-rhythm:1 slipped:1 less:1 developed:1 approved:1 sales:1 two:1 stroke:1 actively:1 trading:1 shares:1 1.2:1 close:1 fibrillation:1 1.1:1 index:1 26:1 $:1 rose:1 anticlotting:1 three:2 declined:1 than:2 2:1 treatment:1 fourth:1 expected:1 closed:1 eventually:1 after:2 's:2 risk:1 earlier:1 hours:1 fell:1 five:1 approval:1 stocks:1 analyst:1 atrial:1 billion:1 both:1 lower:2 --:4 could:1 months:2 companies:2 drug:1 patients:1 points:1 disorder:1 called:1 comes:1
stock_PFE r_up	less:1 developed:1 midnight:1 trade:2 bright:1 session:3 deadline:1 fifth:1 25:1 giant:1 atrial:1 23:1 rose:2 add:1 treatment:1 rich:1 congressional:1 2012:1 around:1 awaiting:1 developments:1 --:1 companies:2 did:1 higher:1 disorder:1 leaders:1 edition:1 extended:1 index:2 jumped:1 anticlotting:2 patients:1 shares:4 new:1 avert:1 hours:2 dividend:1 $:2 payout:1 ahead:2 31:1 losses:1 reports:1 plus:1 slightly:1 heart-rhythm:1 into:1 approval:2 open:1 pharmaceutical:1 two:1 fibrillation:1 expected:2 meeting:1 500:1 flat:1 offer:1 company:1 than:1 fiscal-cliff:1 11:1 up:1 n't:1 while:2 actively:2 2013:1 were:1 called:1 months:1 investors:1 cents:1 0.3:1 0.2:1 1.9:1 stroke:1 drug:2 have:1 moves:1 negotiations:1 risk:1 4.1:1 equities:1 fourth:1 stock:1 added:1 's:4 after:3 approved:1 cliff:1 fiscal:1 lower:1 futures:2 points:2 came:1
stock_PFE r_up	specific:1 marketplace:1 show:1 virtues:1 large:1 much:1 businesses:1 take:1 steps:1 public:1 can:1
stock_PFE r_down	deal:2 eventually:2 into:2 upfront:2 sales:2 according:2 spinal:2 licensing:2 total:2 any:2 worse:2 said:2 potential:2 $:10 lead:2 addition:2 damage:2 program:2 5:2 which:2 inherited:2 entered:2 cause:2 over:2 entitled:2 worldwide:2 royalties:2 's:2 diseases:2 get:2 weakness:2 milestone:2 million:6 agreement:2 death:2 70:6 group:2 payment:2 advance:2 receive:2 up:4 future:4 payments:2 time:2 muscle:2 starting:2 65:2
stock_PFE r_up	named:4 old:2 years:2 65:2 partner:2 financial:2 resigned:2 since:2 had:2 also:2 continue:2 chairman:4 biotechnology:2 new:2 has:4 2010:2 officer:2 life:2 focuses:2 company:4 leadership:2 70:2 president:2 appointed:2 he:2 54:2 board:2 companies:2 joined:2 chief:2 became:2 2007:2 science:2 served:2 investments:2
stock_PFE r_up	emerging:1 ways:1 slower:1 money:1 health-care:1 year:1 growth:1 signs:1 federal:1 your:1 electric:1 still:1 record:1 spending:1 blue-chip:1 there:1 long:1 low:1 lot:1 6:1 new:1 2011:1 today:1 more:1 bets:1 good:1 's:1 risk:1 may:1 utilities:1 but:1 consecutive:1 not:1 world:1 stocks:1 like:1 earn:1 grew:1 last:1 look:1 third:1 taking:1 according:1 pace:1 without:1 figures:1
stock_PFE r_up	heart:1 they:1 gold:1 increasingly:1 money:1 metric:1 settlements:1 reduce:1 disease:1 bring:1 manager:1 sure:1 go:1 find:1 string:1 pharma:1 their:1 trials:1 needed:1 willing:1 expected:1 clinical:1 trend:1 budgets:1 do:1 cash-strapped:1 good:1 's:2 risk:1 continue:1 drugs:1 big:1 after:1 miners:1 reported:1 job:1 free:1 key:1 not:1 cases:1 relying:1 raising:1 he:2 fraud:1 surprising:1 whether:1 --:1 flow:1 cash:1 whistleblowers:1 're:1 tech:1 can:3 cholesterol:1 agree:1
stock_PFE r_up	sentenced:1 set:1 old:1 leaders:1 some:1 years:2 four:1 conspiracy:1 including:1 's:1 counterfeit:1 court:1 federal:1 make:1 system:1 pharmacy:1 pioneer:1 health:1 prison:1 mail:1 more:1 affordable:1 customers:1 fever:1 pain:1 business:1 drugs:1 price:1 fraud:1 new:1 brands:1 overhaul:1 care:1 restrictions:1 38:1 attempt:1 country:1 medicines:2 sale:1 foreign:1 connection:1 commit:1
stock_PFE r_up	days:1 their:1 leading:1 health-care:1 back:1 shares:1 three:1 61:2 charge:1 industrials:1 gain:1 snapped:1 materials:1 first:1
stock_PFE r_down	firm:1 based:1 guidance:1 estimates:1 lowered:1 dimmer:1
stock_PFE r_down	trim:1 investors:1 bargain:1 including:1 makers:1 lackluster:1 spots:1 should:1 their:1 improve:1 drugs:1 pricey:1 leadership:1 effort:1 look:1 like:1 sectors:1 positions:1 up:1 drug:1 apparel:1 output:1 shook:1
stock_PFE r_up	because:1 help:1 revenue:1 companies:5 sales:1 years:1 2013’s:2 have:1 year:1 still:1 machines:1 profitable:1 top:1 forecast:2 their:1 much:1 dominated:1 earnings:1 which:1 several:1 longtime:1 grown:1 them:1 oil:1 big:1 most-profitable:2 most:1 produce:1 they:1 not:1 line:1 future:1 success:1 these:1 list:1 continue:1 tech:1 banks:1 higher:1 profits:1
stock_PFE r_up	billion:1 biotech:1 sees:1 $:1 rise:1 continuing:1 manages:1 6:1 stocks:1 investor:1 than:1 2013:2 more:1
stock_PFE r_up	sector:1 just:1 among:1 global:1 domestic:2 results:6 ending:2 product:1 ended:2 session:2 controversial:1 its:1 weekly:2 pointing:2 23:1 rose:6 discretionary:1 better:2 only:1 equity:5 quarterly:4 weeks:2 2011:2 happened:1 then:1 around:1 10:1 showing:2 1,500:8 break:1 every:1 preparing:1 trade:1 level:3 six-session:1 morning:2 specific:1 benefit:1 went:2 quarter:2 decliner:1 briefly:1 competition:1 strongest:2 economic:7 close:1 index:2 said:6 mood:2 lead:1 federal:1 since:8 buoyed:2 consecutive:2 strategist:3 seventh:2 expansion:2 step:1 groups:1 manufacturing:2 $:2 gained:1 industry:1 barely:1 fourth-quarter:1 drug:1 a.m.:1 gainer:1 maker:6 first:4 seeing:2 major:2 win:1 into:4 encouraging:5 due:1 down:2 rising:1 seasonally:2 market:3 jobless:2 8.6:1 addition:2 top:2 there:1 anti-clotting:1 two:2 been:1 prosecutor:1 lowest:2 ``:4 funds:4 company:1 but:3 sales:1 released:2 hold:1 former:2 '':3 13:2 showed:2 19:2 nominate:1 while:4 individual:2 500:11 were:1 adjusted:2 5,000:2 streak:1 investors:8 0.3:1 tax:1 head:1 weighed:1 spooked:6 technology:1 gains:3 tumbled:1 4.4:1 mutual:2 generic:1 topped:1 indexes:1 high:1 virtually:1 week:2 topping:3 's:20 track:3 after:12 drift:1 marking:2 flows:2 fell:2 nothing:1 stocks:5 data:11 billion:2 lower:1 pressured:5 steady:1 profit:1 chief:3 points:1 so:1 2007:4 time:4 claims:2 2008:2 nearly:2
stock_PFE r_up	1.4:1 set:1 old:1 squeaks:1 weight:2 feel:2 energy:1 results:1 years:4 helped:2 economic:2 including:3 numbers:1 jobs:1 counts:1 technology:1 children:1 fifth:2 out:2 index:1 use:1 biggest:1 group:1 offering:1 46:1 rose:2 blue-chip:1 initial:1 contributed:1 tiny:1 approved:2 hitting:1 1500:1 earnings:1 which:1 6:1 expected:1 several:1 public:1 day:4 scheduled:1 intraday:1 after:1 's:7 big:1 advance:1 season:1 average:1 continues:1 component:1 seventh:1 its:2 rise:1 important:1 worst:2 gain:2 claims:2 report:1 along:1 data:3 between:1 vaccine:2 jobless:2 four:2 13:3 like:1 17:1 most:1 always:1 age:1 climbed:1 companies:1 up:3 reports:1 sank:2 while:3 points:1 500:2 straight:1 making:1 adolescents:1 round:2 0.3:1 first:1
stock_PFE r_down	firm:1 seven:1 initial:1 tap:1 deal:1 revenue:1 year:1 among:1 trade:1 bring:1 session:1 rising:1 article:1 go:1 home:2 keep:1 market:4 greater:1 wanted:3 $:2 housing:1 since:4 shares:1 looking:1 public:2 just:3 unit:1 which:2 largest:4 expected:1 performance:1 poised:1 bubble:1 brisk:2 500:1 earnings:3 week:2 's:5 plans:1 offering:2 company:4 fourth-quarter:1 they:1 hopes:1 world:1 years:1 2.2:2 growth:1 --:4 markets:1 builder:2 later:1 companies:2 prepping:1 actively:1 published:1 become:2 maker:1 first:2
stock_PFE r_up	sector:6 saying:1 all:1 just:1 show:1 telecom:1 over:1 results:5 trade:2 bearish:1 manager:3 forecast:2 committee:1 years:1 portfolio:4 still:1 its:4 consumer-confidence:2 before:1 impact:1 giant:5 busy:1 $:1 rose:1 point:1 had:3 winning:2 late:1 citing:2 advisories:2 97:1 weakening:2 policy:3 has:2 2013:2 smartphone:1 somebody:1 gains:6 year:1 far:1 couple:3 income:1 1,500:1 sellers:1 among:1 streak:1 front:1 part:1 quarters:1 falling:1 advanced:7 three-day:1 countries:1 --:4 warned:2 companies:10 make:1 morning:1 bag:2 good:1 five-year:3 weighs:1 lifted:4 doing:2 energy:3 some:5 likely:1 added:1 perspective:2 changed:1 our:2 little:1 avoided:1 investment:1 index:4 said:3 bandwagon:1 sentiment:2 jumped:1 decision:1 since:2 near:1 shares:1 research:3 looking:1 health:1 above:1 new:1 firms:2 moderate:1 onslaught:1 after:10 led:1 business:3 jumps:2 handful:1 component:4 confidence:2 here:1 hours:2 reported:5 operating:3 key:2 offset:3 strong:1 roundup:1 acquisition-related:1 last:1 ahead:2 items:1 computers:1 according:4 reports:3 surge:2 other:1 levels:1 surprises:2 mixed:2 share:1 narrow:2 maker:1 crushed:1 first:2 fourth-quarter:7 benefited:1 bell:2 two-day:1 retailer:1 encouraging:2 down:1 rising:3 downside:1 wrap:1 ring:1 174:3 market:2 everybody:1 pharmaceutical:4 '':3 second:1 area:1 leading:2 due:1 least:1 their:1 lot:1 upbeat:1 euro:1 meeting:1 chip:1 500:6 more:3 lowest:1 gained:1 ``:3 interest:1 mostly:3 month:2 estimates:6 company:1 but:1 sales:1 quarterly:4 lift:1 gain:1 prices:4 analyst:3 buying:2 he:2 bets:1 high:2 kind:2 solid:2 markets:1 up:4 value:1 lead:1 recession:1 charges:1 while:5 future:1 pending:1 were:1 making:1 closing:1 gives:1 0.9:1 150:1 trio:1 months:1 600:1 investors:1 nutrition:1 snapping:2 0.3:2 0.2:1 moved:1 0.4:2 disappointing:3 warning:1 drug:1 have:12 close:1 need:1 rally:2 moves:1 saw:1 sits:1 electronic-trading:1 want:1 technology:4 began:1 peace:1 beat:2 topped:5 traders:1 also:2 run:2 issuing:1 earnings:18 which:1 online:1 finding:1 you:2 several:1 start:1 day:2 higher:3 week:1 200:1 oil:4 's:8 highs:1 reporting:3 problems:1 forecasts:3 helping:2 long-term:1 rise:1 fell:1 date:3 stocks:13 data:4 why:1 soared:1 exposure:1 lower:1 off:3 remember:1 third:2 ranks:1 consumer:2 later:1 well:2 sale:1 think:1 chief:1 points:3 so:1 2007:1 agenda:1 time:2 barrel:1 corporate:4 blue-chip:2 latest:1
stock_PFE r_up	sector:4 selected:1 ``:3 results:1 leads:2 ended:1 manager:2 session:3 including:1 portfolio:4 its:2 boosts:1 before:1 27:1 $:2 rose:5 worth:1 winning:1 multi-year:2 citing:2 equity:1 fuel:1 2011:3 regrets:1 smartphone:1 around:2 couple:2 regional:1 1,500:1 early:2 know:1 30:2 not:2 day:1 advanced:2 level:5 --:4 sluggish:1 consumer-confidence:2 companies:3 50:1 morning:1 bag:2 higher:3 better-than-expected:1 lifted:2 doing:2 energy:3 some:1 back:1 disappointing:3 economic:2 perspective:2 seal:1 2.3:2 edged:1 makers:1 best:2 booming:1 index:3 offsetting:2 extend:2 lead:1 jumped:1 decision:1 since:5 near:2 shares:5 research:1 everything:1 intraday:2 closed:1 new:1 firms:1 receiving:1 ever:1 leader:1 we:1 business:1 pushing:1 component:1 reported:1 offset:1 strategist:1 gained:2 advance:1 hits:2 improved:2 ahead:1 33:2 could:1 months:2 according:1 drug:1 range:1 became:1 mixed:2 narrow:2 first:1 fourth-quarter:1 outlook:2 four-month:2 encouraging:1 marked:1 rising:1 another:1 174:1 two-year:2 market:2 '':3 powered:1 diseases:1 hitting:2 their:3 interest:1 markets:4 500:2 mining:1 mostly:4 estimates:1 benchmark:1 policy:1 gain:1 prices:4 last:1 highest:3 surged:3 analyst:1 97:1 helped:2 kind:2 word:1 solid:1 straight:1 up:7 optimism:2 2010:1 while:8 values:1 were:1 closing:1 10th:1 region:1 streak:1 climbed:2 have:4 1.2:1 0.1:1 0.2:5 neglected:1 0.4:1 0.7:2 high:7 reads:1 reports:1 want:1 seen:2 rally:2 technology:3 gains:2 end:2 topped:2 1:1 also:4 other:2 earnings:7 which:1 you:3 five-year:4 200:3 oil:4 's:15 our:2 boosted:1 highs:7 after:2 reach:1 forecasts:3 fueled:2 said:3 72:2 date:1 stocks:15 data:2 lifting:4 exposure:1 billion:1 sentiment:1 industry:2 well:2 2000:1 2007:2 time:2 barrel:1 corporate:1 blue-chip:2 once:1
stock_PFE r_up	sector:1 raised:2 initial:2 investors:2 money:1 correction:2 funds:3 years:1 style:1 trading:2 expected:1 have:1 news:1 spinoff:1 2.2:6 its:1 market:2 out:1 profitable:1 mutual:3 strong:1 20:5 $:6 rose:1 since:4 rings:3 shares:1 next:2 symbol:1 deal:2 unit:1 7:2 largest:3 biggest:1 company:2 into:1 stock:1 billion:2 begin:1 buy:2 's:4 gains:3 offering:3 big:1 showing:1 after:2 ultimately:1 herd:1 most:1 eight:1 year’s:1 jour:1 du:1 opportunity:1 than:2 categories:1 roundup:1 venture-capital:1 12:2 last:3 home:1 invest:1 builder:1 debut:4 up:3 analysis:1 public:2 around:1 jumped:1 following:1 under:1 more:2 pulled:1 maker:2 first:1
stock_PFE r_down	among:1 shed:1 managers:1 package:1 four:1 session:1 trading:2 expect:1 have:1 month’s:1 actively:1 top:3 it’s:1 backers:1 two:1 shares:1 points:3 covered:1 you:1 500:1 giants:2 do:2 's:2 but:1 fell:1 probably:1 not:1 stocks:1 11:1 lower:1 like:2 lost:1 16:1 performers:2 companies:2 116:1 tech:2 were:1
stock_PFE r_down	total:1 rewards:1 return:1 leaders:1 certain:1 avoid:1 restricting:1 companies:1 number:1 limiting:1 down:1 compensation:1 shareholder:1 negative:1 growing:1 outcry:1 years:1 investor:1 top:1 stock:1
stock_PFE r_down	control:1 agreed:1 focus:1 '':1 full:1 multiple-sclerosis:1 partner:1 's:1 blockbuster:1 its:1 pharmaceutical:1 targeting:1 $:1 giving:1 research:1 3.25:1 interest:1 personalized:1 increasing:1 approach:1 ``:1 buy:1 turning:1 early:1 stage:1 billion:1 down:1 industry:1 drug:1 upside:1 medicines:1
stock_PFE r_down	outlook:1 six:1 investors:1 revenue:1 over:1 hallmark:1 ninth:1 years:1 13th:1 phase:1 comments:1 our:1 next:1 seek:1 its:2 copycat:1 said:2 'll:1 patent:3 review:1 biosimilars:1 able:1 per-share:1 fight:1 few:1 details:1 meeting:1 international:2 2017:1 biosimilar:1 markets:1 launching:2 earnings:2 ``:1 '':1 expirations:1 business:1 drugs:2 company:1 expansion:1 period:1 we:1 protection:1 grow:1 new:1 prepares:1 beginning:1 analyst:1 cliff:1 aggressively:1 --:3 many:1 flow:1 cash:1 2013:3 lose:1 history:1
stock_PFE r_up	gaining:1 lifted:3 investors:4 fans:1 within:1 energy:3 0.2:2 lightest:4 major:1 sequestration:1 ending:1 down:2 ended:1 session:1 trading:5 dropped:1 year:3 close:1 rally:3 throughout:1 its:4 out:1 index:1 avert:1 end:2 slipped:1 does:1 rose:2 led:1 shares:3 indexes:3 0.1:1 only:1 dropping:1 above:1 6:3 8:1 territory:1 0.3:1 2013:2 afternoon:1 week:2 finish:1 's:4 that’s:1 decline:1 sixth:1 never:1 benchmark:4 volume:4 reach:1 finished:2 fell:1 if:1 year’s:2 they:1 consecutive:1 2:1 stocks:4 day:2 11:1 10:1 lower:5 narrow:1 last:1 sectors:1 16:1 traded:1 30:2 according:1 deal:1 n't:2 range:1 points:3 survey:1 500:1 components:2 positive:1 retail:3 slightly:3 think:1
stock_PFE r_down	profitable:1 bear-market:2 bears:1 overlooked:2 strategy:2 very:1 market:1
stock_PFE r_up	because:1 money:1 agreed:1 results:1 copies:1 hook:1 heartburn:1 2.1:1 exclusivity:1 before:1 shareholders:1 $:4 generic:1 pay:1 lawsuits:1 claiming:1 negative:1 clinical:1 damages:1 2011:1 sold:1 's:2 may:1 company:1 million:1 reported:1 expired:1 billion:1 patent:1 lost:1 up:1 drug:2 trial:1 settle:1 2008:1
stock_PFE r_up	30:1 less:1 0.1:2 over:2 0.2:1 powerful:1 up:1 high:2 currency:3 rising:2 dropped:1 swung:1 its:1 market:2 finance:3 investor:1 increase:1 stocks:2 20:3 sentiment:3 computers:1 giving:1 tensions:3 create:1 selloff:1 ministers:3 hitting:2 their:1 positive:1 rose:2 between:1 overbought:2 territory:1 meeting:2 higher:1 24:1 intraday:2 earlier:1 edged:1 gains:2 slight:1 showing:2 rise:2 expanded:1 anticipated:1 met:1 chance:1 fell:1 success:1 using:1 manufacturing:3 data:3 than:1 after:3 gained:1 anxiety:2 central:3 14:1 showed:1 countries:3 region:1 losses:1 companies:1 bankers:3 against:3 points:3 components:1 activity:3 consumer:3 spotlight:3 backdrop:3
stock_PFE r_up	conference:1 week:1 his:1 's:1 views:1 vaccines:1 future:1 shared:1
stock_PFE r_down	body:1 marketed:2 cancer:6 certain:1 powerful:3 agent:2 existing:1 second:1 have:1 types:1 information:1 use:1 additional:1 initial:1 other:1 spread:1 treatment:1 chemotherapy:2 type:3 treat:4 meant:1 's:2 packs:1 combines:1 breast:5 new:2 approved:4 advanced:1 --:3 parts:1 drug:4 starting:1 called:1
stock_PFE r_down	pharmaceutical:1 's:1 plans:1 combat:1 fastest-growing:1 health-care:1 companies:1 one:1 markets:1 forge:1 world:1 margins:1 alliances:1 shrinking:1 more:1
stock_PFE r_up	biotech:1 costly:1 fourth-quarter:1 billions:1 expenses:1 '':1 currency:1 cost:1 unfavorable:1 missed:1 delays:1 biosimilars:1 charge:1 health:1 systems:1 surprise:1 net:1 higher:1 ``:1 anticipated:1 reported:1 operating:1 hurt:1 loss:1 versions:1 could:1 obstacles:1 drug:1 facing:1 savings:1 maker:1
stock_PFE r_up	disclosure:1 named:1 because:1 painkiller:1 previously:1 into:1 executive:1 share:1 down:1 laboratory:1 moves:1 its:1 market:1 sell:1 whose:1 management:1 court:1 additional:1 grant:1 patent:1 top:1 two:1 rival:1 looking:1 reinstated:1 call:1 unit:1 under:1 new:1 struck:1 earnings:1 's:4 plans:1 government:1 company:1 after:1 part:1 gain:1 sweeping:1 overhaul:1 payment:1 made:1 license:1 monopoly:1 18:1 could:1 months:1 well:1 days:1 chief:1 said:1 were:1 claims:1 comes:1
stock_PFE r_up	0.9:1 advance:1 2009:1 's:1 rally:1 tenacious:1 began:1 losses:1 overcoming:1 tied:1 crisis:1 high:1 back:1 exceeded:1 financial:1 stock:1 its:1 previous:1
stock_PFE r_up	consulting:1 deal:1 share:1 reached:1 its:1 $:2 service:1 helps:1 new:1 has:1 buy:1 company:1 outfit:1 76:1 address:1 hopes:1 manufacturer:1 billion:1 talent:1 challenge:1 roughly:1 valuing:1
stock_PFE r_down	development:1 contested:1 liver:1 generation:1 industry:1 disease:1 treatments:1 drug:1 next:1 race:1 stopped:1 hepatitis:1 introduce:1 experimental:1 out:1
stock_PFE r_down	strengthened:1 consulting:1 winner:1 antibiotic:1 proposed:1 saying:1 omitted:1 lack:1 product:1 competition:1 high:1 rate:1 looks:1 withdrawn:1 pharmaceutical:1 giant:1 investors:1 generic:1 there:1 submit:1 its:1 business:1 trigger:1 potentially:1 low:1 rhythm:1 new:1 fatal:1 week:1 them:2 's:1 all-weather:1 initiated:1 warnings:1 may:1 after:1 but:1 chance:1 proxy:1 coverage:1 robust:1 valuation:1 former:1 like:1 irregular:1 many:1 study:1 proposals:1 according:1 yield:1 heart:1 continue:1 small:1
stock_PFE r_down	valued:1 hit:1 $:3 last:1 objectives:1 million:1 up:1 drug:1 two:1 compensation:1 out:1 three:1 key:1 year:1 financial:1 total:1 2011:3 maker:1 2.5:3 2012:3
stock_PFE r_up	among:1 all:1 set:1 proved:1 household:1 health-care:1 share:1 according:1 held:2 year:1 still:1 its:1 market:2 most:1 cut:1 end:1 $:2 prior:1 pet:1 things:1 trillion:2 credit-ratings:1 their:1 rates:1 which:1 resilient:1 downturn:1 1.32:1 has:1 2011:1 worth:1 2012:5 topping:1 global:1 's:5 increased:1 company:1 1.45:1 said:2 report:1 animals:1 recent:1 billion:1 10:3 non-financial:2 last:1 level:1 climbed:1 companies:3 cash:4 spending:1 amount:1 budgets:1 growing:1 record:1
stock_PFE r_down	less:1 legal:1 year:1 still:1 7.9:1 $:1 top:1 40:3 total:1 new:1 more:1 earlier:1 's:3 though:1 company:1 million:1 than:2 received:1 valued:1 up:1 compensation:1 officer:1 2012:1
stock_PFE r_up	short:1 which:1 supply:1 drugs:1 showing:1 companies:1 been:1 have:1 rising:1 interest:1 injectable:1 often:1
stock_PFE r_up	cancer:2 companies:1 second:1 inventors:1 have:1 led:1 its:1 market:2 court:1 patent:1 decision:1 shares:1 traders:1 going:1 way:1 under:1 gets:1 2013:1 more:1 's:5 gains:1 slight:1 but:1 early:1 drug:3 fast-growing:1 protection:1 rejected:1 stocks:1 abroad:1 case:1 positioning:1 against:1 pullback:1 patients:1 enter:1 popular:1 efforts:1 quarter:1 options:1
stock_PFE r_down	managed:1 deal:1 trend:1 global:1 years:1 economic:1 fast:1 during:1 crisis:1 around:1 said:1 grinding:1 reality:1 ambitious:1 development:1 gains:1 big:1 becoming:1 after:1 but:2 halt:1 news:1 roundup:1 venture-capital:1 real-estate:1 ahead:1 months:1 well:1 bankers:1 analysis:1 launched:1 activity:1 quarter:1 bodes:1 first:1
stock_PFE r_up	program:1 own:1 behavior:1 investors:1 hint:1 executive:2 some:1 soon:1 trade:2 down:1 pushed:1 session:2 including:1 higher:1 have:1 cancel:1 recover:3 violates:2 market:1 brush:1 while:1 easing:2 bottles:2 pharma:1 would:1 also:1 aside:1 make:2 able:1 bad:1 shares:2 next:1 makers:1 their:2 because:1 future:1 complaints:1 treatment:1 expected:2 firms:1 has:1 easier:2 stock:1 begin:1 's:4 buckling:1 payouts:3 rules:2 big:1 pressure:1 recalled:1 pay-for-performance:1 quantitative:1 report:1 ethics:2 wound:1 investor:1 massive:1 biggest:1 level:1 --:1 should:1 taking:1 futures:1 companies:4 drug:1 compensation:2 actively:2 stopped:1 payments:1 policies:2 revising:2 executives:1 its:1 could:1 otherwise:2
stock_PFE r_down	pharmaceutical:1 healthy:1 cells:2 after:1 focus:1 drug:1 leaving:1 tumor:1 while:1 agents:1 which:1 coming:1 alone:1 years:1 into:1 market:1 research:1
stock_PFE r_up	among:1 money:2 rest:1 four:1 put:2 expect:1 have:1 year:1 your:2 best:1 giving:1 interviews:1 their:1 asking:1 market:2 2013:1 2012:1 them:1 gains:1 advice:1 forecasts:1 ranked:1 know:2 they:1 not:1 strategists:1 now:2 they’re:1 light:1 clients:1 modified:1 original:1 forecasters:3
stock_PFE r_down	firm:1 sending:1 driving:1 49:2 drugs:1 could:1 profit:1 deliver:1 shares:1 next:1 four:1 healthy:1 growth:1 year:1 higher:1
stock_PFE r_up	league:1 winner:1 had:1 table:1 surprise:1 quarter:1 first:1
stock_PFE r_up	purchases:1 news:2 bank:1 its:2 intraday:1 slow:1 monthly:1 fears:1 should:1 central:1 meeting:2 500:1 higher:1 's:2 around:2 highs:2 after:1 early:1 quell:1 last:1 stocks:3 day:2 lifting:1 roundup:2 venture-capital:2 bar:1 third:2 always:1 up:2 analysis:2 record:3 release:1 climb:1 minutes:2 bond:1
stock_PFE r_up	sharp:1 give:1 money:1 float:2 sales:2 experts:1 another:1 year:1 rally:2 decline:1 record:1 spending:1 less:1 other:1 events:1 after:1 gains:1 though:1 reporting:1 paid:1 records:2 doctors:1 report:1 improved:1 stocks:4 day:1 last:1 showed:1 double-digit:1 presentations:1 dinners:1 tech:1 payments:1 retailers:3 reduced:1
stock_PFE r_down	firm:1 cut:1 organic:1 revenue:1 anticipated:1 budgets:1 reported:1 growth:1 advertising:2 sharply:1 were:1 lower-than-expected:1 more:1 quarter:1 than:1 first:1
stock_PFE r_up	sell:1 said:1 's:1 third:1 business:1 antitrust:1 competitive:1 commission:1 maintain:1 formula:1 party:1 proposal:1 accepted:1 conditions:1 market:1
stock_PFE r_down	profitable:1 says:1 goods:1 's:1 gangs:1 illegal:1 mainly:1 drug:1 have:1 report:1 become:1 criminal:1
stock_PFE r_down	billion:1 1.5:3 filing:1 would:1 $:3 offering:1 since:1 initial:1 up:1 expects:1 debut:1 public:1 according:1 largest:1 regulatory:1 its:1 raise:1
stock_PFE r_down	among:1 managers:1 money:1 energy:1 financial:1 including:1 shares:1 have:2 year:1 rally:1 poll:1 market:1 lead:1 bullishness:1 been:2 concerns:1 policy:1 laggards:1 's:2 shows:1 led:1 gains:1 mess:1 utilities:1 levels:1 defensive:1 despite:1 such:1 cyclical:1 staples:1 sectors:1 16,000:2 record:1 while:1 materials:1 economy:1 consumer:1 latest:1
stock_PFE r_up	deal:1 over:2 capitalists:1 one:1 defense:1 partner:1 unusual:1 three:1 $:1 two:1 next:1 start:1 firms:1 several:1 stalwart:1 worth:1 firm:1 lawyers:1 million:1 most:1 years:1 decades:1 country:1 up:1 leaving:1 accomplished:1 drug-discovery:1 venture:1 product-liability:1
stock_PFE r_down	drugs:1 decline:1 patent:1 first-quarter:1 formerly:1 loss:1 profit:1 45:1 sales:1 heart:1 reported:1 protection:1 nearly:1 pressure:1 continued:1
stock_PFE r_down	sector:1 trade:1 session:1 hepatitis:1 cold:1 provision:1 $:1 rose:2 expectations:1 late:1 premarket:1 herald:1 string:1 far:1 income:1 nation:1 they:1 not:1 now:1 multiple:1 companies:2 taxes:1 large:1 benefit:1 right:1 some:2 actively:1 trading:1 begun:1 year:1 first-quarter:1 even:1 index:1 profit:2 since:1 projected:1 shares:1 everything:1 new:2 go-go:1 run:1 reaching:1 quite:1 reported:1 although:1 regulatory:1 manufacturer:1 ahead:1 healthy:1 industry:1 annual:1 days:1 times:1 analysts:1 think:1 revenue:2 home-building:2 1990s:1 market:1 question:1 due:1 next:1 clinical:1 6:1 expected:1 bubble:1 drugs:1 company:1 but:1 bull:1 surged:1 second-quarter:1 whether:1 successes:1 could:1 biotech:1 30:1 helped:1 all-time:1 say:1 have:1 seen:1 blockbuster:1 bolstered:1 43:1 equipment:1 earnings:1 largest:1 's:5 highs:1 closings:1 fell:1 stocks:1 fiscal:1 sclerosis:1
stock_PFE r_up	global:1 cheap:1 focus:1 trade:1 discovered:1 manager:1 session:1 innovative:1 talks:1 its:1 excludes:1 group:1 $:1 sodium:1 merger:1 3:1 should:1 source:1 investigational:1 treatment:2 premarket:1 policy:1 struck:1 has:1 earnings:1 between:1 anticipated:1 therapy:1 they:1 half:1 own:1 countries:1 --:4 companies:4 6.4:1 stopped:1 injectable:1 noted:1 replacement:1 week:1 tougher:1 past:1 actively:1 trading:1 year:2 close:1 said:1 marketed:1 shares:2 include:1 outside:1 scientists:1 firms:2 conditions:1 we:2 eating:1 payroll:1 notable:1 agreement:2 regulators:1 leadership:1 approval:1 come:1 21:1 received:1 months:1 drug:1 long-term:1 already:1 revenue:1 into:1 down:1 names:1 news:1 there:1 two:1 their:1 2:3 lot:1 expected:3 recent:1 meeting:1 500:1 glucose:1 ``:1 both:1 season:1 company:1 slump:1 known:2 believe:1 than:2 12:1 look:1 up:1 economic:1 can:1 were:2 merits:1 inhibitor:2 care:1 adults:1 0.3:1 sales:1 general:1 '':1 say:1 have:1 ready:1 partner:1 market-moving:1 trials:1 write:1 also:1 potential:1 build:1 insurers:1 shrink:1 stock:1 development:1 begin:1 continues:1 's:11 reportedly:1 collaboration:2 earlier:1 most:1 president:1 stocks:1 data:1 approved:1 diabetes:2 later:1 disease:1 more:1 media:1 position:1 oral:1
stock_PFE r_down	saying:1 unemployment:1 money:1 alternatives:1 results:1 quarters:1 report:1 session:1 high-profile:1 its:4 pause:2 $:1 zone:1 surprises:2 writes:1 charge:1 advisories:2 attractive:1 contrary:1 tax:1 2016:2 split:1 gains:2 rise:1 watch:2 facing:1 longest:1 reforms:1 trade:1 now:1 day:1 announcing:1 lost:1 stimulus:1 companies:4 yield:1 leave:1 underlying:1 cholesterol:2 money-market:1 higher:1 fare:1 see:1 actively:1 trading:1 changes:1 year:1 's:4 best:1 concern:1 index:1 treasurers:1 broad:1 section:1 since:2 shares:2 tend:1 dividends:1 new:2 boost:1 kicked:1 led:1 slight:1 a.m:2 sold:1 monetary:1 reported:1 complicate:1 weaker-than-expected:1 latest:1 losing:1 dividend:2 roundup:1 hits:3 hunting:1 could:2 drug:5 place:1 action:1 star:1 maker:2 among:3 outlook:1 revenue:1 win:1 billions:1 replace:1 down:1 conventional:1 would:2 their:2 monthly:1 fluctuate:1 few:1 offers:1 taken:1 500:8 more:1 flat:2 eyes:1 hug:1 posting:1 funds:2 company:1 tally:2 but:1 wisdom:1 expected:1 economic:1 lowered:1 prices:1 off:1 line:1 highest:1 valuation:1 analyst:1 those:1 disappointing:1 13:1 has:2 behemoth:1 value:1 n't:2 record:4 future:1 ongoing:1 today:1 3.2:1 gives:1 dollars:1 something:1 streak:1 liabilities:1 investors:2 almost:1 share:1 sales:2 biggest:1 high:2 full-year:1 timer:1 have:2 rally:1 accounting:1 technology:1 no:1 patent:1 pay:1 make:1 struggles:1 potential:2 earnings:5 which:1 9:1 stock:1 week:1 first-quarter:2 closes:1 after:3 yesterday:1 fell:1 stocks:5 data:4 billion:1 fighter:1 assets:1 amid:3 futures:4 daily:1 finds:1 reports:2 cheer:1 payers:1 2009:1 corporate:2 once:1
stock_PFE r_down	help:1 appetite:1 issuer:1 20:1 $:4 had:1 only:1 book:1 weeks:1 gains:2 lost:1 morning:1 slide:1 bond:1 deal:3 some:1 competition:1 fold:1 year:1 close:1 52:1 declined:1 closer:1 index:2 said:1 profit:1 away:2 afloat:1 shares:1 bln:2 international:1 told:1 led:1 protection:1 debt:4 intense:1 patent:1 last:2 movers:2 foreign:1 maker:1 into:2 number:1 corporate-bond:1 brought:1 rising:1 names:1 pharmaceutical:1 8.3:1 long:1 few:1 markets:1 500:2 more:1 selling:1 offering:3 but:2 priced:1 demand:1 10:1 17:3 record:3 can:1 history:1 investors:2 almost:1 sales:1 have:2 seen:1 rally:2 technology:1 totaled:1 generic:1 also:1 setting:1 which:1 largest:2 inch:1 sin:2 's:3 yesterday:1 helping:1 most:1 fell:1 coming:1 stocks:1 recent:1 billion:2 kept:1 amid:1 sale:1 person:2 reputation:1 overseas:1 corporate:1 order:1 usual:1
stock_PFE r_down	into:1 humans:1 converts:1 year:1 seen:1 initial:1 next:1 other:1 pets:1 2014:2 presentation:1 dogs:1 offering:1 drugs:1 funds:1 company:1 treatments:1 possible:1 investor:1 raising:1 ahead:1 according:1 public:1 cats:1
stock_PFE r_up	already:1 help:1 up:3 past:1 brain:1 second:1 through:1 15000:3 cruising:1 its:1 market:1 again:1 said:1 system:1 disorders:1 failed:1 ordering:1 sale:1 three:1 research:1 immune:1 clinical:1 treat:1 online:2 medicine:1 widespread:1 has:1 setting:1 today:1 counterfeits:1 's:6 risen:1 time:1 erectile:1 effort:1 must:1 days:1 16:1 counter:1 disease:1 pill:1 trial:1 patients:1 disappointment:1 each:1 late-stage:1 antibody:1 latest:1
stock_PFE r_up	thwart:1 significantly:1 painkiller:1 powerful:1 trade:1 session:2 weekly:2 jumped:1 shares:1 better:1 version:1 expected:1 new:1 previous:1 's:1 gains:3 extend:1 earlier:1 abuse:1 stocks:1 than:1 ruled:1 digits:1 versions:1 movers:2 double:1 companies:1 drug:1 n't:2 --:2 actively:1 does:1 notch:2 quartet:1
stock_PFE r_up	emerging:1 cancer:1 give:1 almost:1 anyway:1 evidence:1 cold:1 provided:1 medications:1 over-the-counter:1 system:1 immune:1 safety:1 sick:1 parents:1 warnings:1 toddlers:1 half:1 not:1 using:1 cough:1 harnessing:1 recent:1 products:1 weapon:1 early-stage:1 against:1 survey:1 studies:1
stock_PFE r_down	enter:1 heated:1 battle:1 considering:1 few:1 their:1 has:1 we:1 around:1 generic-drug:1 company:1 after:1 early:1 approaches:1 takeover:1 reading:1 they:1 fray:1 made:1 whether:1 rebuffed:1 while:1 stories:1 evaluating:1 were:1 options:1
stock_PFE r_down	hone:1 shed:1 's:1 plans:1 drugs:1 humans:1 company:1 stake:1 continuing:1 focus:1 vaccines:1 majority:1 animal-health:1 efforts:1 its:3
stock_PFE r_down	firm:1 private-equity:1 raised:1 sell:1 generic-drug:1 deal:1 billion:1 estimates:1 nearing:1 owned:1 spinoff:1 itself:1 through:1 which:1 9:1 2017:1 maker:1 $:1
stock_PFE r_down	prospect:1 purchases:1 via:1 financial:1 have:1 move:1 reduce:1 one:1 rising:1 begun:1 home:1 its:2 monthly:1 support:1 largest:1 markets:2 's:1 plans:1 may:1 effect:1 nation:1 react:1 regular:1 borrowers:1 headquarters:1 yields:1 feeling:1 builders:1 bond:2
stock_PFE r_down	considering:1 billion:1 selling:1 's:1 venture:1 deal:1 joint:1 billionaire:1 company:1 1.8:1 up:1 contract:1 fetch:1 their:1 holding:1 manufacturing:1 could:1 $:1
stock_PFE r_up	biotech:1 oncology:1 because:1 hoping:1 office:2 certain:1 into:1 preliminary:1 tax:1 ``:2 evidence:1 '':2 substantial:1 year:1 go:1 improvement:1 market:1 overhaul:1 cancer:2 suggests:1 breakthroughs:1 agency:1 been:1 should:1 clinical:1 helps:2 which:1 transformative:1 has:1 development:1 eyes:1 's:1 diseases:1 mull:1 drugs:2 billionaire:1 safe:1 took:1 lab:1 effect:1 host:1 important:1 decide:1 new:1 based:1 law:1 spur:1 treating:1 breakthrough:1 appeal:1 last:1 effective:1 --:1 could:1 companies:1 sale:1 drug:2 loses:1 whether:1 products:1 serious:1 head:1 experimental:1 view:1
stock_PFE r_down	evidence:1 give:1 certain:1 others:1 tax:1 slowing:1 disease:1 '':1 substantial:1 businesses:1 have:1 signs:1 beyond:1 based:1 impact:1 some:1 designates:1 group:2 broad:1 breakthroughs:1 42:1 while:1 improvement:1 current:1 may:1 clinical:1 new:1 boost:1 multinational:1 ``:1 's:1 diseases:1 offer:1 drugs:3 big:1 showing:1 designated:1 treatments:1 prolonged:1 lives:1 preliminary:1 hopes:1 overhaul:1 years:1 effort:1 why:1 raising:1 treating:1 both:1 announcing:1 could:2 uncertainty:1 companies:2 coalition:1 drug:1 n't:1 suggests:1 patients:1 so:1 push:1 serious:1 works:1
stock_PFE r_down	diagnoses:1 eating:1 look:2 lead:1 profit:2 companies:3 opportunities:1 may:1 drug:1 new:1
stock_PFE r_up	deal:1 combination:1 reasons:1 potent:1 years:1 n't:2 alone:1 can:1 time:1 go:1 making:1 find:1 first:1
stock_PFE r_up	talked:1 low-cost:1 over:1 long-running:1 competition:1 charges:1 agreed:1 64:1 have:1 sought:1 reached:2 throughout:1 makers:1 before:2 total:1 $:10 touts:2 generic:5 expired:2 copies:1 launches:2 proceeds:1 settlement:3 their:2 turnaround:3 details:1 suit:1 2.15:10 branded:1 heartburn:2 dispute:1 company’s:1 selling:1 's:2 gains:1 generic-drug:1 get:1 patent-infringement:4 sold:1 after:1 related:1 background:1 resolves:1 effort:1 billion:4 patent:3 lost:1 movers:2 damages:3 up:3 drug:2 --:6 compensation:1 pay:2 profits:1 updates:1
stock_PFE r_up	some:1 sales:1 bribery:1 have:1 tipster:1 reached:1 settlement:1 its:1 patent-infringement:1 staff:1 $:1 generic:1 their:1 damages:1 2.15:1 drugs:1 allegations:1 prescribe:1 uses:1 anonymous:1 doctors:1 cases:1 widespread:1 billion:1 unauthorized:1 involved:1 launches:1 investigating:1
stock_PFE r_up	outlook:1 can:1 series:1 agreed:1 some:1 1.6:1 related:1 trade:3 four:2 case:1 session:3 stops:1 throughout:1 cites:1 setbacks:1 terminated:2 functions:1 said:1 $:1 pay:1 had:2 negative:1 shares:3 research:1 better:1 other:1 clinical:2 basic:1 treatment:1 mid-stage:1 which:1 expected:3 new:1 setback:1 has:1 details:1 memory:1 tests:4 settle:1 's:18 halt:1 generic-drug:1 patent-infringement:1 after:3 lowered:1 therapy:1 liver:4 background:1 believe:1 stable:1 elderly:1 manufacturer:1 billion:1 reverse:1 --:3 study:1 hunt:2 companies:4 disease:3 drug:6 maker:1 n't:1 trial:2 patients:3 actively:3 does:1 action:1 its:1 industry:1 experimental:2 latest:1
stock_PFE r_up	trade:1 actively:3 trading:4 opportunities:1 index:2 jumped:2 explain:1 shares:3 41:1 points:6 way:1 under:1 expected:1 markets:1 2013:2 higher:2 added:2 's:7 highlight:1 stocks:2 appears:1 change:1 38:1 16:2 --:2 climbed:2 companies:3 session:3 risks:1 were:2 experts:1
stock_PFE r_down	's:1 deal:1 supply:1 transfer:1 company:1 disease:1 therapy:1 treatment:1 reached:1 technology:1 arm:1 replacement:1
stock_PFE r_down	explain:1 opportunities:1 experts:1 risks:1 way:1 under:1 highlight:1 markets:1 appears:1 change:1
